|
Tuesday, November 15, 2022
Print Entire 2022 Program:
 |
|
| SESSION 1 SCHEDULE | |
|
Tuesday
SESSION 1:
PROGRESS IN CORONARY ARTERY STENTING, TRANSCATHETER VALVE REPLACEMENT, AND TREATMENT OF ASCENDING AORTIC DISEASE
Moderators:Hazim J. Safi, MD / Roxana Mehran, MD
|
|
| x | |
| 6:45 AM - 6:50 AM | Opening Remarks |
| Presenter(s):Frank J. Veith, MD | |
| View Slides in PDF | |
| CORONARY STENTS | |
| 6:50 AM - 6:55 AM | What Is New In Coronary Artery Stenting: How Good Are New Drug Eluting Stents: Is There A Role For Bare Metal Stents |
| Presenter(s):Martin B. Leon, MD | |
| View Slides in PDF | |
| 6:56 AM - 7:01 AM | Left Main PCI With Drug-Eluting Stents Versus CABG: Clinical Trial Synthesis And Take-Home Messages |
| Presenter(s):Gregg W. Stone, MD | |
| View Slides in PDF | |
| TRANSCATHETER HEART VALVES | |
| 7:02 AM - 7:07 AM | Update On Status Of Transcatheter Mitral Valve Replacement/Repair (TMVR) |
| Presenter(s):Juan F. Granada, MD | |
| View Slides in PDF | |
| 7:08 AM - 7:13 AM | DEBATE: Update On Transcatheter Aortic Valve Replacement (TAVR): A Cardiologist’s View |
| Presenter(s):Martin B. Leon, MD | |
| View Slides in PDF | |
| 7:14 AM - 7:19 AM | DEBATE: Update On Current State Of TAVR: A Cardiac Surgeon’s View: What Is The Role Of Surgery In Aortic Valve Disease Treatment And How To Avoid The Need For Alternative Access Sites |
| Presenter(s):Ali B. Khoynezhad, MD, PhD | |
| View Slides in PDF | |
| THE ASCENDING AORTA | |
| 7:20 AM - 7:25 AM | Progress In Endovascular Graft Treatment Of Ascending Aortic Lesions: What Is The Status Of IDEs And Industry Made Graft |
| Presenter(s):Rodney A. White, MD | |
| View Slides in PDF | |
| 7:26 AM - 7:31 AM | Progress In Endovascular Combined Devices For Repairing Lesions Of The Ascending Aorta And The Aortic Valve: The Endo-Bentall Concept |
| Presenter(s):Ali B. Khoynezhad, MD, PhD | |
| View Slides in PDF | |
| 7:32 AM - 7:37 AM | Endo-Bentall Using A Rendezvous-Access: Why A Combined Transfemoral/Transapical Access Is The Way To Go: How To Do It And Results |
| Presenter(s):Tilo Koelbel, MD, PhD | |
| View Slides in PDF | |
| 7:38 AM - 7:43 AM | Endovascular Treatment Of Type A Aortic Dissections (TAADs) In 2022: What Is Here And What Is Coming |
| Presenter(s):Ali Azizzadeh, MD | |
| View Slides in PDF | |
| 7:44 AM - 7:50 AM | Panel Discussion |
| END OF SESSION 1 | |
| SESSION 2 SCHEDULE | |
|
Tuesday
SESSION 2:
PROGRESS IN THE TREATMENT OF AORTIC ARCH LESIONS AND AORTIC DISSECTIONS
Moderators:Alan B. Lumsden, MD, FACS / Anthony L. Estrera, MD
|
|
| x | |
| 7:50 AM - 7:55 AM | Hybrid Repair Of Aortic Arch And Thoracic Aortic Aneurysms Using ThoraFlex (Hybrid) And Relay Devices For Frozen Elephant Trunk (FET) And TEVAR: Indications And Results |
| Presenter(s):Ourania Preventza, MD / Joseph S. Coselli, MD | |
| View Slides in PDF | |
| 7:56 AM - 8:01 AM | Current Status Of Hybrid Arch Repair With Elephant Trunk And FET: What Does The Future Hold And How Often Are Secondary Procedures Required |
| Presenter(s):Anthony L. Estrera, MD | |
| View Slides in PDF | |
| 8:02 AM - 8:07 AM | Update On Endovascular Arch Repair With Cook 2- Or 3-Branched Device For Lesions Involving The Entire Aortic: Indications, Results And Can It Be Combined With An Endo-Bentall: When Is Open Repair The Best Treatment |
| Presenter(s):Stephan Haulon, MD | |
| View Slides in PDF | |
| 8:08 AM - 8:13 AM | Comparison Of Early And Mid-Term Results With 2-Branched Endograft (Relay – Terumo Aortic) And Single Branched Device (Nexus – Endospan) For Treatment Of Zone 0 Arch Lesions |
| Presenter(s):Toru Kuratani, MD, PhD | |
| View Slides in PDF | |
| 8:14 AM - 8:19 AM | Update On Relay Branch For Arch Lesion Endovascular Repairs: Advantages, Limitations And Results |
| Presenter(s):Vicente Riambau, MD, PhD / Ciro Ferrer, MD, PhD / Martin Czerny, MD | |
| View Slides in PDF | |
| 8:20 AM - 8:25 AM Power Point Presentation with Synched Audio |
Direction-Turnover Technique For Endovascular Repair Of Aortic Arch Lesions With Branched Or In Vitro Fenestrated Endografts |
| Presenter(s):Qingsheng Lu, MD / Zaiping Jing, MD | |
| View Slides in PDF | |
| 8:26 AM - 8:31 AM | Total And Partial Aortic Arch Lesion Repairs With The Gore TAG Single Branch Endograft: An Off-The-Shelf (OTS) Device For Revascularizing Arch Branches: Experience To Date, Advantages And Limitations |
| Presenter(s):Michael D. Dake, MD / Himanshu Patel, MD | |
| View Slides in PDF | |
| 8:32 AM - 8:37 AM | How Best To Treat TBADs Extending Into The Arch Or Ascending Aorta; When Open, When Endo, When Hybrid |
| Presenter(s):I-Hui Wu, MD, PhD | |
| View Slides in PDF | |
| 8:38 AM - 8:43 AM Power Point Presentation with Synched Audio |
How To Prevent Complications During Partial Or Total Endovascular Aortic Arch Repairs: Value Of Special Radiopaque Markers |
| Presenter(s):Chang Shu, MD | |
| View Slides in PDF | |
| 8:44 AM - 8:49 AM | How Best To Treat Aortic Arch Lesions: Customized Versus Chimney Versus Physician Modified Endografts: When Open: Role Of Each |
| Presenter(s):Nicola Mangialardi, MD | |
| View Slides in PDF | |
| 8:50 AM - 8:55 AM | Value Of Ascending Aortic Banding As Primary Or Adjunctive Treatment For Aortic Arch Lesions |
| Presenter(s):Chun Che Shih, MD, PhD | |
| View Slides in PDF | |
| 8:56 AM - 9:02 AM | Panel Discussion |
| END OF SESSION 2 | |
| SESSION 3 SCHEDULE | |
|
Tuesday
SESSION 3:
PROGRESS IN THE ENDOVASCULAR TREATMENT OF AORTIC DISSECTIONS: REPORTING STANDARDS, CLASSIFICATION SYSTEMS, STABILISE, AND MORE
Moderators:Joseph V. Lombardi, MD, MBA / Michael D. Dake, MD
|
|
| x | |
| 9:02 AM - 9:07 AM | New SVS-STS Aortic Dissection Reporting Standards And Classification System: How Do They Help In Determining Precisely High Risk TBAD Patients |
| Presenter(s):Joseph V. Lombardi, MD, MBA | |
| View Slides in PDF | |
| 9:08 AM - 9:13 AM | The TEM Aortic Dissection Classification System: What Is It And How Does It Improve Clinical Practice |
| Presenter(s):Martin Czerny, MD | |
| View Slides in PDF | |
| 9:14 AM - 9:19 AM Power Point Presentation with Synched Audio |
Current Advances And Trends In TEVAR Treatment For Type B Aortic Dissection In China: More Or Less Liberal Use; More Or Less Aortic Coverage; What Adjunctive Procedures Are Used More |
| Presenter(s):Weiguo Fu, MD | |
| View Slides in PDF | |
| 9:20 AM - 9:25 AM | Update On The STABILISE Concept For Treating Acute And Chronic TBADs By Disrupting The Intimal Flap By Overdilating The Distal Bare Stent: How It Works, Precautions, And Should It Be The Treatment Of Choice |
| Presenter(s):Jean-Marc Alsac, MD, PhD | |
| View Slides in PDF | |
| 9:26 AM - 9:31 AM | Considerations For Parallel Endografts In The Management Of Arch Vessels In Very Proximal Type B Aortic Dissections |
| Presenter(s):David J. Minion, MD | |
| View Slides in PDF | |
| 9:32 AM - 9:37 AM | Dual Lumen Interventions To Promote False Lumen Thrombosis In Chronic Aortic Dissections: The FLIRT Procedure: Indications, Technique And Results |
| Presenter(s):Christoph A. Nienaber, MD, PhD | |
| View Slides in PDF | |
| 9:38 AM - 9:43 AM | There Will Always Be A Need For Open Repair For Post-Dissection TAAAs: In What Circumstances |
| Presenter(s):Hazim J. Safi, MD / Anthony L. Estrera, MD | |
| View Slides in PDF | |
| 9:44 AM - 9:49 AM | Distal Stent-Graft Induced New Re-Entry Tears (SINEs) With TEVAR Treatment Of TBADs: Prevention By Avoiding Oversizing And Ballooning And Using Tapered Endografts |
| Presenter(s):Ludovic Canaud, MD, PhD | |
| View Slides in PDF | |
| 9:50 AM - 9:55 AM | The Impact Of Distal Stent-Graft Induced New Entry Tears On Aortic Remodeling Of Chronic TBADs: How To Prevent And Treat Them |
| Presenter(s):Chun Che Shih, MD, PhD | |
| View Slides in PDF | |
| 9:56 AM - 10:01 AM | Highlights From The New AHA, ACC, AATS, SVS, ACR, STS, SVM, SCAI, SCA Aortic Disease Guidelines |
| Presenter(s):James H. Black, III, MD | |
| View Slides in PDF | |
| 10:02 AM - 10:07 AM | The Global Experience With Endovascular Aortic Repair In >200 Patients With Connective Tissue Disease: Is There A Role |
| Presenter(s):Anders Wanhainen, MD, PhD | |
| View Slides in PDF | |
| 10:08 AM - 10:14 AM | Panel Discussion |
| 10:14 AM - 10:24 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 3 | |
| SESSION 4 SCHEDULE | |
|
Tuesday
SESSION 4:
MORE NEW DEVELOPMENTS IN THE TREATMENT OF TBADs, THORACIC AORTIC DISEASE AND THORACOABDOMINAL ANEURYSMS (TAAAs)
Moderators:Hazim J. Safi, MD / Ali B. Khoynezhad, MD, PhD
|
|
| x | |
| 10:24 AM - 10:29 AM | Long-Term Durability Of Open Repair Of Type I-IV TAAAs Remains Excellent: When Should It Be The First Line Treatment And When Should A Hybrid (Endo + Open) Down-Staging Approach Be Used To Improve Outcomes: How To Do The Latter |
| Presenter(s):Mark Conrad, MD, MMSc / Richard P. Cambria, MD | |
| View Slides in PDF | |
| 10:30 AM - 10:35 AM | New Strategies And Indications For Open TAAA Repair Including Failed EVAR And F/B/EVAR: Technical Tips And Results |
| Presenter(s):Andrea Kahlberg, MD / Roberto L.V. Chiesa, MD / Germano Melissano, MD | |
| View Slides in PDF | |
| 10:36 AM - 10:41 AM | Aortic Arch Repairs With Frozen Elephant Trunk (FET) Followed By Open Or Endo Extensions For TAAA Repairs: Techniques And Outcomes; Importance Of Staging |
| Presenter(s):Michael J. Jacobs, MD | |
| View Slides in PDF | |
| 10:42 AM - 10:47 AM | Lessons Learned From The STABLE I And II Trials: What Are The Short And Long-Term Benefits And Limitations Of A Distal Bare Stent Combined With A Proximal Covered Stent: The Petticoat Procedure |
| Presenter(s):Joseph V. Lombardi, MD, MBA | |
| View Slides in PDF | |
| 10:48 AM - 10:53 AM | Changing Current Trends In Management And Outcomes With Acute TBADs: Based On 3000 Patients In The IRAD Registry Over 25 Years: What Is Helping And What Is Not |
| Presenter(s):Santi Trimarchi, MD, PhD | |
| View Slides in PDF | |
| 10:54 AM - 10:59 AM | Why Is F/B/EVAR The Best Treatment For Post TBAD TAAAs: Challenges And Results From A 10-Year Experience |
| Presenter(s):Eric L.G. Verhoeven, MD, PhD / Athanasios Katsargyris, MD | |
| View Slides in PDF | |
| 11:00 AM - 11:05 AM | Roles Of Inner And Outer Branched Endografts And The t-Branch OTS Device (Cook) To Treat TAAAs After TBADs: Technical Tips And Results |
| Presenter(s):Marcelo Ferreira, MD | |
| View Slides in PDF | |
| 11:06 AM - 11:12 AM | Panel Discussion |
| 11:12 AM - 11:17 AM | Gore TAMBE Endovascular Graft Device For TAAA Repair: How Does It Work: Advantages And Limitations |
| Presenter(s):Michel Makaroun, MD / Mark A. Farber, MD | |
| View Slides in PDF | |
| 11:18 AM - 11:23 AM | Unitary Manifold Endograft System For Complex Type 4 TAAAs, Aneurysms With Chronic TBADs, Ruptured Complex AAAs And Failed Prior EVAR Repairs: How Does It Work And Up To 9-Year Results |
| Presenter(s):Patrick W. Kelly, MD | |
| View Slides in PDF | |
| 11:24 AM - 11:29 AM | Type A Aortic Dissection With Malperfusion: When Should TEVAR Be The First Order Of Business Before Fixing The Ascending Aorta: Where Should The TEVAR Be Placed And What Are The Advantages And Dangers |
| Presenter(s):Firas F. Mussa, MD | |
| View Slides in PDF | |
| 11:30 AM - 11:35 AM | Improved Aortic Remodeling With TEVAR And A Distal Bare Metal Stent In Acute Complicated TBAD |
| Presenter(s):Christoph A. Nienaber, MD, PhD | |
| View Slides in PDF | |
| 11:36 AM - 11:41 AM | Embolization And Other Strategies To Achieve Complete False Lumen Exclusion With Endovascular Repair Of Dissecting Aneurysms With TAAAs |
| Presenter(s):Carlos H. Timaran, MD | |
| View Slides in PDF | |
| 11:42 AM - 11:47 AM | Varying Solutions To Treat Type 1 Endoleaks After TEVAR And EVAR |
| Presenter(s):Nicola Mangialardi, MD | |
| View Slides in PDF | |
| 11:48 AM - 11:53 AM | High Failure Rate Of Best Medical Treatment For Intramural Hematoma Mandates Increased Use Of TEVAR: Does This Help Outcomes |
| Presenter(s):Jean M. Panneton, MD | |
| View Slides in PDF | |
| 11:54 AM - 12:00 PM | Panel Discussion |
| 12:00 PM - 1:00 PM | Lunch Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 4 | |
| SESSION 5 SCHEDULE | |
|
Tuesday
SESSION 5:
NEW DEVELOPMENTS IN ABDOMINAL AORTIC ANEURYSM (AAA) ETIOLOGY AND TREATMENT, EVAR AND EVAS (ENDOVASCULAR ANEURYSM SEALING) (5 And 4 ¾-MINUTE [SS] TALKS)
Moderators:Ronald L. Dalman, MD / Grace J. Wang, MD, MSCE
|
|
| x | |
| 1:00 PM - 1:05 PM | Current Pros And Cons Of The Nellix EVAS Endograft For AAA Repair: Latest Update Of The EVAS 2 IDE Trial Of The Modified Improved Nellix Endograft With 2-Year Results: Why Is Mid-Term Mortality Better With EVAS Than EVAR |
| Presenter(s):Marc L. Schermerhorn, MD / Jeffrey P. Carpenter, MD | |
| View Slides in PDF | |
| 1:06 PM - 1:11 PM | What Is The Best Type Of Evidence To Evaluate The Relative Value Of EVAR Versus Open Repair: RCTs May Not Reflect Reality As Well As Other Methods: The NICE Guidelines Prove It |
| Presenter(s):Matt M. Thompson, MD | |
| View Slides in PDF | |
| 1:12 PM - 1:17 PM | Failing EVARs Are An Enlarging Epidemic: Etiology And How Best To Avoid And Treat The Problem |
| Presenter(s):Murray L. Shames, MD | |
| View Slides in PDF | |
| 1:18 PM - 1:23 PM | Diabetes And AAAs: Facts, Clues And Potential Treatment Opportunities |
| Presenter(s):Ronald L. Dalman, MD | |
| View Slides in PDF | |
| 1:24 PM - 1:29 PM | [SS] Further Thoughts About The Odd Relationship Between Diabetes And AAA Disease: How Should It Influence Treatment |
| Presenter(s):Christos D. Liapis, MD | |
| View Slides in PDF | |
| 1:29 PM - 1:34 PM | [SS] How Does Metformin Work To Slow AAA Growth At The Cellular Level: Could It Be Effective Treatment For Small AAAs: Is It The Reason For Decreased AAA Incidence In Diabetics |
| Presenter(s):Kak Khee Yeung, MD, PhD | |
| View Slides in PDF | |
| 1:34 PM - 1:39 PM | [SS] The Metformin For AAA Growth Inhibition (MAAGI) Multicenter Trial: Design And 3-Year Results |
| Presenter(s):Anders Wanhainen, MD, PhD | |
| View Slides in PDF | |
| 1:39 PM - 1:46 PM | Panel Discussion |
| Moderator(s): Michel Makaroun, MD / Caron B. Rockman, MD | |
| 1:46 PM - 1:51 PM | Evolved Treatment Algorithm For Aortic Graft Infections Endo And Open: Lessons Learned From A Large Tertiary Experience |
| Presenter(s):Martin R. Back, MD | |
| View Slides in PDF | |
| 1:52 PM - 1:57 PM | Decreased AAA Sac Diameter After EVAR Is Associated With Good Outcomes While Sac Stability Is Not |
| Presenter(s):Andres Schanzer, MD | |
| View Slides in PDF | |
| 1:57 PM - 2:02 PM | Sac Dynamics After EVAR Influence Long-Term Survival: What Can Be Done To Improve AAA Sac Shrinkage: Can Filling The Sac With Polymer Plugs From Shape Memory Medical Promote Shrinkage: The AAA-SHAPE-NLD Study |
| Presenter(s):Michel M.P. Reijnen, MD, PhD / Andrew Holden, MBChB | |
| View Slides in PDF | |
| 2:03 PM - 2:08 PM | In Patients Suitable For EVAR Or Open Repair, Adverse Neck Anatomy (Short, Wide, Angulated) Is Associated With Increased Reintervention And Mortality Rates Equally After Open And Endo Repairs: From The DREAM RCT: How Should This Influence Treatment |
| Presenter(s):Jan D. Blankensteijn, MD | |
| View Slides in PDF | |
| 2:09 PM - 2:14 PM | How Best To Treat Iliac Aneurysms In 2022: When Endo; Open Repair Is Sometimes Essential: Technical Tips |
| Presenter(s):Heron E. Rodriguez, MD | |
| View Slides in PDF | |
| 2:15 PM - 2:20 PM | EVAR Surveillance Models Have Failed: How They Should Be Changed |
| Presenter(s):Ian Loftus, MD / Pete Holt, MD, PhD | |
| View Slides in PDF | |
| 2:21 PM - 2:26 PM | Which AAA Patients Should Get Open Repair (OR) In 2022: Young Healthy Patients With Large AAAs Do Better With OR: But EVAR Outcomes Are Improving While OR Outcomes Are Not |
| Presenter(s):Marc L. Schermerhorn, MD | |
| View Slides in PDF | |
| 2:27 PM - 2:40 PM | Panel Discussion And Break Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 5 | |
| SESSION 6 SCHEDULE | |
|
Tuesday
SESSION 6:
MORE ABOUT AAAs AND EVAR: UPDATES ON THE UK NICE AAA GUIDELINES AND SACCULAR AAAs
|
|
| x | |
| 2:40 PM - 2:45 PM | Are Key Points In The NICE Guidelines For Treatment Of AAAs Still Valid And Should They Be Applied And Used More Widely Or Less Widely |
| Presenter(s):Nicholas J.W. Cheshire, MD | |
| View Slides in PDF | |
| 2:46 PM - 2:51 PM | Review Of All AAA Guidelines: Do They Support Or Refute The NICE AAA Guidelines |
| Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh, F | |
| View Slides in PDF | |
| 2:52 PM - 2:57 PM Power Point Presentation with Synched Audio |
Why Are The NICE AAA Guidelines So Flawed: Has Bias Played A Role |
| Presenter(s):Frans L. Moll, MD, PhD | |
| View Slides in PDF | |
| 2:58 PM - 3:03 PM | Are The NICE AAA Guidelines The End Of EVAR In The UK: Why The Guidelines Are Wrong And Can They Be Fixed |
| Presenter(s):Michael P. Jenkins, MBBS, BSc, MS, FRCS, FEBVS | |
| View Slides in PDF | |
| 3:04 PM - 3:09 PM | Impact Of NICE AAA Draft And Final Guidelines On Complex AAA Endovascular Repair: Will They Be Good For Patients |
| Presenter(s):Tara M. Mastracci, MD | |
| View Slides in PDF | |
| 3:10 PM - 3:15 PM | What Has Been The Impact Of The UK NICE AAA Guidelines In Germany And Elsewhere – Despite Their Flaws |
| Presenter(s):Dittmar Boeckler, MD | |
| View Slides in PDF | |
| 3:16 PM - 3:21 PM | Long-Term Results Of The OVER RCT: Pertinence To NICE AAA Guidelines: How Operator Training And Experience Influence EVAR Outcomes |
| Presenter(s):Jon S. Matsumura, MD | |
| View Slides in PDF | |
| 3:22 PM - 3:27 PM | Why EVAR Is Not The Best Treatment For All AAAs – Especially In Young Patients (<70) With A Long Life Expectancy |
| Presenter(s):Fabio Verzini, MD, PhD, FEBVS | |
| View Slides in PDF | |
| 3:28 PM - 3:33 PM | Spontaneous Infrarenal Acute Aortic Syndrome: What Is It And How Should It Be Treated |
| Presenter(s):Felice Pecoraro, MD | |
| View Slides in PDF | |
| 3:34 PM - 3:39 PM Power Point Presentation with Synched Audio |
Should Saccular AAAs Be Fixed At A Smaller Diameter Than Fusiform AAAs: How Should Saccular AAA Diameter Be Measured: To Include The Normal Aorta Or Not |
| Presenter(s):Frans L. Moll, MD, PhD | |
| View Slides in PDF | |
| 3:40 PM - 3:45 PM | With Failed EVAR, When Is F/EVAR The Best Treatment: Tips And Tricks For Performing It Successfully |
| Presenter(s):Andres Schanzer, MD | |
| View Slides in PDF | |
| 3:46 PM - 3:56 PM | Panel Discussion |
| END OF SESSION 6 | |
| SESSION 7 SCHEDULE | |
|
Tuesday
SESSION 7:
MORE NEW DEVELOPMENTS IN THE TREATMENT OF AORTIC DISSECTIONS AND THORACIC PATHOLOGY; STROKE PREVENTION WITH TEVAR
Moderators:Mark A. Farber, MD / Manju Kalra, MBBS
|
|
| x | |
| 3:56 PM - 4:01 PM | Update On Prevention Of Gas Emboli And Stroke With TEVAR And Other Cardiovascular Interventions: Why It’s Such A Big Deal: What Is The STEP 2 Study Telling Us |
| Presenter(s):Tilo Koelbel, MD, PhD / Stephan Haulon, MD | |
| View Slides in PDF | |
| 4:02 PM - 4:07 PM | How Well Do Young/Old Patients Recover Mentally And Physically After Treatment For Type A And Type B Aortic Dissections: What Can Be Done To Improve This Recovery |
| Presenter(s):Richard G.J. Gibbs, FRCS | |
| View Slides in PDF | |
| 4:08 PM - 4:13 PM | Update On Value Of Embolic Brain Protection Devices For Proximal TEVAR And TAVR Procedures: When Are They Indicated And When Not |
| Presenter(s):Joseph V. Lombardi, MD, MBA / Jeffrey P. Carpenter, MD | |
| View Slides in PDF | |
| 4:14 PM - 4:19 PM | Physician Modified Double Fenestrated Stent-Grafts For Total Aortic Arch Repair: Results In 100 Patients: Advantages And Limitations |
| Presenter(s):Ludovic Canaud, MD, PhD | |
| View Slides in PDF | |
| 4:20 PM - 4:25 PM | Will More Oversizing Of Thoracic Endografts Prevent Bird Beaking And Type I Endoleaks With TEVAR In The Aortic Arch: Will Oversizing Cause Other Problems: What Is The Optimal Sizing In This Location |
| Presenter(s):Thomas L. Forbes, MD | |
| View Slides in PDF | |
| 4:26 PM - 4:31 PM | Natural History Of Aortic Intramural Hematomas (IMHs) And Predictors Of Need For TEVAR Treatment: Which IMH Patients Do Not Need TEVAR |
| Presenter(s):I-Hui Wu, MD, PhD | |
| View Slides in PDF | |
| 4:32 PM - 4:37 PM | How To Deal With An Uncontrolled And Enlarging False Lumen After TEVAR For TBADs |
| Presenter(s):Cherrie Z. Abraham, MD | |
| View Slides in PDF | |
| 4:38 PM - 4:43 PM | Long-Term (>5 Years) Good Results Of Valiant Captiva Endografts For TEVAR In TBAD Patients: Advantages And Disadvantages |
| Presenter(s):Joseph E. Bavaria, MD | |
| View Slides in PDF | |
| 4:44 PM - 4:49 PM | How To Treat Aortic Dissections With An Entry Tear In The Aortic Arch |
| Presenter(s):Santi Trimarchi, MD, PhD | |
| View Slides in PDF | |
| 4:50 PM - 4:56 PM | Panel Discussion |
| END OF SESSION 7 | |
| SESSION 8 SCHEDULE | |
|
Tuesday
SESSION 8:
MORE NEW DEVELOPMENTS REGARDING TBADs AND TEVAR: NATURAL HISTORY; NEED FOR AND TIMING OF TEVAR FOR ACUTE UNCOMPLICATED TBADs
Moderators:Joseph E. Bavaria, MD / Thomas L. Forbes, MD
|
|
| x | |
| 4:56 PM - 5:01 PM | Long-Term Outcomes Of Medically Managed Acute TBADs: How Were Patients Selected For This Treatment |
| Presenter(s):Thomas C. Bower, MD | |
| View Slides in PDF | |
| MEGA DEBATE ON TREATMENT OF ACUTE UNCOMPLICATED TBADs | |
| 5:02 PM - 5:07 PM | DEBATE: Many Uncomplicated Acute TBADs Never Need Invasive Interventions And Are Better Treated Medically; How To Select Such Patients |
| Presenter(s):Rachel E. Clough, PhD, FRCS | |
| View Slides in PDF | |
| 5:08 PM - 5:13 PM | DEBATE: With Uncomplicated Acute TBADs, The Case For Waiting 2-6 Weeks From Onset And Then Limiting Aortic Coverage With TEVAR |
| Presenter(s):Mark A. Farber, MD | |
| View Slides in PDF | |
| 5:14 PM - 5:19 PM | DEBATE: With Uncomplicated TBADs, The Case For Early TEVAR With Extensive Aortic Coverage In Most Patients |
| Presenter(s):William D. Jordan Jr., MD / Brad Leshnower, MD | |
| View Slides in PDF | |
| 5:20 PM - 5:25 PM | DEBATE: Early Intervention For Acute TBADs (7-30 Days After Onset) With TEVAR For Acute TBADs Prevents Abdominal Extension Of False Lumen And TAAA Formation |
| Presenter(s):Rodney A. White, MD | |
| View Slides in PDF | |
| 5:26 PM - 5:31 PM | Impact Of Timing On Outcomes After TEVAR For Acute Uncomplicated TBAD Patients: When Is Medical Treatment Indicated |
| Presenter(s):Ali Azizzadeh, MD | |
| View Slides in PDF | |
| 5:32 PM - 5:37 PM | Incidence And Importance Of Reinterventions Following F/B/EVAR: Are They A Marker Of Bad Care Or Good Care: From The Aortic Research Consortium (ARC) |
| Presenter(s):Sara L. Zettervall, MD / Benjamin W. Starnes, MD / Andres Schanzer, MD | |
| View Slides in PDF | |
| 5:38 PM - 5:43 PM | With TBADs Distal Fenestrations Are As Important As The Primary Tear: What Can And Should Be Done About Them |
| Presenter(s):Frank R. Arko, MD | |
| View Slides in PDF | |
| 5:44 PM - 5:49 PM | Techniques For And Advantages Of Rerouting A Misplaced TEVAR Which Is Leading To A Growing False Lumen And Malperfusion In Acute TBAD Patients |
| Presenter(s):David M. Williams, MD | |
| View Slides in PDF | |
| 5:50 PM - 5:55 PM | Re-Entry Specific Endovascular Therapy (RESET), i.e., TEVAR Plus Dealing With Re-Entry Tears Improves Outcomes: How To Do It |
| Presenter(s):Jean M. Panneton, MD | |
| View Slides in PDF | |
| 5:56 PM - 6:02 PM | Panel Discussion |
| 6:02 PM - 6:02 PM | End of Program A |
| END OF SESSION 8 | |
| SESSION 9 SCHEDULE | |
|
Tuesday
SESSION 9:
PROGRESS IN VASCULAR ROBOTICS, LAPAROSCOPY, GUIDANCE SYSTEMS AND SIMULATION
Moderators:Willem Wisselink, MD / Celia Riga, MD, FRCS
|
|
| x | |
| 6:44 AM - 6:49 AM | Opening Remarks |
| Presenter(s):Enrico Ascher, MD | |
| View Slides in PDF | |
| 6:50 AM - 6:55 AM | Update On Endovascular Robotics: They Have A Promising Future |
| Presenter(s):Joseph J. Ricotta II, MD, MS, DFSVS, FACS | |
| View Slides in PDF | |
| 6:56 AM - 7:01 AM | Laparoscopic Assisted Aortofemoral Bypasses For Juxtarenal Aortic Occlusions: Why It Is The Best Treatment Method As Indicated By Long And Short Term Outcomes: What Are The Risks |
| Presenter(s):Joseph S. Giglia, MD | |
| View Slides in PDF | |
| 7:02 AM - 7:07 AM | Laparoscopic Robotic Assisted Aortic Surgery: Is It Worthwhile And Cost Effective In The Endovascular Era: Based On A 7-Year Experience In 87 Patients |
| Presenter(s):Dr. Pierre-Olivier Thiney, MD | |
| View Slides in PDF | |
| 7:08 AM - 7:13 AM | Laparoscopic Aortic Surgery: How I Did It Routinely And Why I Stopped After More Than 150 Cases |
| Presenter(s):Laurent Chiche, MD, FEBVS | |
| View Slides in PDF | |
| 7:14 AM - 7:19 AM | Present Status And Future Potential Of Radiation Free Guidewire And Catheter Guidance: The Fiber Optic RealShape (FORS) From Philips: What Are Microbots And How Do They Work |
| Presenter(s):Barry T. Katzen, MD | |
| View Slides in PDF | |
| 7:20 AM - 7:25 AM | Updated Experience With The Fiberoptic 3D Endovascular Guidance With The FORS System (Philips): How Does It Work, Advantages And Limitations |
| Presenter(s):Joost van Herwaarden, MD, PhD | |
| View Slides in PDF | |
| 7:26 AM - 7:31 AM | Update On The 3D Radiation Free Intraoperative Positioning System (IOPS) From Centerline For Endovascular Guidance: How Does It Work, Advantages And Limitations |
| Presenter(s):Matthew J. Eagleton, MD | |
| View Slides in PDF | |
| 7:32 AM - 7:37 AM | The MAZE BOX: A Simple Table Top Endovascular Simulator For Training In Endovascular Tasks And Procedures |
| Presenter(s):Barend M.E. Mees, MD, PhD, FEBVS | |
| View Slides in PDF | |
| 7:38 AM - 7:44 AM | Panel Discussion |
| END OF SESSION 9 | |
| SESSION 10 SCHEDULE | |
|
Tuesday
SESSION 10:
NEW DEVELOPMENTS IN CAROTID DISEASE AND ITS TREATMENT; DIFFERING VIEWS ON TREATMENT OF ASYMPTOMATIC CAROTID STENOSIS (ACS) AND CAROTID SCREENING
|
|
| x | |
| 7:44 AM - 7:49 AM | International Variations In Carotid Stenosis Treatment Within Countries And Between Countries Is Huge Despite All The RCTs On Which They Are Based Being The Same: What Are The Implications |
| Presenter(s):Maarit Venermo, MD, PhD | |
| View Slides in PDF | |
| 7:50 AM - 7:55 AM | Current Optimal Treatment For Carotid Artery Dissection: When Best Medical Therapy (BMT), When Open Surgery, When Carotid Stenting (CAS) With Proximal Embolic Protection |
| Presenter(s):Felice Pecoraro, MD | |
| View Slides in PDF | |
| 7:56 AM - 8:01 AM | What Vascular Surgeons And Vascular Specialists Need To Know About What Can Be Learned From MRI And MRA Studies Of The Head And Neck |
| Presenter(s):Allan L. Brook, MD | |
| View Slides in PDF | |
| 8:02 AM - 8:07 AM | Update On Near Total Occlusions And String Signs Of The Internal Carotid Artery (ICA): How Are They Best Treated: When Conservatively; When Invasively By CEA; By CAS: How Does Newer Imaging Help |
| Presenter(s):Christos D. Liapis, MD | |
| View Slides in PDF | |
| 8:08 AM - 8:13 AM | Update On Isolated Carotid Webs As A Cause Of Cryptogenic Stroke: How Best To Diagnose And Treat: How Should Asymptomatic Webs Be Treated |
| Presenter(s):Evan C. Lipsitz, MD, MBA | |
| View Slides in PDF | |
| 8:14 AM - 8:20 AM | Panel Discussion |
| DIFFERING VIEWS ON TREATMENT OF ACS | |
| 8:20 AM - 8:25 AM | DEBATE: ALL Asymptomatic Carotid Stenosis (ACS) Patients Are Best Treated Medically: Invasive Treatment Causes More Harm Than Good |
| Presenter(s):Anne L. Abbott, MD, PhD, FRACP | |
| View Slides in PDF | |
| 8:26 AM - 8:31 AM Power Point Presentation with Synched Audio |
DEBATE: Not So: About 25% Of ACS Patients Can Benefit From CEA Or CAS And Should Be So Treated |
| Presenter(s):Bruce A. Perler, MD, MBA | |
| View Slides in PDF | |
| 8:32 AM - 8:37 AM | DEBATE: Both Views Are Wrong: Severe Carotid Stenosis Has Declined As A Cause Of Ischemic Stroke To <1% Per Year: So <5% Of ACS Patients Should Be Treated Invasively |
| Presenter(s):Robert W. Chang, MD | |
| View Slides in PDF | |
| 8:38 AM - 8:43 AM | With ACS: When Not To Treat Invasively And When To Treat Invasively: A Balanced Logical View – But No One Knows Which View Is Right Or Best |
| Presenter(s):Martin Storck, MD, PhD | |
| View Slides in PDF | |
| DIFFERING VIEWS ON CAROTID SCREENING | |
| 8:44 AM - 8:49 AM | DEBATE: The Case For Widespread Carotid Screening |
| Presenter(s):George S. Lavenson, MD | |
| View Slides in PDF | |
| 8:50 AM - 8:55 AM | DEBATE: The Case Against Carotid Screening: It Leads To Unneeded And Possibly Harmful Treatment |
| Presenter(s):Anne L. Abbott, MD, PhD, FRACP | |
| View Slides in PDF | |
| 8:56 AM - 9:01 AM | What Are The Effects Of A Minor Stroke With Apparent Full Recovery: Minor Strokes Are By No Means Minor: Why Is This Important In Evaluating The Conclusions Of The CREST Trial |
| Presenter(s):Emmanuel M. Houdart, MD | |
| View Slides in PDF | |
| 9:02 AM - 9:07 AM | Screening For ACS And Common Femoral Artery Disease: How Can It Guide Lipid Treatment: How Low Should LDL-Cholesterol (LDL-C) Be Pushed And What Will It Do To Carotid Plaques |
| Presenter(s):Stavros K. Kakkos, MD, PhD / Andrew N. Nicolaides, MS, FRCS | |
| View Slides in PDF | |
| 9:08 AM - 9:15 AM | Panel Discussion |
| 9:15 AM - 9:30 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 10 | |
| SESSION 11 SCHEDULE | |
|
Tuesday
SESSION 11:
MORE ABOUT CAROTID AND VERTEBRAL DISEASE: UPDATE ON INVASIVE TREATMENT FOR ACUTE STROKES
|
|
| x | |
| 9:30 AM - 9:35 AM | Carotid Artery Aneurysms: What Etiologies Cause Them; When Is Endovascular Treatment Best And Technical Tips For Doing So Successfully |
| Presenter(s):Klaus D. Mathias, MD | |
| View Slides in PDF | |
| 9:36 AM - 9:41 AM | When After Thrombolysis Treatment For A Stroke Should Carotid Endarterectomy (CEA) Be Performed And What Is The Best Timing For Those CEAs: Delay Has Consequences: But CEA Within 48 Hours Of Symptom Onset Has A Higher Complication Rate |
| Presenter(s):Maarit Venermo, MD, PhD | |
| View Slides in PDF | |
| 9:42 AM - 9:47 AM | Why Vascular Surgeons Should Become Involved In Intracranial Endovascular Treatments For Acute Strokes: How To Learn These Procedures And Benefit Patients |
| Presenter(s):Laura Capoccia, MD, PhD | |
| View Slides in PDF | |
| 9:48 AM - 9:53 AM | With Acute Strokes What Is New With Endovascular Intracranial Techniques For Arterial Clot Removal: How Can Artificial Intelligence (AI) And Intraarterial Thrombolysis With Alteplase (Genentech) Help – From The CHOICE RCT |
| Presenter(s):Adnan H. Siddiqui, MD, PhD / L. Nelson Hopkins, MD | |
| View Slides in PDF | |
| 9:54 AM - 9:59 AM | How Can Intolerance To Carotid Clamping Be Predicted Before CEA: It Is An Indication For CAS |
| Presenter(s):Piotr Myrcha, MD, PhD | |
| View Slides in PDF | |
| 10:00 AM - 10:05 AM | Acute Stroke Interventions: What Is New: Who Should Do Them And Lessons Learned |
| Presenter(s):Horst Sievert, MD | |
| View Slides in PDF | |
| 10:06 AM - 10:11 AM | How Best To Treat An ICA Occlusion With Distal Embolization: Sequence And Timing Of Treatment: Site Of Treatment (OR Versus Angio Suite Versus Hybrid Room): Technical Tips |
| Presenter(s):Adnan H. Siddiqui, MD, PhD / L. Nelson Hopkins, MD | |
| View Slides in PDF | |
| 10:12 AM - 10:17 AM | Differences In Outcomes Of Carotid Interventions (CEA And CAS) In Women And Younger Patients: What Is The Impact Of These Differences On Patient Management |
| Presenter(s):Caron B. Rockman, MD | |
| View Slides in PDF | |
| 10:18 AM - 10:23 AM | Endovascular Interventions In The Vertebro-Basilar System For Acute Strokes: A New Horizon, What Is Involved And Results |
| Presenter(s):Ivo Petrov, MD, PhD | |
| View Slides in PDF | |
| 10:24 AM - 10:30 AM | Panel Discussion |
| END OF SESSION 11 | |
| SESSION 12 SCHEDULE | |
|
Tuesday
SESSION 12:
PROGRESS IN THE TREATMENT OF AORTIC AND AORTO-ILIAC OCCLUSIVE DISEASE
Moderators:Daniel G. Clair, MD / Wayne W. Zhang, MD
|
|
| x | |
| 10:30 AM - 10:35 AM | Current Concepts And Techniques For Treating External Iliac Artery Endofibrosis In Committed Athletes: What Works And Doesn’t Work: Is There A role For Endovascular Treatment |
| Presenter(s):Kenneth J. Cherry, MD | |
| View Slides in PDF | |
| 10:36 AM - 10:41 AM | Iliac Stenosis In Professional Cyclists: How To Diagnose And Treat: ABIs Don’t Help |
| Presenter(s):Gabriel Szendro, MD | |
| View Slides in PDF | |
| 10:42 AM - 10:47 AM | Value Of VBX Balloon Expandable Covered Stents In Treating Complex Aorto-Iliac Occlusive Disease: Advantages And Limitations |
| Presenter(s):Palma M. Shaw, MD, MBA, FACS, RPVI, DFSVS | |
| View Slides in PDF | |
| COVERED ENDOVASCULAR RECONSTRUCTION OF THE AORTIC BIFURCATION (CERAB) PROCEDURE | |
| 10:48 AM - 10:53 AM | Long-Term Outcomes Of The CERAB Procedure With Covered Stents For Complex Aorto-Iliac Occlusive Disease: Why It’s Better Than Kissing Stents And Which Covered Stent Works Best |
| Presenter(s):Michel M.P. Reijnen, MD, PhD / Peter C.J. Goverde, MD | |
| View Slides in PDF | |
| 10:54 AM - 10:59 AM | The CERAB Technique: From A Niche Procedure To A Worldwide Solution For Complex Aorto-Iliac Occlusive Disease |
| Presenter(s):Maria A. Ruffino, MD, EBIR, FCIRSE | |
| View Slides in PDF | |
| 11:00 AM - 11:05 AM | Covered Endovascular Reconstruction Of The Aortic Bifurcation (CERAB) Technique: Multicenter UK Experience |
| Presenter(s):Hany M. Zayed, MD | |
| View Slides in PDF | |
| 11:06 AM - 11:11 AM | Value Of Shockwave Intravascular Lithotripsy (IVL) For Calcified Aorto-Iliac Occlusive Disease Treatment And Other Lower Extremity Arterial Lesions: The DISRUPT PAD III RCT |
| Presenter(s):Andrew Holden, MBChB / Gunnar Tepe, MD / William A. Gray, MD | |
| View Slides in PDF | |
| 11:12 AM - 11:18 AM | Panel Discussion |
| 11:18 AM - 11:23 AM | Treatment Of Infrarenal And Pararenal Aortic Stenosis: When Stents; When Stent-Grafts; When Open Bypass Or Endarterectomy |
| Presenter(s):Sigrid Nikol, MD | |
| View Slides in PDF | |
| 11:24 AM - 11:29 AM | Endovascular Treatment Of Difficult Aorto-Iliac Occlusions: Technical Tips And Late Results: Is Open Repair Ever Needed |
| Presenter(s):Sonia Ronchey, MD, PhD | |
| View Slides in PDF | |
| 11:30 AM - 11:35 AM | DEBATE: How To Treat Chronic Flush Juxtarenal Aortic Occlusions Endovascularly With Safety: Endo Is The Way To Go |
| Presenter(s):David J. Minion, MD | |
| View Slides in PDF | |
| 11:36 AM - 11:41 AM | DEBATE: Not So: Open Surgery Is The Best Way To Treat Flush Juxtarenal Aortic Occlusions Safely: Technical Tips On How To Do It Transperitoneally And Retroperitoneally |
| Presenter(s):Thomas C. Bower, MD | |
| View Slides in PDF | |
| 11:42 AM - 11:47 AM | DEBATE: Both Wrong: Hybrid Repairs Are Best For Complex Aorto-Iliac Occlusive Disease: Technical Tips On How To Do It |
| Presenter(s):Yamume Tshomba, MD | |
| View Slides in PDF | |
| 11:48 AM - 11:53 AM | Impact Of Female Gender On Outcomes Of Endovascular Treatment Of Aorto-Iliac Occlusive Disease: When Is Open Repair Indicated |
| Presenter(s):Franco Grego, MD | |
| View Slides in PDF | |
| 11:54 AM - 12:00 PM | Panel Discussion |
| 12:00 PM - 1:00 PM | Lunch Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 12 | |
| SESSION 13 SCHEDULE | |
|
Tuesday
SESSION 13:
NEW CONCEPTS, MACHINE LEARNING AND ARTIFICIAL INTELLIGENCE (AI) (See Also Session 87)
|
|
| x | |
| 1:00 PM - 1:05 PM Power Point Presentation with Synched Audio |
What Is Big Data In Vascular Surgery: How Can It Be Used With Artificial Intelligence (AI) In Evidence Based Medicine: Could It Replace Randomized Controlled Trials (RCTs) |
| Presenter(s):Jean-Baptiste Ricco, MD, PhD | |
| View Slides in PDF | |
| 1:06 PM - 1:11 PM | What Is The Bright Future Of AI And Robotic Technology In Vascular Surgery |
| Presenter(s):Willem Wisselink, MD | |
| View Slides in PDF | |
| 1:12 PM - 1:17 PM | How AI Will Change The Way We Practice Medicine |
| Presenter(s):Lindsay Machan, MD | |
| View Slides in PDF | |
| 1:18 PM - 1:23 PM | Update On How Vascular Treatment Will Intersect With Other New Technologies: Wearable Trackers, AI, And Using CT Scans To Predict Plaque Histology (ElucidVivo) |
| Presenter(s):David H. Deaton, MD, FACS | |
| View Slides in PDF | |
| 1:24 PM - 1:29 PM | How 3D And 4D Machine Learning Is Changing Vascular Surgery |
| Presenter(s):Matthew T. Menard, MD | |
| View Slides in PDF | |
| 1:30 PM - 1:35 PM | Is Image Fusion Guidance For Complex And Simple Aortic Procedures Really Worthwhile And Cost Effective: Why Is It A Question |
| Presenter(s):Rachel E. Clough, PhD, FRCS | |
| View Slides in PDF | |
| 1:36 PM - 1:41 PM | How Can AI Facilitate AAA Monitoring And Volume Measurement Before And After EVAR |
| Presenter(s):Stephan Haulon, MD | |
| View Slides in PDF | |
| 1:42 PM - 1:47 PM | High Fidelity Computer Modeling: How Can It Help In Graft Selection And Procedural Performance With TEVAR And EVAR |
| Presenter(s):Santi Trimarchi, MD, PhD | |
| View Slides in PDF | |
| 1:48 PM - 1:53 PM | Siemens I-Flow: A New Intelligent Technology To Improve The Endo Treatment Of Lower Extremity Occlusive Disease |
| Presenter(s):Ravi K. Veeraswamy, MD | |
| View Slides in PDF | |
| 1:54 PM - 1:59 PM | Dual Fluoroscopy With Digital Zooming And Other Strategies To Decrease Radiation During Complex AAA Repairs |
| Presenter(s):Carlos H. Timaran, MD | |
| View Slides in PDF | |
| 2:00 PM - 2:05 PM | How Can AI Be Used To Predict Endoleaks And AAA Growth: Will It Have Clinical Value |
| Presenter(s):Kak Khee Yeung, MD, PhD | |
| View Slides in PDF | |
| 2:06 PM - 2:12 PM | Panel Discussion |
| END OF SESSION 13 | |
| SESSION 14 SCHEDULE | |
|
Tuesday
SESSION 14:
PART 1: VASCULAR SURGERY’S NUMBERS AND IDENTITY AND HOW TO MEET THE SPECIALTY’S NEEDS FOR ITS SERVICES; THE IMPORTANCE OF MENTORSHIP IN VASCULAR SURGERY
PART 2: LATE BREAKING DEVELOPMENTS IN COVID RELATED VASCULAR DISEASE ISSUES |
|
| x | |
| PART 1 – VASCULAR SURGERY'S NUMBERS AND IDENTITY AND HOW TO MEET THE SPECIALTY'S NEEDS FOR ITS SERVICES; THE IMPORTANCE OF MENTORSHIP IN VASCULAR SURGERY | |
| 2:12 PM - 2:17 PM | What Makes Vascular Surgery Different, Why Are There Insufficient Numbers Of Vascular Surgeons: How Can We Expand Our Numbers |
| Presenter(s):Evan C. Lipsitz, MD, MBA | |
| View Slides in PDF | |
| 2:18 PM - 2:23 PM | Update On Applicants For 0+5 And 5+2 Vascular Surgery Training Programs: The Number Of Applicants Is Up: What About Their Quality: Do We Need More Programs |
| Presenter(s):Peter L. Faries, MD, FACS / Murray L. Shames, MD | |
| View Slides in PDF | |
| 2:24 PM - 2:29 PM | Increased Diversity In Vascular Surgery And Will It Improve The Shortage Of Vascular Surgeons |
| Presenter(s):Dawn M. Coleman, MD | |
| View Slides in PDF | |
| 2:30 PM - 2:35 PM | Why US News & World Report Cannot And Does Not Rank Vascular Surgery Programs: Vascular Surgery Needs To Be An Independent ABMS Approved Specialty: Why Isn’t It |
| Presenter(s):James H. Black, III, MD | |
| View Slides in PDF | |
| 2:36 PM - 2:41 PM | The Key To More Vascular Surgeons Is Better Exposure To Medical Students: We Are A Hidden Specialty Because Of Our Subordinate Specialty Status Which Also Limits Our Training Programs |
| Presenter(s):Jerry Goldstone, MD, FACS, FRCSEd | |
| View Slides in PDF | |
| 2:42 PM - 2:47 PM | The Importance Of Mentorship In Vascular Surgery: How Best To Achieve It |
| Presenter(s):Audra A. Duncan, MD | |
| View Slides in PDF | |
| 2:48 PM - 2:53 PM | Panel Discussion |
| PART 2 – LATE BREAKING DEVELOPMENTS IN COVID RELATED VASCULAR DISEASE ISSUES | |
| 2:54 PM - 2:59 PM | The COVID Pandemic And Its Effects On The Staffing And Economics Of A Hospital System: How Best To Deal With These Effects |
| Presenter(s):Samuel R. Money, MD, MBA | |
| View Slides in PDF | |
| 3:00 PM - 3:05 PM | Late Breaking Factual Developments In The Prophylaxis And Treatment Of COVID-19: Update On The Real Value Of Vaccines, Boosters And Antivirals |
| Presenter(s):Clayton J. Brinster, MD | |
| View Slides in PDF | |
| 3:06 PM - 3:11 PM | Impact Of COVID-19 On The Extra- And Intracranial Circulation: How Effective Are Endovascular Treatments |
| Presenter(s):Allan L. Brook, MD | |
| View Slides in PDF | |
| 3:12 PM - 3:17 PM | How Does COVID Influence The Occurrence Of Luminal Thrombus During CEA And CEA Timing; What Should Be Done During Invasive Treatment |
| Presenter(s):Domenico Valenti, DMChir, PhD, FRCS, FRCS(Ed), FEBVS | |
| View Slides in PDF | |
| 3:18 PM - 3:23 PM | Panel Discussion |
| 3:24 PM - 3:36 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 14 | |
| SESSION 15 SCHEDULE | |
|
Tuesday
SESSION 15:
PROGRESS IN THE TREATMENT OF VISCERAL AND RENAL ARTERY DISEASE
Moderators:James C. Stanley, MD / Michael C. Dalsing, MD
|
|
| x | |
| 3:36 PM - 3:41 PM | DEBATE: All Visceral And Renal Artery Aneurysms Can Be Treated Endovascularly |
| Presenter(s):Robert A. Lookstein, MD, MHCDL, FSIR, FAHA | |
| View Slides in PDF | |
| 3:42 PM - 3:47 PM | DEBATE: Open Treatment Of Visceral And Renal Artery Aneurysms Is Sometimes Best: When Is This |
| Presenter(s):Timur P. Sarac, MD | |
| View Slides in PDF | |
| 3:48 PM - 3:53 PM | Open Retrograde SMA Stenting: When Is It Indicated And How To Do It |
| Presenter(s):Richard J. Powell, MD | |
| View Slides in PDF | |
| 3:54 PM - 3:59 PM | With Acute Mesenteric Ischemia With Peritoneal Signs, Laparotomy And Retrograde SMA Stenting Is The Best Treatment: Technical Tips To Do It Safely And Quickly |
| Presenter(s):Markus K. Furrer, MD | |
| View Slides in PDF | |
| 4:00 PM - 4:05 PM | Technical Tips For Recanalizing Long Complex Visceral Artery (SMA) Occlusions |
| Presenter(s):Armando Mansilha, MD, PhD, FEBVS | |
| View Slides in PDF | |
| 4:06 PM - 4:11 PM | Renal And Visceral Arterial Interventions: How To Get Into Trouble And How To Get Out Of Trouble |
| Presenter(s):Benjamin M. Jackson, MD / Ronald M. Fairman, MD | |
| View Slides in PDF | |
| 4:12 PM - 4:17 PM | Update On New SVS Practice Guidelines For Treating Visceral Artery Aneurysms; When Endo; When Open |
| Presenter(s):Rabih A. Chaer, MD | |
| View Slides in PDF | |
| 4:18 PM - 4:23 PM | The Vascular Low Frequency Consortium: What Is It And What Does It Tell Us About The Size When Renal Artery Aneurysms Become Dangerous: It Is >3 cm In Diameter |
| Presenter(s):Peter F. Lawrence, MD | |
| View Slides in PDF | |
| 4:24 PM - 4:29 PM | Optimal Current Treatment Of Renal Artery Aneurysms: When Endo; When Open; Technical Tips |
| Presenter(s):Fred A. Weaver, MD, MMM | |
| View Slides in PDF | |
| 4:30 PM - 4:36 PM | Panel Discussion |
| END OF SESSION 15 | |
| SESSION 16 SCHEDULE | |
|
Tuesday
SESSION 16:
UPDATE ON OPEN VASCULAR SURGICAL AND HYBRID PROCEDURES; PROGRESS IN THE TREATMENT OF AORTIC COARCTATIONS
Moderators:Linda M. Harris, MD / Jerry Goldstone, MD, FACS, FRCSEd
|
|
| x | |
| OPEN AND HYBRID VASCULAR SURGERY | |
| 4:36 PM - 4:41 PM | Coral Reef Atherosclerotic Lesions Of The Aorta And Common Femoral Artery Are Best Treated By Open Repair |
| Presenter(s):Laurent Chiche, MD, FEBVS | |
| View Slides in PDF | |
| 4:42 PM - 4:47 PM | Technical Tips For Performing Retroperitoneal Aorto-Bifemoral Bypass (Video Presentation) |
| Presenter(s):William J. Quinones-Baldrich, MD | |
| View Slides in PDF | |
| 4:48 PM - 4:53 PM Power Point Presentation with Synched Audio |
Tips And Tricks For Open Retroperitoneal Exposure Of The Aorta And All Its Abdominal Branches |
| Presenter(s):Kamphol Laohapensang, MD | |
| View Slides in PDF | |
| 4:54 PM - 4:59 PM | Update On Minimal Incision For Retroperitoneal Aorto-Bifemoral Bypass And Other Procedures: Technical Tips And Limitations |
| Presenter(s):Robert M. Proczka, MD, PhD | |
| View Slides in PDF | |
| 5:00 PM - 5:05 PM | Duplex Surveillance Should Be Used After All Open Aorto-Bifemoral Bypasses: It Improves Outcomes |
| Presenter(s):Keith D. Calligaro, MD | |
| View Slides in PDF | |
| 5:06 PM - 5:11 PM | Thoraco-Bifemoral Bypass: A Good Option After All Endo And Open Standard Approaches Have Failed: Technical Tips |
| Presenter(s):Manju Kalra, MBBS | |
| View Slides in PDF | |
| 5:12 PM - 5:17 PM Power Point Presentation with Synched Audio |
Update On Renal Consequences Of Left Renal Vein Division During Open AAA Repair: It Is Not Always Benign |
| Presenter(s):Kimihiro Komori, MD, PhD | |
| View Slides in PDF | |
| 5:18 PM - 5:23 PM | Panel Discussion |
| UPDATE ON COARCTATION TREATMENT | |
| 5:23 PM - 5:28 PM | The Importance Of Microanatomy In Endovascular And Open Surgical Treatment Of Abdominal Aortic Coarctations |
| Presenter(s):James C. Stanley, MD | |
| View Slides in PDF | |
| 5:29 PM - 5:34 PM | DEBATE: Endovascular Techniques Are The Best Treatment For Aortic Coarctations: When Bare Stents; When Covered Stents; Precautions |
| Presenter(s):Zvonimir Krajcer, MD, FACC | |
| View Slides in PDF | |
| 5:35 PM - 5:40 PM | DEBATE: Not So: Open Surgery Is Sometimes Needed: What Are The Indications |
| Presenter(s):Michael J. Jacobs, MD | |
| View Slides in PDF | |
| 5:41 PM - 5:46 PM | Value Of BeGraft (From Bentley), A Balloon Expandable Covered Stent In Treating Aortic Coarctations: Can It Treat All Cases |
| Presenter(s):Elchanan Bruckheimer, MBBS | |
| View Slides in PDF | |
| 5:47 PM - 5:52 PM | Positive Aortic Remodeling In Aortic Coarctations Following TEVAR From The Ascending Aorta As Well As Distally |
| Presenter(s):Frank R. Arko, MD | |
| View Slides in PDF | |
| 5:53 PM - 5:58 PM | Axillo-Unifemoral And Axillo-Bifemoral Bypasses Have Equal Patency For More Than A Year: Why The Bilateral Procedure Should Only Be Used When Bilateral Ischemia Exists |
| Presenter(s):Jeffrey J. Siracuse, MD, MBA, FACS | |
| View Slides in PDF | |
| 5:59 PM - 6:05 PM | Panel Discussion |
| 6:05 PM - 6:05 PM | End of Program B |
| END OF SESSION 16 | |
| SESSION 17 SCHEDULE | |
|
Tuesday
SESSION 17:
MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE APPROACH – PART 1
Moderators:Michael R. Jaff, DO
|
|
| x | |
| 7:00 AM - 7:05 AM | Introduction To The Symposium |
| Presenter(s):Frank J. Veith, MD | |
| 7:05 AM - 7:15 AM | Welcome And Introduction |
| Presenter(s):Michael R. Jaff, DO | |
| View Slides in PDF | |
| 7:15 AM - 7:25 AM | The Basics Of Pulmonary Embolism Diagnosis: What Is The Role Of The History, Exam, Biomarkers |
| Presenter(s):Raghu Kolluri, MD | |
| View Slides in PDF | |
| 7:25 AM - 7:35 AM | Do We Need An Echocardiogram To Manage Acute Submassive PE |
| Presenter(s):David M. Dudzinski, MD | |
| View Slides in PDF | |
| 7:35 AM - 7:45 AM | Advanced Imaging For PE: What Is The Optimal Strategy For The Diagnosis Of Acute And Chronic PE |
| Presenter(s):Brian B. Ghoshhajra, MD, MBA | |
| View Slides in PDF | |
| 7:45 AM - 7:55 AM | Testing For Cancer And Other Hypercoagulable States In PE |
| Presenter(s):Rachel Rosovsky, MD, MPH | |
| View Slides in PDF | |
| 7:55 AM - 8:05 AM | The First Opportunity – The Emergency Physician Algorithm For Acute PE Management |
| Presenter(s):D. Mark Courtney, MD | |
| View Slides in PDF | |
| 8:05 AM - 8:20 AM | Medical Treatment Of PE: When, Why, For How Long, And How Can I Remember |
| Presenter(s):Geno J. Merli, MD, MACP, FHM, FSVM | |
| View Slides in PDF | |
| 8:20 AM - 8:30 AM | Intravenous Thrombolytic Therapy For PE: No Need For Catheter-Based Intervention |
| Presenter(s):Jay Giri, MD, MPH | |
| View Slides in PDF | |
| 8:30 AM - 8:45 AM | An Overview Of Technologies For Management Of High-Risk PE |
| Presenter(s):Eric A. Secemsky, MD, MSc | |
| View Slides in PDF | |
| 8:45 AM - 8:55 AM | Ultrasound-Assisted Pharmacomechanical Thrombectomy: Does This Really Work |
| Presenter(s):Linda Le, MD | |
| View Slides in PDF | |
| 8:55 AM - 9:05 AM | Percutaneous Mechanical Thrombectomy Without Lytics: The Indigo System |
| Presenter(s):Robert A. Lookstein, MD, MHCDL, FSIR, FAHA | |
| View Slides in PDF | |
| 9:05 AM - 9:15 AM | Percutaneous Mechanical Thrombectomy Without Lytics: The FlowTriever System |
| Presenter(s):Mitchell D. Weinberg, MD | |
| View Slides in PDF | |
| 9:15 AM - 9:25 AM | Step-By-Step Technical Tips For Pharmacomechanical Intervention For PE |
| Presenter(s):Gary M. Ansel, MD | |
| View Slides in PDF | |
| Moderator(s): Michael R. Jaff, DO | |
| 9:25 AM - 9:40 AM | Panel Discussion |
| Panelist(s): Gary M. Ansel, MD / D. Mark Courtney, MD / David M. Dudzinski, MD / Brian B. Ghoshhajra, MD, MBA / Jay Giri, MD, MPH / Raghu Kolluri, MD / Linda Le, MD / Robert A. Lookstein, MD, MHCDL, FSIR, FAHA / Geno J. Merli, MD, MACP, FHM, FSVM / Rachel Rosovsky, MD, MPH / Eric A. Secemsky, MD, MSc / Mitchell D. Weinberg, MD | |
| 9:40 AM - 10:10 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 17 | |
| SESSION 18 SCHEDULE | |
|
Tuesday
SESSION 18:
MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE APPROACH – PART 2
Moderators:Michael R. Jaff, DO
|
|
| x | |
| 10:10 AM - 10:20 AM | Large Bore Aspiration Thrombectomy: Tips, Tricks And Pearls |
| Presenter(s):Ripal T. Gandhi, MD, FSVM, FSIR | |
| View Slides in PDF | |
| 10:20 AM - 10:30 AM | Vortex Strategy For Massive PE |
| Presenter(s):Christopher J. Kwolek, MD, MBA | |
| View Slides in PDF | |
| 10:30 AM - 10:40 AM | ECMO And Surgical Thromboembolectomy For Massive PE: When, How, And Why |
| Presenter(s):Mark G. Davies, MD | |
| View Slides in PDF | |
| 10:40 AM - 10:55 AM | What Algorithm Is Best For Acute PE Intervention |
| Presenter(s):Keith M. Sterling, MD | |
| View Slides in PDF | |
| 10:55 AM - 11:10 AM | Vena Cava Filters In PE Treatment: Do We Need To Do This, And If So, When |
| Presenter(s):John A. Kaufman, MD, MS | |
| View Slides in PDF | |
| 11:10 AM - 11:25 AM | Balloon Pulmonary Angioplasty For Chronic Thromboembolic Pulmonary Hypertension: Has This Become Mainstream |
| Presenter(s):Kenneth Rosenfield, MD | |
| View Slides in PDF | |
| 11:25 AM - 11:35 AM | The Team Approach To PE Management: The National PERT Consortium |
| Presenter(s):William B. Keeling, MD | |
| View Slides in PDF | |
| Moderator(s): Michael R. Jaff, DO | |
| 11:35 AM - 12:00 PM | Challenging Cases And “PERT” Decisions |
| Panelist(s): Mark G. Davies, MD / John A. Kaufman, MD, MS / William B. Keeling, MD / Christopher J. Kwolek, MD, MBA / Kenneth Rosenfield, MD / Keith M. Sterling, MD / Ido Weinberg, MD, MSc | |
| 12:00 PM - 12:00 PM | End of Program C-1 |
| 12:01 PM - 1:00 PM | Lunch Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 18 | |
| SESSION 19 SCHEDULE | |
|
Tuesday
SESSION 19:
HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENTS
Moderators:Cynthia K. Shortell, MD / Iris Baumgartner, MD
|
|
| x | |
| 1:00 PM - 1:05 PM | Key Points From The SVS Appropriate Use Criteria For Management Of Intermittent Claudication |
| Presenter(s):Karen Woo, MD, PhD / Jessica P. Simons, MD, MPH | |
| View Slides in PDF | |
| 1:06 PM - 1:11 PM | Endovascular Treatments Including Atherectomy For Lower Extremity Occlusive Disease Are Associated With Poorer Long-Term Patient Survival: How Is It Related To Their Endovascular Treatments And/Or Their Underlying |
| Presenter(s):Dipankar Mukherjee, MD | |
| View Slides in PDF | |
| 1:12 PM - 1:17 PM | Real Five-Year Single Center Results With Atherectomy For De Novo Lower Extremity Lesions And In Stent Restenosis: How Good Or Bad Are They |
| Presenter(s):Russell H. Samson, MD, DFSVS, RVT, FACS | |
| View Slides in PDF | |
| 1:18 PM - 1:23 PM | Intravascular Lithotripsy For Peripheral Arterial Occlusive Lesions: Theory, Data, And What We Don’t Know |
| Presenter(s):Scott L. Stevens, MD | |
| View Slides in PDF | |
| 1:24 PM - 1:29 PM Power Point Presentation with Synched Audio |
How Do SoundBite Wires (From SoundBite Medical) Help To Cross Calcified Lesions, Especially BTK |
| Presenter(s):Marianne Brodmann, MD | |
| View Slides in PDF | |
| 1:30 PM - 1:35 PM | Alternate Approaches To Lower Extremity Arteries When Standard Approaches Are Prevented By Scarring Or Infection |
| Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS | |
| View Slides in PDF | |
| 1:36 PM - 1:41 PM Power Point Presentation with Synched Audio |
Current Status And Prospects For Sirolimus Coated Devices And Bioresorbable Stents ATK And BTK |
| Presenter(s):Marianne Brodmann, MD | |
| View Slides in PDF | |
| 1:42 PM - 1:47 PM | Natural Progression Of High-Risk Chronic Limb Threatening Ischemia (CLTI): The CLariTI Study: How Can Deep Vein Arterialization (DVA) And Pedal Loop Revascularization Alter This Progression |
| Presenter(s):Anahita Dua, MD, MS, MBA | |
| View Slides in PDF | |
| 1:48 PM - 2:04 PM | Panel Discussion |
| END OF SESSION 19 | |
| SESSION 20 SCHEDULE | |
|
Tuesday
SESSION 20:
MORE HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENT
Moderators:Vincent L. Rowe, MD / Patrick J. Geraghty, MD
|
|
| x | |
| 2:04 PM - 2:09 PM | Ten Golden Rules To Train Vascular Surgeons In Distal Bypass Procedures In 2022 Francesco Spinelli, MD |
| Presenter(s):Francesco Spinelli, MD | |
| View Slides in PDF | |
| 2:10 PM - 2:15 PM | Free Tissue Flap Transfer For CLTI With Deep Venous Arterialization: Indications, Precautions And Results |
| Presenter(s):John M. Felder, MD / Patrick J. Geraghty, MD | |
| View Slides in PDF | |
| 2:16 PM - 2:21 PM | New Developments In How To Determine High Risk Stents And Bypass Grafts For Post Procedural Thrombosis: Selective Anticoagulation To Prevent Such Thrombosis |
| Presenter(s):Anahita Dua, MD, MS, MBA | |
| View Slides in PDF | |
| 2:22 PM - 2:27 PM | Near Infrared Spectroscopy (NIRS) For Real-Time Monitoring Of Deep Tissue Oxygenation During Peripheral Angioplasty For CLTI Treatment: Intra-Procedural Value And Follow-Up Results |
| Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR | |
| View Slides in PDF | |
| 2:28 PM - 2:33 PM | Feasibility And Utility Of Pedal Acceleration Time (PAT) As A Novel Assessment Tool For Limb Ischemia And Adequacy Of Revascularization Procedures |
| Presenter(s):Vincent L. Rowe, MD | |
| View Slides in PDF | |
| 2:34 PM - 2:39 PM | What Are The Best Ways To Evaluate CLTI Treatment Outcomes: Physiology, Wound Healing, Anatomy (Angiography Or Ultrasound), MACE Or MALE: Why It Matters |
| Presenter(s):Ido Weinberg, MD, MSc / Mitchell D. Weinberg, MD | |
| View Slides in PDF | |
| 2:40 PM - 2:45 PM | Head To Head Comparison Of The SUPERA Interwoven Stent And Drug Eluting Stents For The Treatment Of Femoropopliteal Lesions: Advantages, Disadvantages And Specific Indications For Each |
| Presenter(s):Iris Baumgartner, MD | |
| 2:46 PM - 2:52 PM | Panel Discussion |
| 2:52 PM - 3:00 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 20 | |
| SESSION 21 SCHEDULE | |
|
Tuesday
SESSION 21:
HOT NEW SHORT SUMMARY TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE (ALL TALKS ARE 4 ¾ MINUTES)
Moderators:Neal S. Cayne, MD / Gary M. Ansel, MD
|
|
| x | |
| 3:00 PM - 3:05 PM | Key Steps For Success With Radial Artery Access For Remote Visceral, Renal Or Lower Extremity Lesion Treatment |
| Presenter(s):Marcelo Guimaraes, MD, MBA, FSIR | |
| View Slides in PDF | |
| 3:05 PM - 3:10 PM | Value And Technical Tips To Make The Supera Stent Work In Curved And Angulated Non-SFA Lesion Locations |
| Presenter(s):Rajiv Parakh, MBBS, MS, FRCS | |
| View Slides in PDF | |
| 3:10 PM - 3:15 PM | Why And When Angiographic Final Evaluation Of Interventional Treatment Is Inadequate: What Else Is Needed And When |
| Presenter(s):Gary M. Ansel, MD | |
| View Slides in PDF | |
| 3:15 PM - 3:20 PM | How Should COVID-19 Change The Approach To Managing Acute Limb Ischemia |
| Presenter(s):Palma M. Shaw, MD, MBA, FACS, RPVI, DFSVS | |
| View Slides in PDF | |
| 3:20 PM - 3:25 PM | Patient Reported Outcomes For Treatments For Intermittent Claudication: What Are They And Why Are They Important |
| Presenter(s):Jessica P. Simons, MD, MPH | |
| View Slides in PDF | |
| 3:25 PM - 3:30 PM | 12 Commandments For A Successful BTK Intervention In Patients With CLTI Including How To Perform An Antegrade Femoral Artery Puncture And Easily Pass The Guidewire Into The SFA |
| Presenter(s):Ali Amin, MD, RVT, FACS, FACC | |
| View Slides in PDF | |
| 3:30 PM - 3:35 PM | Importance Of Technical Factors In Use Of Drug Coated Balloons (DCBs): Value Of IVUS And DCB Undersizing: Are There Differences With Chronic Total Occlusions (CTOs) |
| Presenter(s):Eric A. Secemsky, MD, MSc / Jihad A. Mustapha, MD | |
| View Slides in PDF | |
| 3:35 PM - 3:40 PM | Local Anesthetic Injection Into Lesion Site Facilitates PTA And Stent Placement: How To Do It (Video Presentation |
| Presenter(s):Andrej Schmidt, MD | |
| View Slides in PDF | |
| 3:40 PM - 3:45 PM | Panel Discussion |
| 3:45 PM - 3:50 PM | Value Of Tack Optimized Balloon Angioplasty In Lower Extremity Interventions: When Should They Be Used And When Not (Tacks From Intact Vascular) |
| Presenter(s):Lawrence A. Garcia, MD | |
| View Slides in PDF | |
| 3:50 PM - 3:55 PM | Three-Year Results Of The Lutonix DCB BTK Trial: Final Results Of This Landmark Trial Missed Its Primary Endpoint: Among Lessons Learned Is That Duplex Lacks Sensitivity For Critical Findings: How To Improve BTK IDE Trial Design |
| Presenter(s):Patrick J. Geraghty, MD | |
| View Slides in PDF | |
| 3:55 PM - 4:00 PM | The Optimal Stent And Techniques For Treating Occlusive Lesions In Heavily Calcified Superficial Femoral Arteries |
| Presenter(s):Hany M. Zayed, MD | |
| View Slides in PDF | |
| 4:00 PM - 4:05 PM | How Best To Use DCBs To Treat Femoro-Popliteal Lesions |
| Presenter(s):Fabrizio Fanelli, MD, EBIR | |
| View Slides in PDF | |
| 4:05 PM - 4:10 PM Power Point Presentation with Synched Audio |
What Is Small Artery Disease (SAD) Below The Ankle: With CLTI How Should This Be Treated: With Or Without DEBs |
| Presenter(s):Marianne Brodmann, MD | |
| View Slides in PDF | |
| 4:10 PM - 4:15 PM | Heel Ulceration And Ischemic Gangrene Involving The Achilles Tendon Should Not Be An Indication For A BTK Amputation: How To Save Such A Limb |
| Presenter(s):Mark G. Davies, MD | |
| View Slides in PDF | |
| 4:15 PM - 4:20 PM | Popliteal Artery-To-Distal Bypass For Limb Salvage: Current Status, Technical Tips And Value: When Is It Better Than Endovascular Treatments |
| Presenter(s):Francesco Spinelli, MD | |
| View Slides in PDF | |
| 4:20 PM - 4:25 PM | Hybrid Lower Extremity Revascularizations: When And Why Are They Better Than Endo Approaches |
| Presenter(s):Joseph S. Giglia, MD | |
| View Slides in PDF | |
| 4:25 PM - 4:30 PM | Panel Discussion |
| END OF SESSION 21 | |
| SESSION 22 SCHEDULE | |
|
Tuesday
SESSION 22:
MORE HOT NEW SHORT SUMMARY TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND CHRONIC LIMB THREATENING ISCHEMIA (CLTI) [ALL TALKS ARE 4 ¾ MINUTES]
Moderators:Brian G. DeRubertis, MD / Lawrence A. Garcia, MD
|
|
| x | |
| 4:30 PM - 4:35 PM | CLTI Is A Global Epidemic; How Can A CLTI Program Decrease Its Morbidity |
| Presenter(s):Barry T. Katzen, MD | |
| View Slides in PDF | |
| 4:35 PM - 4:40 PM | Technical Tips For Open Tibial And Pedal Artery Exposures And Open Venous Exposures For Deep Venous Arterialization |
| Presenter(s):William P. Robinson, MD | |
| View Slides in PDF | |
| 4:40 PM - 4:45 PM | Bare Metal Stents (BMSs) Still Have A Role In The Superficial Femoral Artery (SFA): In Precisely What Circumstances |
| Presenter(s):Lawrence A. Garcia, MD | |
| View Slides in PDF | |
| 4:45 PM - 4:50 PM | Intravascular Lithotripsy And DCB Versus DCB Alone In The Treatment Of Infrapopliteal Lesions In Diabetics: The Rationale And Design Of The DEBATE-BTK SHOCK RCT |
| Presenter(s):Francesco Liistro, MD | |
| View Slides in PDF | |
| 4:50 PM - 4:55 PM | How To Size Lower Extremity Target Arteries For Endo Treatments Accurately Using Intravascular Ultrasound (IVUS): Why It Is Important |
| Presenter(s):Jos C. van den Berg, MD, PhD | |
| View Slides in PDF | |
| 4:55 PM - 5:00 PM | Lower Extremity Interventions (PTA, Stents, Atherectomy) Under IVUS Guidance: Its Costs, Value And Limitations |
| Presenter(s):Ignacio Escotto, MD | |
| View Slides in PDF | |
| 5:00 PM - 5:05 PM | Panel Discussion |
| 5:05 PM - 5:10 PM | Best Treatment For Heavily Calcified Occlusive Lesions And When Are Re-Entry Devices Needed With Retrograde Recanalizations: Tips On How To Use Them |
| Presenter(s):Erwin Blessing, MD | |
| View Slides in PDF | |
| 5:10 PM - 5:15 PM | Knowing When Not To Do A Major Amputation After All Possibilities Are Exhausted: Understanding How Bias Affects Your Professional Decision-Making |
| Presenter(s):Robert B. McLafferty, MD, MBA | |
| View Slides in PDF | |
| 5:15 PM - 5:20 PM | How To Do Bypass Surgery To Heavily Non-Compressible Calcified Target Arteries |
| Presenter(s):Enrico Ascher, MD / Frank J. Veith, MD | |
| View Slides in PDF | |
| 5:20 PM - 5:25 PM | Early Failure Of Endovascular Treatment Of Tibial Disease With CLTI Is Associated With Increased Amputation Rates: How Can It Be Predicted And Is A Primary Open Bypass A Solution |
| Presenter(s):Mark G. Davies, MD | |
| View Slides in PDF | |
| 5:25 PM - 5:30 PM | 2-Year Results With Sirolimus Coated Drug Eluting Stents (DESs) For Fempop Lesions: The ILLUMINA Trial |
| Presenter(s):Andrea Kahlberg, MD | |
| View Slides in PDF | |
| 5:30 PM - 5:35 PM | Contemporary Comparative Results Of BTK Open Bypass Revascularization: Heparin Bonded PTFE Grafts Versus In Situ Or Reversed Vein Grafts: When Are PTFE Grafts To Tibial/Peroneal Arteries Worthwhile |
| Presenter(s):Carlo Pratesi, MD / Giovanni Pratesi, MD | |
| View Slides in PDF | |
| 5:35 PM - 5:40 PM | Distal Bypasses Under Nerve Block Without General Anesthesia Improves Results Of Bypasses For CLTIs |
| Presenter(s):Nobuyoshi Azuma, MD | |
| View Slides in PDF | |
| 5:40 PM - 5:45 PM | Techniques For Overcoming Problems With Subintimal Angioplasty For Chronic Total Occlusions (CTOs): Like Inability To Re-Enter The True Lumen: Fancy Gadgets (Outback, Pioneer, Enteer, OffRoad) Are Almost Never Needed |
| Presenter(s):Ali Amin, MD, RVT, FACS, FACC | |
| View Slides in PDF | |
| 5:45 PM - 5:50 PM | The Growing Recognition Of Tibial And Pedal Calcification: How Does It Influence The Choice Of Endo Versus Open Bypass Treatment |
| Presenter(s):Michael S. Conte, MD | |
| View Slides in PDF | |
| 5:50 PM - 6:00 PM | Panel Discussion |
| 6:00 PM - 6:00 PM | End of Program C-2 |
| END OF SESSION 22 | |
|
Wednesday, November 16, 2022
Print Entire 2022 Program:
|
|
| SESSION 23 SCHEDULE | |
|
Wednesday
SESSION 23:
GENERALITIES IN THE ENDOVASCULAR AND OPEN TREATMENT OF LOWER EXTREMITY OCCLUSIVE DISEASE AND CLTI (5 AND 4 ¾-MINUTE SHORT SUMMARY [SS] TALKS)
Moderators:Enrico Ascher, MD / Andrej Schmidt, MD
|
|
| x | |
| 6:40 AM - 6:45 AM | How Do Prior Endovascular Interventions Affect Future Lower Extremity Bypass Outcomes For CLTI |
| Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS | |
| View Slides in PDF | |
| 6:46 AM - 6:51 AM | Do Diabetic Patients With CLTI And Substantial Foot Necrosis Have Time For An Endovascular First Strategy: Why Primary Open Bypass Treatment Is Better |
| Presenter(s):Katariina M. Noronen, MD, PhD | |
| View Slides in PDF | |
| 6:52 AM - 6:57 AM | Presenting Symptoms Of Lower Extremity Occlusive Disease And Intermittent Claudication In Women: How Do They Differ From Those In Men |
| Presenter(s):Linda M. Harris, MD | |
| View Slides in PDF | |
| 6:58 AM - 7:03 AM | Selective Coronary Revascularization Based On Preop CT Fractional Flow Reserve (FFRct) Improves 3-Year Survival Of CLTI Patients After Revascularization: Are Current Cardiac Evaluation Guidelines Out Of Date |
| Presenter(s):Christopher K. Zarins, MD / Dainis K. Krievins, MD | |
| View Slides in PDF | |
| 7:04 AM - 7:09 AM | Small Artery Disease (SAD), Medial Artery Calcification (MAC) And Below The Ankle (BTA) Disease: Major Causes Of CLTI With A Poor Prognosis: How Are They Best Treated Endovascularly |
| Presenter(s):Roberto Ferraresi, MD | |
| View Slides in PDF | |
| OPTIMAL TECHNIQUES FOR VESSEL PREP FOR ENDOVASCULAR TREATMENTS | |
| 7:10 AM - 7:15 AM | [SS] Optimal Different Techniques Of Vessel Prep For Plain Old Balloon Angioplasty (POBA), Drug Coated Balloon (DCB) Treatment And Drug Eluting Stent (DES) Treatment |
| Presenter(s):Fabrizio Fanelli, MD, EBIR | |
| View Slides in PDF | |
| 7:15 AM - 7:20 AM | [SS] Technical Tips For Vessel Prep Before DCBs And DESs: It Is Different And Not Simple |
| Presenter(s):Erwin Blessing, MD | |
| View Slides in PDF | |
| 7:20 AM - 7:25 AM | Tips And What Is New For Safe Radial Access For Renal/Visceral And Lower Extremity Interventions: How Far Distally In The Leg Can Lesions Be Treated |
| Presenter(s):Craig M. Walker, MD | |
| View Slides in PDF | |
| 7:26 AM - 7:31 AM | What Are The Downsides To Trans-Radial Or Pedal Access |
| Presenter(s):Gary M. Ansel, MD | |
| View Slides in PDF | |
| TECHNICAL TIPS ON GUIDEWIRE CHOICE AND USAGE | |
| 7:32 AM - 7:37 AM | [SS] Tips For Treating Difficult BTK/BTA Lesions: How To Get A Guidewire Across A Long Calcified Occlusion And Getting A Resistant Balloon To Go Over The Wire |
| Presenter(s):Marco G. Manzi, MD | |
| View Slides in PDF | |
| 7:37 AM - 7:42 AM | [SS] Guidewire Tips For Treating BTK And Crural Artery Lesions |
| Presenter(s):Craig M. Walker, MD | |
| View Slides in PDF | |
| 7:42 AM - 7:47 AM | [SS] Guidewire Tips For Treating Lesions Below The Ankle (BTA): Sliding, Piercing, Dissecting, Retrograde Maneuvers |
| Presenter(s):Roberto Ferraresi, MD | |
| View Slides in PDF | |
| 7:47 AM - 7:53 AM | Panel Discussion |
| END OF SESSION 23 | |
| SESSION 24 SCHEDULE | |
|
Wednesday
SESSION 24:
NEW DEVELOPMENTS IN ATHERECTOMY, STENTS (UNCOATED, COATED AND BIORESORBABLE) [ALL TALKS ARE 5 MINUTES]
Moderators:Craig M. Walker, MD / Iris Baumgartner, MD
|
|
| x | |
| PROGRESS IN ATHERECTOMY | |
| 7:53 AM - 7:58 AM | New Developments In Laser Atherectomy: What Makes It Different: When Is It Beneficial With Certainty |
| Presenter(s):George L. Adams, MD | |
| View Slides in PDF | |
| 7:59 AM - 8:04 AM | Index Atherectomy Interventions For Intermittent Claudication Are Associated With Higher Reintervention Rates Than Other Endovascular Treatments: Is This Device Specific |
| Presenter(s):Caitlin W. Hicks, MD, MS | |
| View Slides in PDF | |
| 8:05 AM - 8:10 AM | Update On Optical Coherence Tomography (OCT) Guided Atherectomy (Pantheris) For In Stent Restenosis (ISR): Why It Is More Effective Treatment: From The INSIGHT Trial |
| Presenter(s):Todd R. Vogel, MD, MPH | |
| View Slides in PDF | |
| 8:11 AM - 8:16 AM | Current Role Of Atherectomy In Treating Lower Extremity CLTI: A Vascular Surgeon’s View |
| Presenter(s):James F. McKinsey, MD | |
| View Slides in PDF | |
| UPDATE ON THE SUPERA STENT | |
| 8:17 AM - 8:22 AM Power Point Presentation with Synched Audio |
Update On The Advantages Of The Supera Vasculomimetic (VMI) Stent For Treating Long Complex Fempop Occlusive Lesions: Is There Value To DCB Vessel Prep First |
| Presenter(s):Peter C.J. Goverde, MD | |
| 8:23 AM - 8:28 AM | The Supera Interwoven Stent: When Is It The Best Treatment And How To Optimally Deploy This Unique Stent |
| Presenter(s):D. Christopher Metzger, MD / Craig M. Walker, MD | |
| View Slides in PDF | |
| DRUG ELUTING STENTS (DESs) FOR BTK LESIONS | |
| 8:29 AM - 8:34 AM | Updated 10-Year Experience With Everolimus DESs To Treat Long Infrapopliteal Lesions Causing CLTI: Indications, Results, Value And Limitations |
| Presenter(s):Robert A. Lookstein, MD, MHCDL, FSIR, FAHA | |
| View Slides in PDF | |
| 8:35 AM - 8:40 AM | Bioresorbable Everolimus DESs To Treat BTK Lesions Causing CLTI: Promising Results Up To 5-7 Years: From The DISAPEAR Registry And A Meta-Analysis Of The Absorb Stent From Abbott |
| Presenter(s):Steven Kum, MD / Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi) | |
| View Slides in PDF | |
| 8:41 AM - 8:46 AM | An Update Of Long-Term Outcomes For Drug-Eluting Resorbable Scaffolds Below-The-Knee (BTK) And Progress Of The LIFE-BTK Trial With The Esprit Stent From Abbott |
| Presenter(s):Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi) / Sahil A. Parikh, MD / Brian G. DeRubertis, MD | |
| View Slides in PDF | |
| 8:47 AM - 8:52 AM | Update On A 3-French Compatible Microstent (From Micro Medical) For Antegrade Or Retrograde Insertion To Treat Tibial Artery Lesions: The STAND And HEAL Trials |
| Presenter(s):Robert E. Beasley, MD, FSIR, FSCAI | |
| View Slides in PDF | |
| 8:53 AM - 9:00 AM | Panel Discussion |
| END OF SESSION 24 | |
| SESSION 25 SCHEDULE | |
|
Wednesday
SESSION 25:
LOWER EXTREMITY TOPICS RELATED TO THE DRUG COATED DEVICES CAUSING INCREASED MORTALITY CONTROVERSY: DO PACLITAXEL COATED DEVICES CAUSE INCREASED MORTALITY: DEB AND DES ALTERNATIVES TO PACLITAXEL AND RELATED ISSUES
Moderators:Kenneth Ouriel, MD, MBA / Sahil A. Parikh, MD
|
|
| x | |
| 9:00 AM - 9:05 AM | Older And More Recent Meta-Analyses Still Reveal An Increased Mortality Signal In Patients Receiving Paclitaxel Coated Devices Compared To Uncoated Devices: The More Recent Study Of DCBs In BTK Arteries Showed Increased Mortality And Amputation Rates After Only 1 Year |
| Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR | |
| View Slides in PDF | |
| 9:06 AM - 9:11 AM | An Update Of The Real-World Evidence Evaluating Paclitaxel Coated Device Safety In Treating Fempop And Crural Artery Lesions: The SAFE-PAD Study |
| Presenter(s):Eric A. Secemsky, MD, MSc | |
| View Slides in PDF | |
| 9:12 AM - 9:17 AM | The Paclitaxel Increased Mortality Effect Reported By Dr. Katsanos et al. Seems Not To Be Confirmed By Added Data: Let’s Put 4 Years Of Frenetic Activity Into Perspective |
| Presenter(s):Peter A. Schneider, MD | |
| View Slides in PDF | |
| 9:18 AM - 9:23 AM Power Point Presentation with Synched Audio |
Large Population Based German Multicenter Study Of Paclitaxel Coated BTK DCBs And DESs Indicates Decreased Mortality And Amputation Rates Compared To Uncoated Devices |
| Presenter(s):Christian A. Behrendt, MD | |
| 9:24 AM - 9:29 AM | The SWING Study: First In Human Use Of A Sirolimus DCB In Arteries Below-The-Knee |
| Presenter(s):Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi) / Andrew Holden, MBChB / Peter A. Schneider, MD | |
| View Slides in PDF | |
| 9:30 AM - 9:35 AM | Alternatives To Paclitaxel Coated Devices For Limiting Intimal Hyperplasia After Treatment: Sirolimus Coating, Bioresorbables And Adventitial Drug Delivery With The Bullfrog Device: How Do Paclitaxel And Limus Drugs Work And How Do They Differ |
| Presenter(s):William A. Gray, MD | |
| View Slides in PDF | |
| 9:36 AM - 9:41 AM | Progress And Problems With A Sustained Release Limus DCB: 3-Year Results With The Magic Touch DCB: From The SIRONA Study |
| Presenter(s):Dierk Scheinert, MD / Thomas Zeller, MD | |
| View Slides in PDF | |
| 9:42 AM - 9:47 AM Power Point Presentation with Synched Audio |
The Light And Darkness Of Fluoropolymer-Based Limus DESs In The Treatment Of Femoropopliteal Lesions |
| Presenter(s):Marianne Brodmann, MD | |
| 9:48 AM - 9:53 AM | Key New Developments In Endovascular Treatments For CLTI |
| Presenter(s):Sahil A. Parikh, MD | |
| View Slides in PDF | |
| 9:54 AM - 9:59 AM | Are DESs Ever Associated With Aneurysmal Degeneration: Is It Related To The Drug (Paclitaxel Or Limus) Or To The Fluoropolymer Excipient To Which The Drug Is Attached) |
| Presenter(s):Theodosios Bisdas, MD | |
| View Slides in PDF | |
| 10:00 AM - 10:08 AM | Panel Discussion |
| 10:08 AM - 10:18 AM | Lunch Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 25 | |
| SESSION 26 SCHEDULE | |
|
Wednesday
SESSION 26:
NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBs) AND DRUG ELUTING STENTS (DESs): UPDATES ON RANDOMIZED CONTROLLED TRIALS (RCTs) AND BTK LESION TREATMENTS WITH DCBs AND DESs
Moderators:Joseph L. Mills, MD / John R. Laird, MD
|
|
| x | |
| NEW INFORMATION ON DCBs AND DESs FOR FEMPOP LESIONS: UPDATES ON RCTs | |
| 10:18 AM - 10:23 AM | Cost Effectiveness Analysis Of Drug Eluting Technologies For Femoropopliteal Lesions Show That They Are Worth The Increased Device Costs |
| Presenter(s):Stefan Mueller-Huelsbeck, MD | |
| View Slides in PDF | |
| 10:24 AM - 10:29 AM | Stellarex (Philips) DCBs With Low Dose Paclitaxel Is Safe And Has Higher Patency Rates Than POBA With Fempop Lesions At 5 Years In The ILLUMENATE US And European RCTs: There Was No Paclitaxel Mortality Signal |
| Presenter(s):Sean P. Lyden, MD / Marianne Brodmann, MD / Sahil A. Parikh, MD / William A. Gray, MD | |
| View Slides in PDF | |
| 10:30 AM - 10:35 AM | Pooled Data From The In.Pact RCT And Real World DCB Trials For SFA-Pop Lesions Show Safety And Efficacy For 5 Years Compared To POBA: Will The Advantage Of DCBs Diminish With Time |
| Presenter(s):Peter A. Schneider, MD / John R. Laird, MD / Thomas Zeller, MD | |
| View Slides in PDF | |
| 10:36 AM - 10:41 AM | New Findings From The DRASTICO Study Comparing DESs To DCBs For Fempop Lesions: 5-Year Results With TASC A/B Lesions Versus TASC C/D Lesions |
| Presenter(s):Francesco Liistro, MD | |
| View Slides in PDF | |
| 10:42 AM - 10:47 AM | Value Of In.Pact DCBs For Long Complex SFA-Pop Lesions Including ISR And CTOs: Technical Tips And Contraindications: From The Global Registry: What Is The Best Endo Treatment For These Lesions |
| Presenter(s):Gunnar Tepe, MD / Marianne Brodmann, MD | |
| View Slides in PDF | |
| 10:48 AM - 10:53 AM | Update On The Randomized Head To Head Comparison Of In.Pact (Medtronic) And Ranger (Boston Scientific) DCBs For Complex SFA Lesions: 2-Year Results Of The COMPARE RCT: Similar Results With Different Paclitaxel Dosages |
| Presenter(s):Dierk Scheinert, MD / Sabine Steiner, MD | |
| View Slides in PDF | |
| 10:54 AM - 10:59 AM Power Point Presentation with Synched Audio |
Update On The Global RANGER II RCT Comparing Ranger DCBs With POBA: How Does It Help Us Determine The Best Treatment For Long Complex ATK Lesions |
| Presenter(s):Marianne Brodmann, MD | |
| 11:00 AM - 11:05 AM | New Information On The Safety And Effectiveness Of The Cook Zilver PTX DES Based On Global Trials Including A RCT: When Is It The Best Treatment |
| Presenter(s):Michael D. Dake, MD | |
| 11:06 AM - 11:11 AM | 2-Year Results Of The IMPERIAL RCT Head To Head Comparison Of The Zilver PTX DES (Cook) With The Eluvia DES (Boston Scientific): Both Are Safe And Effective: Is There A Difference |
| Presenter(s):Stefan Mueller-Huelsbeck, MD / William A. Gray, MD / Thomas Zeller, MD | |
| View Slides in PDF | |
| 11:12 AM - 11:18 AM | Panel Discussion |
| NEW INFORMATION ON BTK DCBs AND DESs | |
| 11:18 AM - 11:23 AM | Advances In BTK Drug Delivery Technology And DCBs: What Have We Learned From The In.Pact Deep BTK DCB Trial And New Challenges With Treating CLTI Patients |
| Presenter(s):Thomas Zeller, MD | |
| View Slides in PDF | |
| 11:24 AM - 11:29 AM | The Sirolimus DCB BTK Era Begins – Current Experience With The Selution DEB And Design Of The SELUTION SLR .014 BTK IDE Trial: Early Results From Singapore And Europe |
| Presenter(s):Patrick J. Geraghty, MD | |
| View Slides in PDF | |
| 11:30 AM - 11:35 AM | Orbital Vessel Preparation To Maximize DCB Efficacy In Calcified BTK Lesions: OPTIMIZE BTK RCT 1-Year Results |
| Presenter(s):Thomas Zeller, MD | |
| View Slides in PDF | |
| 11:36 AM - 11:41 AM Power Point Presentation with Synched Audio |
3-Year Results From The AcoArt II BTK DCB RCT Show Safety With No Increased Mortality And Improved Patency Versus POBA |
| Presenter(s):Wei Guo, MD / Francesco Liistro, MD | |
| View Slides in PDF | |
| 11:42 AM - 11:47 AM | Why Some BTK DCB Trials Have Not Shown Uniformly Better Results: Technical And Balloon Factors Matter |
| Presenter(s):Francesco Liistro, MD | |
| 11:48 AM - 11:53 AM | Update On The SAVAL Trial With A Self-Expanding DES (From Boston Scientific) For BTK Occlusive Lesions |
| Presenter(s):Miguel F. Montero, MD / Jihad A. Mustapha, MD | |
| View Slides in PDF | |
| 11:54 AM - 12:00 PM | Panel Discussion |
| 12:00 PM - 1:00 PM | Lunch Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 26 | |
| SESSION 27 SCHEDULE | |
|
Wednesday
SESSION 27:
PROGRESS IN EXOTIC AND EXTREME NEW TREATMENTS FOR VERY DISTAL LOWER EXTREMITY DISEASE CAUSING ADVANCED CLTI: HOW TO SAVE THE “NO OPTION FOR TREATMENT” LIMB OR THE “DESERT FOOT” WITH NO PATENT TARGET ARTERIES
|
|
| x | |
| 1:00 PM - 1:05 PM | No Option CLTI: What Is It: What Are The Actual Options For Treatment |
| Presenter(s):Hisham Rashid, FRCS, FRCS(Gen) | |
| View Slides in PDF | |
| 1:06 PM - 1:11 PM | Contemporary Survival After Below-Knee Amputation (BKA), Above-Knee Amputation (AKA), Bilateral Amputations For Trauma; For Vascular Disease: It Is Definitely Worthwhile Saving Limbs Especially In Vascular Patients |
| Presenter(s):Philip P. Goodney, MD, MS | |
| View Slides in PDF | |
| VALUE OF PROSTHETIC (PTFE) TIBIAL BYPASSES | |
| 1:12 PM - 1:17 PM | Value Of Spliced Vein Grafts Versus PTFE Grafts For Bypasses When A Single Autologous Vein Is Inadequate |
| Presenter(s):Joseph L. Mills, MD | |
| View Slides in PDF | |
| 1:18 PM - 1:23 PM | PTFE Tibial And Peroneal Artery Bypasses Can Save No Option Limbs Which Would Otherwise Require Amputation: They Have Worthwhile Long-Term Patency Rates And Limb Salvage Rates |
| Presenter(s):Hasan H. Dosluoglu, MD / Gregg S. Landis, MD / Richard F. Neville, MD / Enrico Ascher, MD / Frank J. Veith, MD | |
| View Slides in PDF | |
| 1:24 PM - 1:29 PM | PTFE Tibial And Peroneal Bypasses: Cases With Ultra-Long-Term Patency And Limb Salvage Prove Their Value When There Are No Other Options: Why Do They Work For Some Surgeons But Not Others |
| Presenter(s):Gregg S. Landis, MD / Richard F. Neville, MD / Hasan H. Dosluoglu, MD / Frank J. Veith, MD | |
| View Slides in PDF | |
| 1:30 PM - 1:35 PM | For Patients Facing Amputation With No Endo Options Or Useable Vein, PTFE Tibial Bypasses Are A Worthwhile Option That Yields Acceptable Mid-Term Patency And Long-Term Limb Salvage Rates |
| Presenter(s):R. Clement Darling III, MD | |
| View Slides in PDF | |
| 1:36 PM - 1:41 PM | Current Outcomes With PTFE Bypasses To Infrapopliteal (Tibial) Targets: Is There Variability Between Surgeons And Institutions |
| Presenter(s):Matthew T. Menard, MD | |
| View Slides in PDF | |
| UPDATE ON FOOT VEIN ARTERIALIZATION FOR CLTI | |
| 1:42 PM - 1:47 PM | Role And Value Of Vein Arterialization: Best Way To Do It And Long-Term Results: From The Pioneer |
| Presenter(s):Pramook Mutirangura, FRCS (Edinburgh) | |
| View Slides in PDF | |
| 1:48 PM - 1:53 PM | Pathophysiology Of Venous Arterialization And Neo Angiogenesis For No Option CLTI: How To Predict When It Will Work And When It Won’t: What Is The Medial Arterial Calcification (MAC) Score And Its Significance |
| Presenter(s):Roberto Ferraresi, MD | |
| View Slides in PDF | |
| 1:54 PM - 1:59 PM | Pivotal US Trial (PROMISE II), US Feasibility Study (PROMISE I) And European 2-Year Registry Results With Deep Vein Arterialization With The LimFlow Device For CLTI With Gangrene Shows Reasonable Limb Salvage And Wound Healing |
| Presenter(s):Daniel G. Clair, MD / Andrej Schmidt, MD / Daniela Branzan, MD | |
| View Slides in PDF | |
| 2:00 PM - 2:05 PM | How To Perform The LimFlow Procedure: Equipment Required And Technical Tips |
| Presenter(s):Miguel F. Montero, MD | |
| View Slides in PDF | |
| 2:06 PM - 2:11 PM | Deep Vein Arterialization And Valve Lysis By Surgical Means For No Option Desert Feet With Gangrene: How To Do It And Results |
| Presenter(s):Richard F. Neville, MD | |
| View Slides in PDF | |
| 2:12 PM - 2:18 PM | Panel Discussion |
| END OF SESSION 27 | |
| SESSION 28 SCHEDULE | |
|
Wednesday
SESSION 28:
NEW DEVELOPMENTS IN STENTS; PROSTHETIC GRAFTS; ENDOVASCULAR BYPASSES; STENT GRAFTS AND TREATMENT OF IN STENT RESTENOSIS (ISR)
Moderators:Linda M. Harris, MD / Mark A. Adelman, MD
|
|
| x | |
| 2:18 PM - 2:23 PM | Why The BioMimics 3D Stent Should Be The Treatment Of Choice In Complex Patients And Lesions |
| Presenter(s):Peter Gaines, MD / Michael K.W. Lichtenberg, MD / | |
| View Slides in PDF | |
| ARTERIAL PTFE BYPASSES | |
| 2:24 PM - 2:29 PM | RCT Comparing Heparin Bonded PTFE (Propaten) Grafts With Plain PTFE Grafts For BTK CLTI Bypasses: Is Heparin Bonding Helpful |
| Presenter(s):Yann Gouëffic, MD, PhD | |
| View Slides in PDF | |
| 2:30 PM - 2:35 PM | Hybrid Fluoroscopically Guided Improved Method For Restoring Patency To Occluded PTFE Bypasses: It’s Less Invasive And More Effective |
| Presenter(s):Neal S. Cayne, MD / Frank J. Veith, MD | |
| View Slides in PDF | |
| PERCUTANEOUS BYPASSES | |
| 2:36 PM - 2:41 PM | Percutaneous (PQ) Transvenous Fempop PTFE Bypasses With The Torus 2 Device (Now From Endologix): How It Works And Status Of The DETOUR And TORUS Trials In The US: 1-Year Results |
| Presenter(s):Sean P. Lyden, MD / Daniel G. Clair, MD / Peter A. Schneider, MD | |
| View Slides in PDF | |
| 2:42 PM - 2:47 PM | 4-Year Results Of The Detour PQ Fempop Arterial Bypass Routed Through The Femoral Vein: Will It Make Open Bypass Obsolete |
| Presenter(s):Dainis K. Krievins, MD | |
| View Slides in PDF | |
| 2:48 PM - 2:53 PM | A Novel Technique For Percutaneous Extravascular Fempop Bypass - Routing A PTFE Graft Through The Soft Tissue Of The Thigh: It Is A Transcatheter Technique That Is Clampless, Sutureless And Without External Exposure: How Does It Work And Results |
| Presenter(s):Pierre G. Sarradon, MD, MDC / Jean Pierre Becquemin, MD, FRCS | |
| View Slides in PDF | |
| 2:54 PM - 2:58 PM | Panel Discussion |
| NEW INFORMATION ON STENT-GRAFTS | |
| 2:58 PM - 3:03 PM | Can Viabahn Stent-Grafts Be Used Safely And Effectively In The SFA For CLTI: From Pooled Multicenter Data: What Are The Limitations Of These Devices |
| Presenter(s):Michel M.P. Reijnen, MD, PhD | |
| View Slides in PDF | |
| 3:04 PM - 3:09 PM | How Can IVUS Improve Outcomes When Self-Expanding Stent-Grafts (Viabahn) Are Used To Treat SFA Occlusive Lesions |
| Presenter(s):Eric A. Secemsky, MD, MSc | |
| View Slides in PDF | |
| 3:10 PM - 3:15 PM | Advantages, Limitations And Results Of Gore VBX BE Stent-Graft For Occlusive Disease In Various Vascular Beds And For F/B/EVAR Branches |
| Presenter(s):Rocco Giudice, MD / Ciro Ferrer, MD, PhD | |
| View Slides in PDF | |
| TREATMENT OF IN STENT RESTENOSIS (ISR) | |
| 3:16 PM - 3:21 PM | Laser Atherectomy May Facilitate Endovascular Treatment Of ISR But Does Not Provide Long-Term Benefit: How Should ISR Be Treated |
| Presenter(s):Russell H. Samson, MD, DFSVS, RVT, FACS | |
| View Slides in PDF | |
| 3:22 PM - 3:27 PM | The Excimer Laser For Treating ISR: It Has A Role In Crossing And Debulking Difficult Lesions: Technical Tips |
| Presenter(s):Craig M. Walker, MD | |
| View Slides in PDF | |
| 3:28 PM - 3:33 PM | How Best To Treat Long Difficult Complex SFA Lesions Including Those From ISR |
| Presenter(s):Sonia Ronchey, MD, PhD | |
| View Slides in PDF | |
| 3:34 PM - 3:46 PM | Panel Discussion And Break (Visit Exhibits And Pavilions – 2nd and 3rd Floors) |
| END OF SESSION 28 | |
| SESSION 29 SCHEDULE | |
|
Wednesday
SESSION 29:
LOWER EXTREMITY TRIALS; GUIDELINES; FOOT PERFUSION EVALUATION METHODS AND VALUE OF ANGIOSOMES
|
|
| x | |
| 3:46 PM - 3:51 PM | The Japanese SPINACH Registry Shows Why WIfI Wound Severity Helps To Select Open Versus Endovascular Treatment And Predicts Patient Survival |
| Presenter(s):Nobuyoshi Azuma, MD | |
| View Slides in PDF | |
| 3:52 PM - 3:57 PM | The New Global Vascular Guidelines And WIfI Staging For CLTI Are Better Than Obsolete TASC Guidelines Because Treatment Recommendations, Revascularization Strategies And Needs For The Future Are Not Based On Lesion Anatomy But Are Nuanced By Other Factors: What Are They |
| Presenter(s):Michael S. Conte, MD | |
| View Slides in PDF | |
| 3:58 PM - 4:03 PM | The Main Outcomes Of The BEST-CLI RCT Comparing Endovascular And Open Treatment Of Lower Extremity Ischemia: Limitations And What Will Be Its Value |
| Presenter(s):Alik Farber, MD, MBA / Matthew T. Menard, MD / Kenneth Rosenfield, MD | |
| View Slides in PDF | |
| 4:04 PM - 4:13 PM | Panel Discussion On Meaning And Significance Of Best-CLI Results |
| Panelist(s): Marianne Brodmann, MD / Michael S. Conte, MD / Matthew T. Menard, MD / Kenneth Rosenfield, MD | |
| METHODS FOR EVALUATING FOOT PERFUSION | |
| 4:13 PM - 4:18 PM | Value Of Perfusion Assessment Of The CLTI Foot Before Treatment And For Quality Control After Revascularization: How Best To Do It |
| Presenter(s):Maarit Venermo, MD, PhD | |
| View Slides in PDF | |
| 4:19 PM - 4:24 PM Power Point Presentation with Synched Audio |
How And Why To Measure Foot Perfusion During Endo Treatments: Hyperspectral Imaging, O2 Sensors, etc: When Is The Angiosome Concept Helpful; When Not |
| Presenter(s):Marianne Brodmann, MD | |
| 4:25 PM - 4:30 PM | New Methods For Evaluating Lower Extremity Arterial Lesions And Foot Perfusion Using Fractional Flow (FFR) And MRI; How They Work And Their Value In Assessing Therapeutic Success |
| Presenter(s):Bijan Modarai, PhD, FRCS | |
| View Slides in PDF | |
| 4:31 PM - 4:36 PM | Pedal Arch Patency Is Key To Predicting Limb Salvage With Endovascular Treatment For CLTI With Tissue Necrosis: How Is It Best Evaluated |
| Presenter(s):Hasan H. Dosluoglu, MD / Linda M. Harris, MD | |
| View Slides in PDF | |
| 4:37 PM - 4:42 PM | Foot Perfusion Measurements Are Invaluable In CLTI And Predicting Amputation Healing: They Also Show Why Open Bypasses Are Often Better Than Endovascular Treatments |
| Presenter(s):Werner Lang, MD | |
| View Slides in PDF | |
| 4:43 PM - 4:48 PM | Panel Discussion |
| END OF SESSION 29 | |
| SESSION 30 SCHEDULE | |
|
Wednesday
SESSION 30:
NEW DEVELOPMENTS IN THE TREATMENT OF INTERMITTENT CLAUDICATION AND ACUTE LIMB ISCHEMIA
Moderators:Michael S. Conte, MD / Matthew T. Menard, MD
|
|
| x | |
| INTERMITTENT CLAUDICATION (IC) | |
| 4:48 PM - 4:53 PM | DEBATE: A RCT After 2 Years Shows That Stent Treatment For Intermittent Claudication (IC) Improves Quality Of Life More Than Medical Treatment And Exercise And Is Cost Effective |
| Presenter(s):Hans Lindgren, MD, PhD | |
| View Slides in PDF | |
| 4:54 PM - 4:59 PM | DEBATE: Interventions For IC Are Safe But Lead To Greater Decreased Function And Increased Limb Loss |
| Presenter(s):Jeffrey J. Siracuse, MD, MBA, FACS | |
| View Slides in PDF | |
| 5:00 PM - 5:05 PM | Overuse Of Vascular Interventions For IC Is A Measure Of Poor Care: How Is This Determined |
| Presenter(s):Caitlin W. Hicks, MD, MS / James H. Black, III, MD | |
| View Slides in PDF | |
| 5:06 PM - 5:11 PM | Endovascular Interventions For IC: At 2 Years Only 32% Are Free From IC Recurrence: What Factors Decrease This Recurrence Rate: From A VQI Study |
| Presenter(s):Karen Woo, MD, PhD / Peter F. Lawrence, MD / Michael S. Conte, MD / Adam Beck, MD / Marc L. Schermerhorn, MD | |
| View Slides in PDF | |
| 5:12 PM - 5:16 PM | Panel Discussion |
| ACUTE LIMB ISCHEMIA (ALI) (See Also Session 63) | |
| 5:16 PM - 5:21 PM | Key Points From The 2020 New European Guidelines For Diagnosis And Treatment Of ALI In The Upper And Lower Limbs: When To Use Which Treatments: How Have These Guidelines Been Modified Recently |
| Presenter(s):Martin Bjorck, MD, PhD | |
| View Slides in PDF | |
| 5:22 PM - 5:27 PM | Update On Thrombosuction Devices For Treating ALI: Which Device In Which Circumstance: Advantages And Limitations |
| Presenter(s):Athanasios Katsargyris, MD / Eric L.G. Verhoeven, MD, PhD | |
| View Slides in PDF | |
| 5:28 PM - 5:33 PM | Endovascular Mechanical Thrombectomy Is Obviating The Need For Thrombolytics In ALI: Which Device Is Best – When And Why |
| Presenter(s):Patrick E. Muck, MD, FACS | |
| View Slides in PDF | |
| 5:34 PM - 5:39 PM | Percutaneous Vacuum Thrombectomy For ALI: Devices And Techniques: In 2022 What Is The Residual Role For Thrombolytics And Open Balloon Catheter Thrombectomy |
| Presenter(s):Scott L. Stevens, MD | |
| View Slides in PDF | |
| 5:40 PM - 5:45 PM | Penumbra Indigo Clot Aspiration System: What Makes It Different: Indications And Contraindications: What Is New In 2022 |
| Presenter(s):James F. Benenati, MD | |
| View Slides in PDF | |
| 5:46 PM - 5:51 PM | Value And Technical Tips For Using The Indigo Clot Removal System Before And After Treating ISR And Other Lesions With Balloon And Stents |
| Presenter(s):Frank R. Arko, MD | |
| View Slides in PDF | |
| 5:52 PM - 5:57 PM | How To Treat ALI Under Duplex Ultrasound Guidance: Advantages And Limitations |
| Presenter(s):Natalie A. Marks, MD, RPVI, RVT, FSVM / Enrico Ascher, MD | |
| View Slides in PDF | |
| 5:58 PM - 6:02 PM | Panel Discussion |
| 6:02 PM - 6:02 PM | End of Program D |
| END OF SESSION 30 | |
| SESSION 31 SCHEDULE | |
|
Wednesday
SESSION 31:
ADVANCES IN MEDICAL TREATMENTS, NEW ANTI-ATHEROGENIC DRUGS, VALUE OF RIVAROXABAN AND PREVENTING MIs IN VASCULAR SURGERY PATIENTS
Moderators:Peter Henke, MD / Ido Weinberg, MD, MSc
|
|
| x | |
| 6:46 AM - 6:51 AM Power Point Presentation with Synched Audio |
New Information From The VOYAGER And COMPASS Trials With Rivaroxaban (Xarelto From Janssen And J&J) And Aspirin: How Does It Help In The Management Of Patients With Arterial And Venous Disease: With And Without Kidney Disease And With And Without Statins |
| Presenter(s):Marianne Brodmann, MD | |
| 6:52 AM - 6:57 AM | New Strategies On How To Avoid And Treat Perioperative Myocardial Infarctions (MIs) In Open Vascular Surgery Patients |
| Presenter(s):Peter Henke, MD | |
| View Slides in PDF | |
| 6:58 AM - 7:03 AM Power Point Presentation with Synched Audio |
Update On LDL-C Lowering During A Lifetime: How Low To Strive For With Intensive Drug Therapy: How Young To Start If High; How Old To Continue Statins |
| Presenter(s):J. David Spence, MD | |
| View Slides in PDF | |
| 7:04 AM - 7:09 AM | DEBATE: LDL-C Lowering And Statins For Prophylaxis Of Vascular Events Are Dangerous And Not Helpful: What Does The Latest Evidence Show |
| Presenter(s):Sherif A.H. Sultan, MD, PhD, FRCS, EBQS-VASC, FACS | |
| View Slides in PDF | |
| 7:10 AM - 7:15 AM | DEBATE: Not So: Update On LDL-C Lowering With Statins And Other Drugs Stabilizes And Shrinks Plaques And Decreases Morbid Vascular Events: Stopping Statins Increases Patients’ Risk Of MI And Death |
| Presenter(s):Ron Waksman, MD | |
| View Slides in PDF | |
| 7:16 AM - 7:21 AM | Low Dose Rivaroxaban (Xarelto From Janssen And J&J) And Aspirin Improve Survival And Decrease Major Adverse Limb Events (MALE) After Endo And Open Treatments For PAD/CLTI: From The VOYAGER RCT: What Does The XATOA Prospective Registry Add |
| Presenter(s):Sebastian E. Debus, MD, PhD / Marianne Brodmann, MD | |
| View Slides in PDF | |
| 7:22 AM - 7:27 AM Power Point Presentation with Synched Audio |
How Does The Morbidity And Pathology Of Adverse Events With Arteriosclerosis Depend On Thrombosis: This Explains The Benefits Of Rivaroxaban And Aspirin Seen In The VOYAGER And COMPASS Trials |
| Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
| View Slides in PDF | |
| 7:28 AM - 7:33 AM | New Adjunctive Drugs (Plus Statins) To Lower LDL-Cholesterol (LDL-C) In Vascular Patients: Inclisiran, Bempedoic Acid And Ezetimbe: How Do They Work And When And How To Use Them: Level Of LDL-C To Strive For |
| Presenter(s):Richard Bulbulia, MA, MD, FRCS | |
| View Slides in PDF | |
| 7:34 AM - 7:42 AM | Panel Discussion |
| END OF SESSION 31 | |
| SESSION 32 SCHEDULE | |
|
Wednesday
SESSION 32:
CATHETER BASED TREATMENTS OF RESISTANT HYPERTENSION; MANAGEMENT OF CARDIAC PROBLEMS, SMOKING AND TRANSFUSION IN VASCULAR SURGERY PATIENTS; MORTALITY RISK IN STROKE PATIENTS; VASCULAR AND CARDIAC COMPLICATIONS OF COVID-19
Moderators:Ron Waksman, MD / Michael R. Jaff, DO
|
|
| x | |
| UPDATE ON RENAL DENERVATION FOR HYPERTENSION | |
| 7:42 AM - 7:47 AM | Current Status Of Renal Denervation For Drug Resistant Hypertension: Why The Simplicity Spyral Radiofrequency Denervation System Is Different: Status Of The SPYRAL HTN-OFF MED RCT (Versus Sham) |
| Presenter(s):Sahil A. Parikh, MD | |
| View Slides in PDF | |
| 7:48 AM - 7:53 AM | Updates On Other Methods Of Renal Denervation: Chemical (Alcohol) Infusion Via The Peregrine Catheter (Ablative Solutions) And Ultrasound Via The Paradise Catheter (ReCor Medical) |
| Presenter(s):Horst Sievert, MD | |
| View Slides in PDF | |
| 7:54 AM - 7:59 AM | Update On The Status Of Renal Denervation For Hypertension: Is It Here To Stay: Where Is It Going |
| Presenter(s):Eric A. Secemsky, MD, MSc | |
| View Slides in PDF | |
| OTHER TOPICS RELATED TO VASCULAR DISEASE AND ITS TREATMENT | |
| 8:00 AM - 8:05 AM | How Does the Female Sex Impact The Occurrence Of Lower Extremity Atherosclerosis, Its Treatment And Results Of Treatment |
| Presenter(s):Katherine A. Gallagher, MD | |
| View Slides in PDF | |
| 8:06 AM - 8:11 AM Power Point Presentation with Synched Audio |
How And Why Do Thoracic Stent-Grafts For TEVAR Negatively Affect The Heart |
| Presenter(s):Frans L. Moll, MD, PhD | |
| View Slides in PDF | |
| 8:12 AM - 8:17 AM | When Should Smoking Be Stopped Before AAA Repair; Before Lower Extremity Bypass: At Least 4 Weeks Because Duration Of Cessation Matters |
| Presenter(s):Jeffrey J. Siracuse, MD, MBA, FACS | |
| View Slides in PDF | |
| 8:18 AM - 8:23 AM | Limiting Transfusion And Permitting Anemia After Major Vascular Operations Increases Mortality And Serious Adverse Events Especially In Patients With Cardiac Co-Morbidities |
| Presenter(s):Panos Kougias, MD, MSc | |
| View Slides in PDF | |
| 8:24 AM - 8:29 AM | How To Quantitate Late Mortality Risk In Asymptomatic Carotid Stenosis (ACS) Patients: Why It’s Important In Decision Making And What To Do About It Other Than Treating ACS Patients Non-Invasively |
| Presenter(s):Stavros K. Kakkos, MD, PhD / Andrew N. Nicolaides, MS, FRCS | |
| View Slides in PDF | |
| 8:30 AM - 8:35 AM | Update On Vascular Complications Of COVID-19 Infections: What Is Known And Unknown: How To Diagnose And Treat: Endo Versus Open |
| Presenter(s):Michael E. Barfield, MD | |
| View Slides in PDF | |
| 8:36 AM - 8:41 AM | Update On Cardiac Complications Of COVID-19 Infections: What Is Their Genesis: Diagnosis And Treatment |
| Presenter(s):Roxana Mehran, MD | |
| View Slides in PDF | |
| 8:42 AM - 8:50 AM | Panel Discussion |
| 8:50 AM - 9:06 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 32 | |
| SESSION 33 SCHEDULE | |
|
Wednesday
SESSION 33:
PROGRESS IN MANAGING ENDOLEAKS: UNDERSTANDING THEIR CONSEQUENCES AND PREDICTING, PREVENTING AND TREATING THEM
Moderators:Timur P. Sarac, MD / Peter L. Faries, MD, FACS
|
|
| x | |
| TO TREAT OR NOT TO TREAT TYPE 2 ENDOLEAKS | |
| 9:06 AM - 9:11 AM | Most Type 2 Endoleaks Are Benign: The Case Can Be Made That By Treating Type 2 Endoleaks The Harm And Cost Of Such Treatment Outweighs The Benefits: When If Ever Should They Be Treated: Is There A Relationship With AAA Remodeling |
| Presenter(s):Michel M.P. Reijnen, MD, PhD | |
| View Slides in PDF | |
| TREATING TYPE 1 ENDOLEAKS | |
| 9:12 AM - 9:17 AM | Type 1A Endoleaks After EVAR: Predictability Does Not Equate To Preventability: How Are They Best Treated |
| Presenter(s):Michael J. Singh, MD | |
| View Slides in PDF | |
| 9:18 AM - 9:23 AM | When And How To Treat Type 1 Endoleaks With Embolization: Technical Tips |
| Presenter(s):Robert A. Morgan, MD | |
| View Slides in PDF | |
| 9:24 AM - 9:29 AM | When And How To Use Embolization Coils To Treat Type 1A Endoleaks Successfully: When Won’t Coils Work: How To Diagnose Type 1A Endoleaks Accurately |
| Presenter(s):Sigrid Nikol, MD | |
| View Slides in PDF | |
| 9:30 AM - 9:35 AM | How To Minimize Gutter Type 1A Endoleaks With Chimney EVAR (Ch/EVAR): A Standard Protocol Helps |
| Presenter(s):David J. Minion, MD | |
| View Slides in PDF | |
| 9:36 AM - 9:41 AM Power Point Presentation with Synched Audio |
Fibrin Glue Sac Filling Technique During EVAR To Prevent All Endoleaks: It Should Be Routine And Is A Game Changer Based On A Multicenter Trial: How To Do It |
| Presenter(s):Qingsheng Lu, MD | |
| View Slides in PDF | |
| 9:42 AM - 9:48 AM | Panel Discussion |
| PREVENTION OF TYPE 2 ENDOLEAKS AFTER EVAR | |
| 9:49 AM - 9:54 AM | A RCT Shows The Advantages Of Inferior Mesenteric Artery (IMA) And Lumbar Embolization: The Next Generation Of EVAR Endografts Must Prevent Endoleaks: How Can It Be Done |
| Presenter(s):Dominique Fabre, MD, PhD / Stephan Haulon, MD | |
| View Slides in PDF | |
| 9:55 AM - 10:00 AM | Preventing Threatening Type 2 Endoleaks By IMA Embolization When AAA Sac And IMA Are Large: Indications And Technical Tips And Evidence |
| Presenter(s):Toru Kuratani, MD, PhD | |
| View Slides in PDF | |
| 10:01 AM - 10:06 AM | With A Large IMA (>3 mm), When Should It Be Embolized; When Should It Be Revascularized And Why |
| Presenter(s):Piotr M. Kasprzak, MD | |
| View Slides in PDF | |
| 10:07 AM - 10:12 AM | Selective Coiling Of IMA And Lumbar Arteries Decrease Harmful Type 2 Endoleaks After EVAR: When And How To Do It |
| Presenter(s):Götz M. Richter, MD, PhD | |
| View Slides in PDF | |
| 10:13 AM - 10:19 AM | Panel Discussion |
| TREATMENT OF TYPE 2 ENDOLEAKS AND ENDOTENSION AFTER EVAR | |
| 10:20 AM - 10:25 AM | How Duplex Ultrasound Velocities In Type 2 Endoleaks Determine Behavior And Help In Treatment: Technical Tips |
| Presenter(s):Ross Milner, MD | |
| View Slides in PDF | |
| 10:26 AM - 10:31 AM | Glue Embolization Is Effective Treatment For Most Threatening Type 2 Endoleaks: When And How Best To Do It |
| Presenter(s):Neal S. Cayne, MD | |
| View Slides in PDF | |
| 10:32 AM - 10:37 AM | New Concepts In Post EVAR Endoleaks And Endotension: The Role Of Fabric Fatigue, Concealed Endoleaks And AAA Sac Hygromas: How Can These Be Detected And Best Treated |
| Presenter(s):Sherif A.H. Sultan, MD, PhD, FRCS, EBQS-VASC, FACS | |
| View Slides in PDF | |
| 10:38 AM - 10:43 AM | How To Best Leverage 3D Fusion Software (GE) To Get Into The Nidus And Treat Type 2 Endoleaks: Best Embolic Agent And Value Of Transcaval Access For Type 1 And 2 Endoleaks |
| Presenter(s):Mark W. Mewissen, MD, RVT | |
| View Slides in PDF | |
| 10:44 AM - 10:49 AM | Transgraft Approach To Treat Type 2 Endoleaks: Indications, Equipment, Advantages And Precautions |
| Presenter(s):James F. McKinsey, MD | |
| View Slides in PDF | |
| 10:50 AM - 10:55 AM | Laser Assisted Transgraft Onyx Embolization Of Type 2 Endoleaks: Indications, Equipment And Technique |
| Presenter(s):Zvonimir Krajcer, MD, FACC | |
| View Slides in PDF | |
| 10:56 AM - 11:01 AM | With Type 2 Endoleaks And Sac Expansion Open Sacotomy And Branch Ligation Is The Best Treatment: Why And What Precautions Are Needed To Be Sure There Is No Occult Type 1 Leak |
| Presenter(s):Zachary M. Arthurs, MD | |
| View Slides in PDF | |
| 11:02 AM - 11:11 AM | Panel Discussion |
| END OF SESSION 33 | |
| SESSION 34 SCHEDULE | |
|
Wednesday
SESSION 34:
TCT AND PLINIO ROSSI RECORDED LIVE COMPLEX AND CHALLENGING ENDOVASCULAR CASES
Moderators:TBD
|
|
| x | |
| TCT RECORDED LIVE CHALLENGING ENDOVASCULAR CASES | |
| Moderator(s): Juan F. Granada, MD / Sahil A. Parikh, MD | |
| 11:12 AM - 11:36 AM | PROGRAM TO BE DETERMINED |
| PLINIO ROSSI’S RECORDED LIVE COMPLEX AND CHALLENGING ENDO CASES | |
| Moderator(s): Fabrizio Fanelli, MD, EBIR / Andrew Holden, MBChB / Carlo Setacci, MD | |
| 11:36 AM - 11:48 AM | Reconstruction Of Symptomatic And Chronically Occluded Iliac Veins And IVC (Video Presentation And Discussion) |
| Presenter(s):Marcelo Guimaraes, MD, MBA, FSIR | |
| View Slides in PDF | |
| 11:48 AM - 12:00 PM | A Complex Below-The-Knee Occlusive Case And Management Of Multiple Complications (Video Presentation And Discussion) |
| Presenter(s):Marco G. Manzi, MD | |
| View Slides in PDF | |
| 12:00 PM - 1:00 PM | Lunch Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 34 | |
| SESSION 35 SCHEDULE | |
|
Wednesday
SESSION 35:
RECORDED LIVE CHALLENGING CASES AND INNOVATIVE TECHNIQUES FROM THE LINC GROUP
|
|
| x | |
| 1:00 PM - 1:32 PM | PROGRAM TO BE DETERMINED |
| END OF SESSION 35 | |
| SESSION 36 SCHEDULE | |
|
Wednesday
SESSION 36:
ISSUES IMPORTANT IN VASCULAR SURGERY: LEADERSHIP, HISTORY, EFFICIENCY, MALPRACTICE, SCIENCE, TRAINING AND HUMAN BEHAVIOR
Moderators:Kim J. Hodgson, MD / Dawn M. Coleman, MD
|
|
| x | |
| 1:33 PM - 1:38 PM | How To Succeed In Academic Vascular Surgery: Don’t Be A Revolutionary |
| Presenter(s):Ronald L. Dalman, MD | |
| View Slides in PDF | |
| 1:39 PM - 1:44 PM | Surgeons In The Time Of Pandemics: How Does Our Current COVID Crisis For Surgeons Compare To The Plague And Guy de Chauliac In 14th Century France |
| Presenter(s):Cynthia K. Shortell, MD | |
| View Slides in PDF | |
| 1:45 PM - 1:50 PM | How To Improve Operating Room Efficiency For Vascular Surgical Operations: Why Is Inefficiency In This Setting So Widespread And Hard To Fix |
| Presenter(s):Panos Kougias, MD, MSc | |
| View Slides in PDF | |
| 1:51 PM - 1:56 PM | Patient Reported Outcomes (PROs): What Are They: Importance And Pitfalls: How Do They Differ From Patient Satisfaction |
| Presenter(s):Christopher J. Smolock, MD | |
| View Slides in PDF | |
| 1:57 PM - 2:02 PM | In A Malpractice Proceeding Or Trial What Recourse Does A Physician-Defendant Have When An Expert Witness Provides Inaccurate Or False Testimony |
| Presenter(s):O. William Brown, MD, JD | |
| View Slides in PDF | |
| 2:03 PM - 2:08 PM | RCTs And Meta-Analyses Can Be Flawed And Biased: They Should Only Be Viewed With Other Evidence And Common Sense |
| Presenter(s):George S. Lavenson, MD | |
| View Slides in PDF | |
| 2:09 PM - 2:14 PM | Why Systematic Reviews And Meta-Analyses Can Be Misleading: What To Do About It |
| Presenter(s):Janet T. Powell, MD, PhD | |
| View Slides in PDF | |
| ISSUES IN VASCULAR TRAINING | |
| 2:15 PM - 2:20 PM | Optimal New Training Paradigm For Vascular Surgeons: 0+5 Vascular Surgery Residency Followed By 2 Years Of Cardiac Surgery Residency Training: Why Is It Better Than 2 Extra Years Of Laboratory Research |
| Presenter(s):Alan B. Lumsden, MD, FACS | |
| View Slides in PDF | |
| 2:21 PM - 2:26 PM | Coming Crisis In Vascular Surgical Training – In Both 5+2 And 0+5 Programs: What Can Be Done About It |
| Presenter(s):Michael B. Silva, Jr., MD | |
| View Slides in PDF | |
| 2:27 PM - 2:32 PM | How To Remedy The Deficiency Vascular Fellows And Residents Have In Their Numbers Of Open Vascular Surgical Operations |
| Presenter(s):Malachi Sheahan, MD | |
| View Slides in PDF | |
| 2:33 PM - 2:38 PM | Negative Impact Of The COVID Pandemic On Vascular Surgical Training: How Long Will They Last |
| Presenter(s):Jason T. Lee, MD | |
| View Slides in PDF | |
| 2:39 PM - 2:44 PM | How Human Behavior Is Controlled By Biases And Rationalizations: How To Overcome These And Perform Better |
| Presenter(s):Scott L. Stevens, MD | |
| View Slides in PDF | |
| 2:45 PM - 2:58 PM | Panel Discussion And Break (Visit Exhibits And Pavilions – 2nd and 3rd Floors) |
| END OF SESSION 36 | |
| SESSION 37 SCHEDULE | |
|
Wednesday
SESSION 37:
MORE ISSUE-RELATED TOPICS IMPORTANT TO VASCULAR SURGEONS AND VASCULAR SPECIALISTS; ISSUES RELATED TO OUTPATIENT CENTERS OR OFFICE BASED LABS (OBLs)
Moderators:Anton N. Sidawy, MD, MPH / Krishna Jain, MD
|
|
| x | |
| 2:58 PM - 3:03 PM | The Wellness Of Vascular Surgeons: Physical And Mental: How To Monitor And Promote It: The Importance Of Intraoperative Posture |
| Presenter(s):Samuel R. Money, MD, MBA | |
| View Slides in PDF | |
| 3:04 PM - 3:09 PM | Unfilled Promises With Devices, Drugs And Treatments: Initial Hype That Is Not Fulfilled: It Is Often Hidden: More Transparency Is Needed: A Few Examples |
| Presenter(s):Sherif A.H. Sultan, MD, PhD, FRCS, EBQS-VASC, FACS | |
| View Slides in PDF | |
| 3:10 PM - 3:15 PM | Heart And Vascular Centers Are Artificial Entities That Disadvantage Vascular Surgeons |
| Presenter(s):Malachi Sheahan, MD | |
| View Slides in PDF | |
| 3:16 PM - 3:21 PM Power Point Presentation with Synched Audio |
Effect Of Increased Hydration And Protein Intake On Lower Extremity Arteriosclerotic Ischemia With IC And CLTI: What Is The Evidence And The Mechanism: Will It Change The Game And Decrease The Need For Stents And Bypasses |
| Presenter(s):Juan C. Parodi, MD / Samuel Fernandez, MD | |
| View Slides in PDF | |
| 3:22 PM - 3:27 PM | Vascular Spinoff Revenue In Tertiary Healthcare Systems: More Downstream Benefits From Vascular Surgeons: How To Make Hospital Administrators Appreciate The Value Of Vascular Surgeons |
| Presenter(s):Joseph V. Lombardi, MD, MBA | |
| View Slides in PDF | |
| 3:28 PM - 3:33 PM | The Ever Changing Reimbursement For Lower Extremity Endovascular Therapies In Hospitals And OBLs: Why It’s Happening And Where Is It Going |
| Presenter(s):Sean P. Roddy, MD / Robert M. Zwolak, MD, PhD | |
| View Slides in PDF | |
| 3:34 PM - 3:39 PM | Panel Discussion |
| ISSUES RELATED TO OUTPATIENT CENTERS AND OBLs | |
| 3:39 PM - 3:44 PM | A Balanced View Of Atherectomy In Ambulatory Surgicenters (ASCs) And OBLs In 2022: Are There Differences And Is The Procedure Overused |
| Presenter(s):Krishna Jain, MD | |
| View Slides in PDF | |
| 3:45 PM - 3:50 PM | Why And How Do Outpatient Angio Suites And OBLs Fail |
| Presenter(s):Sam S. Ahn, MD, FACS, MBA | |
| View Slides in PDF | |
| 3:51 PM - 3:56 PM | How Can OBLs Provide Good Vascular Care With Excellent Results, Be Profitable And Still Allow Vascular Surgeons To Only Work From 8 AM to 5 PM |
| Presenter(s):Mark A. Mattos, MD | |
| View Slides in PDF | |
| 3:57 PM - 4:02 PM | Tips And Tricks For Performing High-Risk Lower Extremity Endovascular Procedures Safely And Successfully In An Outpatient Setting |
| Presenter(s):Anil P. Hingorani, MD / Enrico Ascher, MD | |
| View Slides in PDF | |
| 4:03 PM - 4:08 PM | OBL Audits: What Are They Looking For And How To Avoid Civil And Criminal Penalties |
| Presenter(s):O. William Brown, MD, JD | |
| View Slides in PDF | |
| 4:09 PM - 4:13 PM | Panel Discussion |
| END OF SESSION 37 | |
| SESSION 38 SCHEDULE | |
|
Wednesday
SESSION 38:
UPDATES AND ISSUES IMPORTANT TO ALL VASCULAR SURGEONS AND SPECIALISTS: FUTURE REIMBURSEMENT; ETHICS OF FDA ACCESS; VASCULAR REGISTRIES AND THE VQI, VALUE OF GUIDELINES, ENDPOINTS; INDUSTRY RELATIONS; IMPACT OF GOVERNMENT (ACA) AND REGULATORY AGENCIES (FDA)
Moderators:Robert M. Zwolak, MD, PhD / Sean P. Roddy, MD
|
|
| x | |
| 4:13 PM - 4:18 PM | What Obstacles And Blows Are Vascular Surgeons And Other Vascular Specialists Facing In 2022: Will Planned Increased Reimbursement For Office And Hospital Visits Cause Decreases In Procedural Reimbursements |
| Presenter(s):Sean P. Roddy, MD | |
| View Slides in PDF | |
| 4:19 PM - 4:24 PM | How Can Vascular Surgeons Identify High Risk, High-Cost Patients And Help Health Care Systems Control Costs: How To Prevent Inappropriate Treatments In These Patients |
| Presenter(s):Lee Kirksey, MD | |
| 4:25 PM - 4:30 PM | International Consortium of Vascular Registries (ICVR) And The Use Of Real World Evidence To Evaluate Aortic Endograft Performance In Ruptured Aneurysms |
| Presenter(s):Adam Beck, MD | |
| View Slides in PDF | |
| 4:31 PM - 4:36 PM | The Role And Value Of Guidelines In Vascular Practice; Why Guidelines Can Be Misleading; How Should They Be Written To Not Be |
| Presenter(s):Anders Wanhainen, MD, PhD | |
| View Slides in PDF | |
| 4:37 PM - 4:42 PM | Non-Compliance With The SVS AAA Practice Guidelines Is Common: How Does It Impact Outcomes |
| Presenter(s):Elliot L. Chaikof, MD, PhD | |
| View Slides in PDF | |
| 4:43 PM - 4:48 PM | Ethics Of Limiting Access To Potentially Promising Technology: At What Point Is It Ethical To Use And Evaluate An Innovative Technology In A Patient/Clinical Study |
| Presenter(s):Valerie M. Merkle, PhD | |
| View Slides in PDF | |
| 4:49 PM - 4:54 PM | Managing Various Specialties And Generations Of Specialists In A Multi-Specialty Vascular Institute Or Center: How To Optimize Patient Outcomes |
| Presenter(s):Gary M. Ansel, MD | |
| View Slides in PDF | |
| 4:55 PM - 5:00 PM Power Point Presentation with Synched Audio |
Despite What The New York Times And Others Say, Close Relationships Of Vascular Surgeons With Industry Are Mostly Ethical And Beneficial To Patients And Society: Pitfalls To Avoid |
| Presenter(s):Bruce A. Perler, MD, MBA | |
| View Slides in PDF | |
| 5:01 PM - 5:06 PM | How Do Surgeons Drive Vascular Innovation: What Are The Critical Steps Leading To Success |
| Presenter(s):Jeffrey H. Lawson, MD, PhD | |
| View Slides in PDF | |
| 5:07 PM - 5:14 PM | Panel Discussion |
| EVIDENCE BASED MEDICINE ISSUES | |
| Moderator(s): Jack L. Cronenwett, MD / Sean P. Roddy, MD | |
| 5:14 PM - 5:19 PM | Propensity Score Matching Studies: How Do They Work And What Are Their Strengths And Weaknesses |
| Presenter(s):Charles C. Miller, PhD | |
| View Slides in PDF | |
| 5:20 PM - 5:25 PM | Registry Based RCTs: What Are They And Why Are They Better Than Other Evidence Based Techniques |
| Presenter(s):Jens Eldrup-Jorgensen, MD / Jack L. Cronenwett, MD | |
| View Slides in PDF | |
| REGULATORY ISSUES | |
| 5:26 PM - 5:31 PM | Historical Perspective Over The Last 25 Years On FDA Approvals Of EVAR Devices Submitted By Investigators And Industry: Lessons Learned To Guide Future Applications |
| Presenter(s):Dorothy B. Abel, BSBME | |
| View Slides in PDF | |
| JOURNAL ISSUES | |
| 5:32 PM - 5:37 PM | How To Get A Paper Accepted In A High Impact Journal Like The JVS: Does Bias Ever Matter |
| Presenter(s):Peter Gloviczki, MD / Peter F. Lawrence, MD | |
| View Slides in PDF | |
| SVS, GOVERNMENT AND MEDICAL INSURANCE TOPICS | |
| 5:38 PM - 5:43 PM | The SVS Foundation: How Does It Serve Vascular Surgeons And Their Patients |
| Presenter(s):Peter F. Lawrence, MD | |
| View Slides in PDF | |
| 5:44 PM - 5:49 PM | Effects Of The Affordable Care Act (ACA) On Vascular Surgical Outcomes: Does The Medicaid Expansion Of The ACA Improve Outcomes Or Not |
| Presenter(s):Mohammad H. Eslami, MD, MPH | |
| View Slides in PDF | |
| 5:50 PM - 5:55 PM | If You Want Medicare For All Look At The NHS First |
| Presenter(s):Firas F. Mussa, MD | |
| View Slides in PDF | |
| 5:56 PM - 6:05 PM | Panel Discussion |
| 6:05 PM - 6:05 PM | End of Program E |
| END OF SESSION 38 | |
| SESSION 39 SCHEDULE | |
|
Wednesday
SESSION 39:
MORE TOPICS RELATED TO THE THORACIC AORTA, AORTIC DISSECTIONS, INTRAMURAL HEMATOMAS (IMHs), PENETRATING AORTIC ULCERS (PAUs) AND THEIR TREATMENT
Moderators:Ramon Berguer, MD, PhD / Paulo E. Ocke Reis, MD, PhD
|
|
| x | |
| 6:50 AM - 6:55 AM | False Lumen Thrombosis Is An Overused And Meaningless Endpoint In The Treatment Of Uncomplicated TBAD |
| Presenter(s):Firas F. Mussa, MD | |
| View Slides in PDF | |
| 6:56 AM - 7:01 AM | Acute Aortic Dissection (Type A And B) Is More Common Than We Think: From A Swedish Population Based Study: Why Are We Missing Cases And What Can Be Done About |
| Presenter(s):Johnny Steuer, MD, PhD | |
| View Slides in PDF | |
| 7:02 AM - 7:07 AM | Value Of Stent-Grafts In Genetically Triggered Aortopathy |
| Presenter(s):Cherrie Z. Abraham, MD | |
| View Slides in PDF | |
| 7:08 AM - 7:13 AM | What Is Best Medical Treatment For TBAD Patients: How Best To Control Blood Pressure And To Get Patients To Comply: They Don’t |
| Presenter(s):Colin D. Bicknell, MD, FRCS | |
| View Slides in PDF | |
| 7:14 AM - 7:19 AM | Multimodular Approach To Treating Chronic TBADs With TAAAs: Who Needs A F/B/EVAR; Who Needs A Candy-Plug |
| Presenter(s):Tilo Koelbel, MD, PhD / Fiona Rohlffs, MD | |
| View Slides in PDF | |
| 7:20 AM - 7:25 AM | Panel Discussion |
| 7:25 AM - 7:30 AM | Comparison Of The STABILISE And Petticoat Techniques For Treatment Of Acute And Subacute TBADs: Preliminary Results Suggest STABILISE Achieves Better False Lumen Obliteration |
| Presenter(s):Igor A. Laskowski, MD, PhD / Josh B. Goldberg, MD / Heepeel Chang, MD | |
| View Slides in PDF | |
| 7:31 AM - 7:36 AM | Reinterventions After TEVAR For TBADs: How To Plan For The Future At The Index Procedure And Strategies For Successful Repair In The Chronic Phase |
| Presenter(s):Bijan Modarai, PhD, FRCS | |
| View Slides in PDF | |
| 7:37 AM - 7:42 AM | Requirement For Adjunctive Branch Stents After TEVAR For Complicated TBADs Is An Indicator Of Poor Prognosis: What Can Be Done To Offset It |
| Presenter(s):Mark K. Eskandari, MD | |
| View Slides in PDF | |
| 7:43 AM - 7:48 AM | Update On Intramural Hematoma (IMH): The Majority Can Be Managed With Medical Treatment And Close Observation, But Some Require Urgent Intervention: Which Ones |
| Presenter(s):Frank J. Criado, MD | |
| View Slides in PDF | |
| 7:49 AM - 7:54 AM | Natural History And Optimal Treatment For Penetrating Aortic Ulcers (PAUs): When To Observe And When To Treat With TEVAR |
| Presenter(s):Colin D. Bicknell, MD, FRCS | |
| View Slides in PDF | |
| 7:55 AM - 8:00 AM | Panel Discussion |
| END OF SESSION 39 | |
| SESSION 40 SCHEDULE | |
|
Wednesday
SESSION 40:
MORE ADVANCES RELATED TO TREATING PATHOLOGY INVOLVING THE ASCENDING AORTA AND THE AORTIC ARCH; AORTIC DISSECTIONS AND THEIR TREATMENT
Moderators:Rodney A. White, MD / Joseph E. Bavaria, MD
|
|
| x | |
| 8:00 AM - 8:05 AM | The Majority Of TBAD Patients – Complicated And Uncomplicated – Require Secondary Endovascular Procedures After TEVAR: What Secondary Procedures And When |
| Presenter(s):Götz M. Richter, MD, PhD | |
| View Slides in PDF | |
| 8:06 AM - 8:11 AM | Antegrade Stent-Graft Delivery For Treating Acute Type A Dissections: When Is It Advantageous And How To Do It |
| Presenter(s):Ourania Preventza, MD / Joseph S. Coselli, MD | |
| View Slides in PDF | |
| 8:12 AM - 8:17 AM | Status Of A Catheter Aortic Septotomy Device For Treating Aortic Dissections: Why And How Should It Work As A Treatment |
| Presenter(s):Ramon Berguer, MD, PhD / Juan C. Parodi, MD | |
| View Slides in PDF | |
| 8:18 AM - 8:23 AM | Caval Balloon Occlusion: A Better Way Than Rapid Pacing To Permit Precise Stent-Graft Placement In The Proximal Aorta: How To Do It And Is It Better For The Heart |
| Presenter(s):Nuno V. Dias, MD, PhD / Bjõrn Sonesson, MD, PhD | |
| View Slides in PDF | |
| 8:24 AM - 8:29 AM | Updated Experience For Precise TEVAR Placement In Or Near The Arch By Valsalva And PEEP: It Is Safe And Effective: Adenosine, Rapid Pacing And Caval Occlusion Are NOT Needed: How To Do It And How To Do It With A Prosthetic Aortic Valve |
| Presenter(s):Nikolaos Tsilimparis, MD; PhD | |
| View Slides in PDF | |
| 8:30 AM - 8:35 AM | Panel Discussion |
| 8:35 AM - 8:40 AM Power Point Presentation with Synched Audio |
Arch Lesion Repair With Single, Double Or 3-Branched Devices: When Is Each Best And Why: How To Do It From A Totally Femoral Approach |
| Presenter(s):Gustavo S. Oderich, MD FACS | |
| 8:41 AM - 8:46 AM | Chimney Technique For Dealing With Total Arch Lesions And Dissections: How To Make It Work, Limitations And Results |
| Presenter(s):Ivo Petrov, MD, PhD | |
| View Slides in PDF | |
| 8:47 AM - 8:52 AM | Laser Fenestrations And Total Percutaneous Techniques For Endovascular Arch Repair |
| Presenter(s):Timothy A. Resch, MD, PhD | |
| View Slides in PDF | |
| 8:53 AM - 8:59 AM Power Point Presentation with Synched Audio |
In Situ Fenestration With Life Tech Technology For Aortic Arch Aneurysms: An Alternative To Branched Graft Devices And Parallel Grafts: Results In >50 Cases And How Does The New Technology Work |
| Presenter(s):Ralf R. Kolvenbach, MD | |
| View Slides in PDF | |
| 8:59 AM - 9:04 AM | Multicenter International Study On Preloaded Fenestrated Endografts With A Modified Biport Handle (Cook): A Way To Make F/EVAR Easy: How Does The System Work |
| Presenter(s):Nikolaos Tsilimparis, MD; PhD | |
| View Slides in PDF | |
| 9:05 AM - 9:11 AM | Panel Discussion |
| 9:11 AM - 9:24 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 40 | |
| SESSION 41 SCHEDULE | |
|
Wednesday
SESSION 41:
OPEN AND ENDO TREATMENT OF COMPLEX AAAs (JUXTA, PARA- AND SUPRA-RENAL) AND TAAAs; NEW DEVICES FOR THEIR TREATMENT
Moderators:Nuno V. Dias, MD, PhD / Tara M. Mastracci, MD
|
|
| x | |
| COMPLEX AAAs AND TAAAs | |
| 9:24 AM - 9:29 AM | Lower Extremity Ischemic Complications After F/B/EVAR: Etiology And How To Avoid Them |
| Presenter(s):Thomas S. Maldonado, MD | |
| View Slides in PDF | |
| 9:30 AM - 9:35 AM | Long-Term Survival Results After Type II TAAA Endovascular Repair: When Is The Procedure Contraindicated |
| Presenter(s):Matthew J. Eagleton, MD | |
| View Slides in PDF | |
| 9:36 AM - 9:41 AM | How To Make 3 Chimney EVAR With Involvement Of The SMA Safe And Effective |
| Presenter(s):Manish Mehta, MD, MPH | |
| View Slides in PDF | |
| 9:42 AM - 9:47 AM | Value Of Ch/EVAR For Juxtarenal AAAs: They Are As Safe And Effective As Any Other Procedure And Simpler: Based On A Meta-Analysis Of Mid-Term Outcomes |
| Presenter(s):Joost van Herwaarden, MD, PhD | |
| View Slides in PDF | |
| 9:48 AM - 9:53 AM | Risk Factors Associated With Long-Term Mortality And Complications After Open And Endovascular TAAA Repair: What Is The Role Of Open Repair In 2022 |
| Presenter(s):Thomas F. Lindsay, MDCM, FRCS | |
| View Slides in PDF | |
| 9:54 AM - 9:59 AM | Comparison Of Endo And Open Repair Of Post Dissection TAAAs: Which Procedure Is Best And When |
| Presenter(s):Fabio Verzini, MD, PhD, FEBVS | |
| View Slides in PDF | |
| 10:00 AM - 10:05 AM | Comparative Morbidity And Mortality Outcomes Of Open, Hybrid And F/B/EVAR For Type II And III TAAAs Justify Greater Use Of F/B/EVAR For These Complex Lesions |
| Presenter(s):Gilbert R. Upchurch, MD / Sal Scali, MD / Dean Arnaoutakis, MD | |
| View Slides in PDF | |
| 10:06 AM - 10:12 AM | Panel Discussion |
| TOPICS RELATED TO INTERESTING NEW DEVICES | |
| 10:12 AM - 10:17 AM | Update Of A New Hybrid Device (Thoracoflo From Terumo Aortic) For TAAA Repair: How It Works, Clinical Experience And Advantages |
| Presenter(s):Sebastian E. Debus, MD, PhD | |
| View Slides in PDF | |
| 10:18 AM - 10:23 AM | How To Prevent Patch Aneurysms After Open TAAA Repair With Long Antegrade Grafts: How To Treat Them When They Occur |
| Presenter(s):Thomas C. Bower, MD / Manju Kalra, MBBS | |
| View Slides in PDF | |
| 10:24 AM - 10:29 AM | Update On The Role Of Device Engineering And Components On Sac Regression: Failed Regression After EVAR Are Device Related Not Patient Related |
| Presenter(s):Michael C. Stoner, MD | |
| View Slides in PDF | |
| 10:30 AM - 10:35 AM Power Point Presentation with Synched Audio |
WeFlow Device For Juxtarenal AAA, TAAA And Arch Repairs: A New Inner Branch And Outer Branch Approach: How Does It Work And Early Results |
| Presenter(s):Wei Guo, MD | |
| View Slides in PDF | |
| 10:36 AM - 10:40 AM | Panel Discussion |
| END OF SESSION 41 | |
| SESSION 42 SCHEDULE | |
|
Wednesday
SESSION 42:
PROGRESS IN TREATING ILIAC ANEURYSMS; ILIAC BRANCHED DEVICES (IBDs); UPDATE ON MULTILAYER FLOW MODULATING (MLFM) AND OTHER BARE STENTS FOR TREATING ANEURYSMS AND DISSECTIONS
Moderators:Thomas S. Maldonado, MD / Nicholas J.W. Cheshire, MD
|
|
| x | |
| TREATMENT OF ILIAC ANEURYSMS AND IBDs | |
| 10:40 AM - 10:45 AM | Surprisingly, Occlusion Of 1 Or Both Hypogastric Arteries During EVAR Does NOT Result In Serious Adverse Events: From A Large VQI Study |
| Presenter(s):Heepeel Chang, MD | |
| View Slides in PDF | |
| 10:46 AM - 10:51 AM | Update On The Gore IBD Excluder For Treating Iliac Aneurysms And Preserving Hypogastric Artery Flow: Advantages And Limitations: From The European ICEBERG Registry |
| Presenter(s):Michel M.P. Reijnen, MD, PhD | |
| View Slides in PDF | |
| 10:52 AM - 10:57 AM | Experience With Cook IBD For The Treatment Of Common Iliac Aneurysms: Including After Previous EVAR And In Octogenarians |
| Presenter(s):Giovanni B. Torsello, MD | |
| View Slides in PDF | |
| 10:58 AM - 11:03 AM | Long-Term Comparison Of The Cook Zenith And Gore Excluder IBDs: Advantages And Limitations Of Both: What Is The Best Bridging Stent |
| Presenter(s):Giovanni Pratesi, MD | |
| View Slides in PDF | |
| 11:04 AM - 11:09 AM | An Iliac Customized Fenestrated Device (From Terumo Aortic): When And How Can It Work In Anatomies Unsuitable For Branched Endografts: Advantages And Limitations |
| Presenter(s):Fadi Taher, MD / Afshin Assadian, MD | |
| View Slides in PDF | |
| 11:10 AM - 11:15 AM | Advantages Of The Artivion (Formerly CryoLife/Jotec) IBD Device Now From Artivion For Treating Common And Internal Iliac Artery Aneurysms: When Bell Bottom Technique; When IBD |
| Presenter(s):Lee Bouwman, MD, PhD, MSc | |
| View Slides in PDF | |
| 11:16 AM - 11:22 AM | Panel Discussion |
| 11:22 AM - 11:27 AM | Systematic Review And Meta-Analysis Of The Multilayer Flow Modulating Bare Stent (From Cardiatis) For Complex Aortic Lesions: Early And Mid-Term Results Are Still Interesting: Does This Technology Have A Future |
| Presenter(s):George Geroulakos, MD, PhD | |
| View Slides in PDF | |
| 11:28 AM - 11:33 AM | Resurgence Of Interest In Uncovered Bare Stents As A Promising Treatment For Acute Aortic Dissections: What Is Their Future |
| Presenter(s):Rodney A. White, MD | |
| View Slides in PDF | |
| 11:34 AM - 11:39 AM | Role Of Bare Metal AMDS Stents From Artivion (Formerly CryoLife/Jotec) For Repair Of Acute Type A Dissections: Indications And Results |
| Presenter(s):Wilson Y. Szeto, MD / Grayson H. Wheatley, MD | |
| View Slides in PDF | |
| 11:40 AM - 11:45 AM | MLFM Bare Stents Will Be Effective Treatment For Aortic Dissections: How Extensive A Portion Of The Aorta Needs To Be Treated |
| Presenter(s):Claude D. Vaislic, MD | |
| View Slides in PDF | |
| 11:46 AM - 12:00 PM | Panel Discussion |
| 12:00 PM - 1:00 PM | Lunch Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 42 | |
| SESSION 43 SCHEDULE | |
|
Wednesday
SESSION 43:
MORE NEW DEVELOPMENTS IN AAA TREATMENT AND STANDARD EVAR: A NEW DEVICE TO SLOW AAA GROWTH; AAA NECK DILATATION AFTER EVAR; VALUE OF LOW PROFILE AAA ENDOGRAFTS; LINK TO CANCER; IMPROVED ULTRASOUND SURVEILLANCE AND ALL AAAs ARE NOT TIME BOMBS WAITING TO EXPLODE
Moderators:Thomas S. Maldonado, MD / Claude Mialhe, MD
|
|
| x | |
| 1:00 PM - 1:05 PM | Update On A Novel New Technology (Nectero) To Slow AAA Growth; How Does It Work And Early Clinical Results |
| Presenter(s):Venkatesh G. Ramaiah, MD | |
| View Slides in PDF | |
| AAA NECK BEHAVIOR AFTER EVAR | |
| 1:06 PM - 1:11 PM | Optimal Stent Design And Optimal Degree Of Oversizing To Avoid Neck Dilatation And Why It Matters |
| Presenter(s):Carlos F. Bechara, MD | |
| View Slides in PDF | |
| 1:12 PM - 1:17 PM | Aortic Neck Dilatation Is Different After F/EVAR And EVAR: What Is The Reason And Why Is It Important For Outcomes |
| Presenter(s):Thomas S. Maldonado, MD | |
| View Slides in PDF | |
| 1:18 PM - 1:23 PM | Major Aortic Neck Dilatation Occurs Equally After EVAR And Open Repair: From The DREAM RCT: This ONLY Occurs After EVAR With Self-Expanding Endografts |
| Presenter(s):Jan D. Blankensteijn, MD | |
| View Slides in PDF | |
| 1:24 PM - 1:29 PM | Do AAA Necks And Sacs Dilate After F/EVAR For Juxtarenal AAAs At 1 And 5 Years: What Are The Good Or Bad Consequences Of Neck And Sac Enlargement: What Can Be Done To Improve Results |
| Presenter(s):Benjamin W. Starnes, MD | |
| View Slides in PDF | |
| 1:30 PM - 1:35 PM | DEBATE: Low Profile Devices For EVAR Are Failing: Their Future Is Questionable |
| Presenter(s):Hence J.M. Verhagen, MD, PhD | |
| View Slides in PDF | |
| 1:36 PM - 1:41 PM | DEBATE: Not So: Ovation Stent-Grafts (From Endologix) Have Good 5-Year Results With No Neck Dilatation Or Migration Even With Challenging Neck Anatomy: Based On A Multicenter International Study Of A Low Profile Endograft |
| Presenter(s):Mahmoud B. Malas, MD, MHS | |
| View Slides in PDF | |
| 1:42 PM - 1:47 PM | Why We Need A New RCT Comparing EVAR With Watchful Surveillance In Women With Small AAAs |
| Presenter(s):Janet T. Powell, MD, PhD | |
| View Slides in PDF | |
| 1:48 PM - 1:53 PM | Causes And Treatment Of Ureter-To-Iliac Artery Fistula: When Open, When Endo Treatment And Results |
| Presenter(s):Piotr M. Kasprzak, MD | |
| View Slides in PDF | |
| 1:54 PM - 1:59 PM | Presenting Small AAAs As Ticking Time Bombs Or Unexploded Grenades Is Wrong-Headed And Harmful: Diameter-Based Indications For AAA Repair May Lead To Unnecessary Procedures |
| Presenter(s):Frank J. Criado, MD | |
| View Slides in PDF | |
| 2:00 PM - 2:06 PM | Panel Discussion |
| END OF SESSION 43 | |
| SESSION 44 SCHEDULE | |
|
Wednesday
SESSION 44:
MORE NEW DEVELOPMENTS IN AAAs: HOW DOES THROMBUS LOAD EFFECT PROGNOSIS AFTER EVAR AND EVAS; OTHER RELATED AAA TOPICS
Moderators:Ali F. AbuRahma, MD / Janet T. Powell, MD, PhD
|
|
| x | |
| AAA SAC THROMBUS LOAD | |
| 2:06 PM - 2:11 PM | Impact Of Thrombus In AAA Sac And Neck On AAA Behavior And EVAR Outcomes: How To Quantitate Thrombus Load And Distribution |
| Presenter(s):Nicos Labropoulos, BSc (Med), PhD, DIC, RVT | |
| View Slides in PDF | |
| 2:12 PM - 2:17 PM | DEBATE: Large Amount Of AAA Sac Thrombus Promotes Morbidity Without Rupture And With Rupture: By What Mechanisms Is Thrombus Harmful And How Can Thrombus Load Be Quantitated |
| Presenter(s):David H. Deaton, MD, FACS | |
| View Slides in PDF | |
| 2:18 PM - 2:23 PM | DEBATE: Large Flow Luminal Space In An AAA Sac With Minimal Mural Thrombus Is Associated With Adverse Events After EVAR: It Is More Important Than AAA Sac Size: Thrombus May Be Protective |
| Presenter(s):Hence J.M. Verhagen, MD, PhD | |
| View Slides in PDF | |
| OTHER AAA RELATED TOPICS | |
| 2:24 PM - 2:29 PM | Graft Infolding: A Unique EVAR Complication: How To Prevent It And How To Treat It |
| Presenter(s):Ashraf Mansour, MD | |
| View Slides in PDF | |
| 2:30 PM - 2:35 PM | Perioperative Mortality With F/EVAR And B/EVAR Is Inversely Related To Hospital Volume For These Procedures: What About Surgeon Volume From A National Audit Database |
| Presenter(s):Hence J.M. Verhagen, MD, PhD | |
| View Slides in PDF | |
| 2:36 PM - 2:41 PM | Favorable Anatomy For Endovascular Repair Is Preserved During Two Years Of Observation Of Small AAAs |
| Presenter(s):Jon S. Matsumura, MD | |
| View Slides in PDF | |
| 2:42 PM - 2:47 PM | 1-Year Sac Dynamics Predict Survival, Rupture And Need For Re-Intervention Long-Term After EVAR: Shrinkage Is Better Than Stable: Stable Is Better Than Expansion In Population Based Studies |
| Presenter(s):Marc L. Schermerhorn, MD | |
| View Slides in PDF | |
| 2:48 PM - 2:53 PM | Technical Tips To Perform SAFE Large Sheath Percutaneous Femoral Access For Complex AAA EVAR In Obese Or Scarred Groins – Even With Calcified Arteries |
| Presenter(s):Barend M.E. Mees, MD, PhD, FEBVS | |
| View Slides in PDF | |
| 2:54 PM - 2:59 PM | 4X Increased 18F FDG Uptake On PET CT In Female AAA Patients Compared To Males Indicates Increased Aortic Wall Inflammations: Does This Explain Increased Rupture Risk In Females: Implications For Treatment |
| Presenter(s):Natzi Sakalihasan, MD, PhD | |
| View Slides in PDF | |
| 3:00 PM - 3:06 PM | Panel Discussion |
| 3:06 PM - 3:15 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 44 | |
| SESSION 45 SCHEDULE | |
|
Wednesday
SESSION 45:
SHORT HOT AORTIC TOPICS (4 ¾-MINUTE FAST PACED TALKS
Moderators:Timothy A.M. Chuter, DM / Luis A. Sanchez, MD
|
|
| x | |
| 3:15 PM - 3:20 PM | Large Diameter AAA Necks (>34 mm) Negatively Impact Patient Survival After EVAR: Is Inflammation Involved: How Should Such Patients Be Treated |
| Presenter(s):Matt M. Thompson, MD | |
| View Slides in PDF | |
| 3:20 PM - 3:25 PM | A Large Proportion Of EVARs Are Performed On AAAs Smaller Than The SVS Guideline: What Is The Long-Term Effect And What Should Be Done About It |
| Presenter(s):Sal Scali, MD | |
| View Slides in PDF | |
| 3:25 PM - 3:30 PM | Late Delayed Renal Artery Revascularization After Inadvertent Occlusion For Many Days Is Worthwhile: Collaterals Keep The Kidney Viable Although No Urine Is Produced |
| Presenter(s):Nikolaos Tsilimparis, MD; PhD | |
| View Slides in PDF | |
| 3:30 PM - 3:35 PM | Giant Hypogastric Artery Aneurysms: Strategies And Techniques For Treating Them Endovascularly |
| Presenter(s):Jacques Busquet, MD | |
| View Slides in PDF | |
| 3:35 PM - 3:40 PM | Impact Of COVID, The NICE Guidelines And Changing Disease Patterns On AAA Practice In The UK |
| Presenter(s):Ian Loftus, MD / Pete Holt, MD, PhD | |
| View Slides in PDF | |
| 3:40 PM - 3:45 PM | TEVAR For Acute Complicated TBAD: Improved Outcomes When The Endograft Is Extended To Zone 2 Versus Zone 3: Why Is This So |
| Presenter(s):Jean M. Panneton, MD | |
| View Slides in PDF | |
| 3:45 PM - 3:50 PM | Long-Term Propensity Matched Comparison Of Open Repair And F/B/EVAR For Pararenal And Paravisceral AAAs |
| Presenter(s):Giovanni Tinelli, MD, PhD / Yamume Tshomba, MD | |
| View Slides in PDF | |
| 3:50 PM - 3:55 PM | Panel Discussion |
| 3:55 PM - 4:00 PM | Visceral Debranching With A Simple Aortic Endograft Is The Best Way To Treat TAAAs In Good Risk Patients: How To Do It Safely |
| Presenter(s):Guillermo A. Escobar, MD | |
| View Slides in PDF | |
| 4:00 PM - 4:05 PM | Shaggy Aortic Score: What Is It: How Is It Associated With Postoperative Lower Extremity Weakness After F/B/EVAR |
| Presenter(s):Jade S. Hiramoto, MD | |
| View Slides in PDF | |
| 4:05 PM - 4:10 PM | Laser In Situ F/EVAR As An Off-The-Shelf Option For Ruptured Complex Or Short Necked AAAs And Failed EVAR: Experience And Technical Tips |
| Presenter(s):Timothy A. Resch, MD, PhD | |
| View Slides in PDF | |
| 4:10 PM - 4:15 PM | Advantages And Disadvantages Of The BeGraft, BeGraft Plus (Bentley) And Advanta (iCAST™ – Getinge) Bridging Stents For F/B/EVAR: Experience With >2000 Target Vessels |
| Presenter(s):Eric L.G. Verhoeven, MD, PhD / Athanasios Katsargyris, MD | |
| View Slides in PDF | |
| 4:15 PM - 4:20 PM | Update On Performing EVAR With Only IVUS Guidance To Decrease Radiation: Technical Tips And 4-Year Results |
| Presenter(s):Jörg Tessarek, MD | |
| View Slides in PDF | |
| 4:20 PM - 4:25 PM | Risk Factors And Late Clinical Consequences Of AAA Neck Dilatation After EVAR With Self-Expanding Endografts: What Are The Differences In Neck Behavior After Excluder And Endurant Endografts |
| Presenter(s):Hence J.M. Verhagen, MD, PhD | |
| View Slides in PDF | |
| 4:25 PM - 4:35 PM | Panel Discussion |
| END OF SESSION 45 | |
| SESSION 46 SCHEDULE | |
|
Wednesday
SESSION 46:
MORE SHORT HOT NEW TOPICS RELATED TO AORTO-ILIAC AND CAROTID DISEASE AND THEIR TREATMENTS (4 ¾-MINUTE FAST PACED TALKS)
Moderators:Fred A. Weaver, MD, MMM / Michael L. Marin, MD
|
|
| x | |
| 4:35 PM - 4:40 PM | Are Low Profile Devices For EVAR And TEVAR Improving Or Worsening Outcomes |
| Presenter(s):Naoki Fujimura, MD, PhD | |
| View Slides in PDF | |
| 4:40 PM - 4:45 PM | Endovascular Repair Of Thoracic Aneurysms With TEVAR Outside IFUs: Value And Limitations: From A Multicenter Study |
| Presenter(s):Fabio Verzini, MD, PhD, FEBVS | |
| View Slides in PDF | |
| 4:45 PM - 4:50 PM | How To Avoid ‘Lost To Follow Up’ After Invasive Treatment Of AAAs And Why Is It Important |
| Presenter(s):Matthew W. Mell, MD, MS | |
| View Slides in PDF | |
| 4:50 PM - 4:55 PM | The VORTEC Technique For Revascularizing Hypogastric Arteries Without Clamping Or Suturing: How Does It Work And Advantages |
| Presenter(s):Zoran Rancic, MD, PhD, EMBA HSG / Mario L. Lachat, MD | |
| View Slides in PDF | |
| 4:55 PM - 5:00 PM | Impact Of Iliac Aneurysms On The Treatment Of Complex AAAs |
| Presenter(s):Matthew J. Eagleton, MD | |
| View Slides in PDF | |
| 5:00 PM - 5:05 PM | Isolated Iliac Artery AneurysmS Do NOT Need To Be Treated Until They Are At Least 4 Centimeters In Diameter |
| Presenter(s):Christopher J. Smolock, MD | |
| View Slides in PDF | |
| 5:05 PM - 5:10 PM | How To Safely Stent The Large Fenestration Of A ZFEN Endograft When It Is Crossed By Struts: Indications For Doing So And Late Results |
| Presenter(s):Luis A. Sanchez, MD | |
| View Slides in PDF | |
| 5:10 PM - 5:15 PM Power Point Presentation with Synched Audio |
3-Stage Concept For Treating Mega-Aortic Syndrome: Frozen Elephant Trunk (FET), TEVAR, Distal Open Repair: Results |
| Presenter(s):Martin Czerny, MD | |
| 5:15 PM - 5:20 PM | Panel Discussion |
| CAROTID RELATED TOPICS | |
| 5:20 PM - 5:25 PM | New Findings Regarding Carotid In-Stent Restenosis: What Is Its Rate Of Progression And Its Clinical Significance |
| Presenter(s):Zach AbuRahma, DO / Ali F. AbuRahma, MD | |
| View Slides in PDF | |
| 5:25 PM - 5:30 PM | Intracranial Angiography During TCAR: Technique And Value |
| Presenter(s):Peter L. Faries, MD, FACS | |
| View Slides in PDF | |
| 5:30 PM - 5:35 PM Power Point Presentation with Synched Audio |
Clinical Results Of A Micronet Covered Carotid-Stent (C-GUARD): Analysis Of 145 Patients At Two Sites: Advantages And Disadvantages |
| Presenter(s):Christian Wissgott, MD / Christoph Kopetsch, MD / Reimer Andresen, MD | |
| MORE AORTA RELATED TOPICS | |
| 5:35 PM - 5:40 PM | Improved Survival After Implementation Of A Large Scale Dedicated Network For Aortic Emergencies: Why The SOS Aorta System Works |
| Presenter(s):Jean-Marc Alsac, MD, PhD | |
| View Slides in PDF | |
| 5:40 PM - 5:45 PM | Physician Modified Gore C3 Excluder Endograft For TAAA Repair |
| Presenter(s):Wayne W. Zhang, MD | |
| View Slides in PDF | |
| 5:45 PM - 5:50 PM | The Sandwich-Periscope Technique For Left Subclavian Revascularization With Zone 2 TEVAR: It May Be The Best Way And How To Do It |
| Presenter(s):Sukgu Han, MD | |
| View Slides in PDF | |
| 5:50 PM - 5:55 PM | Role Of Endovascular And Open Treatment For Mid Aortic Syndrome In Children, Teenagers And Young Adults |
| Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS | |
| View Slides in PDF | |
| 5:55 PM - 6:00 PM | Supra-Aortic Trunk Revascularization Of Any Sort With TEVAR Increases Stroke Risk |
| Presenter(s):Mark K. Eskandari, MD | |
| View Slides in PDF | |
| 6:00 PM - 6:05 PM | An Unrecognized Mechanism For Causing Aortic Dissections: Shock Wave Energy Rather Than Increased Arterial Pressure Causes The Tear: How Does It Work And How To Decrease The Risk |
| Presenter(s):Erno Remsey-Semmelweis, MD | |
| View Slides in PDF | |
| 6:05 PM - 6:10 PM | Panel Discussion |
| 6:10 PM - 6:10 PM | End of Program F |
| END OF SESSION 46 | |
|
Thursday, November 17, 2022
Print Entire 2022 Program:
|
|
| SESSION 47 SCHEDULE | |
|
Thursday
SESSION 47:
EXCITING NEW OR REDISCOVERED TECHNIQUES, DEVICES OR CONCEPTS
|
|
| x | |
| 6:50 AM - 6:55 AM | Combating Bias In Medical And Vascular Studies And Therapeutic Decision Making: Why It Is Such A Big Deal And What To Do About It |
| Presenter(s):Matthew T. Menard, MD | |
| View Slides in PDF | |
| 6:56 AM - 7:01 AM | Update On Remote Monitoring Of Vascular Grafts: Where Is It At And Where Is It Going |
| Presenter(s):Richard F. Neville, MD | |
| View Slides in PDF | |
| 7:02 AM - 7:07 AM | New Wearable Technologies For Telemonitoring Vascular Diseases And Their Treatments: How Will Innovation Improve Care During And After The COVID-19 Pandemic |
| Presenter(s):Celia Riga, MD, FRCS | |
| View Slides in PDF | |
| 7:08 AM - 7:13 AM Power Point Presentation with Synched Audio |
Value Of Digital Health In Vascular Disease Management: Virtual And Otherwise |
| Presenter(s):Tony S. Das, MD | |
| 7:14 AM - 7:19 AM | Update On Tissue Engineered Biological Arterial Grafts (Humacyte): How Well Are They Working In Patients And In What Vascular Bed |
| Presenter(s):Todd E. Rasmussen, MD, FACS / Alexander Kersey, MD / Jeffrey H. Lawson, MD, PhD | |
| View Slides in PDF | |
| 7:20 AM - 7:25 AM | Why Carotid Plaque Morphology Differs In Patients With An Acute MI And Those With Intermittent Claudication: Why It Matters |
| Presenter(s):Henrik Sillesen, MD, DMSc | |
| View Slides in PDF | |
| 7:26 AM - 7:31 AM | Panel Discussion |
| 7:31 AM - 7:36 AM | Relining Occluded Vein Grafts With Viabahn (Gore) Stent-Grafts Or Supera (Abbott) Bare Stents Can Restore Patency And Avoid Thrombolysis: Techniques And Results |
| Presenter(s):Hans Lindgren, MD, PhD | |
| View Slides in PDF | |
| 7:37 AM - 7:42 AM | Measuring Aortic Diameters Is Inaccurate And Subjective: Even With Newer Imaging Technology, One Can Make The Diameter What You Want: What Are The Implications |
| Presenter(s):Janet T. Powell, MD, PhD | |
| View Slides in PDF | |
| 7:43 AM - 7:48 AM Power Point Presentation with Synched Audio |
Provider Skill Is Not Getting Appropriate Attention In The Health Care Value Equation Of Value = Outcome/Cost: What To Do About It |
| Presenter(s):Lars B. Lonn, MD, PhD | |
| View Slides in PDF | |
| 7:49 AM - 7:54 AM | Why Are Pig Organ Xenografts Now Feasible In Man: Update On Successes, Their Potential Role And What Are Their Limitations |
| Presenter(s):Robert A. Montgomery, MD, D.Phil | |
| View Slides in PDF | |
| 7:55 AM - 8:00 AM Power Point Presentation with Synched Audio |
Non-Compliant Endografts For TEVAR Have A Detrimental Effect On Systolic Blood Pressure And Cardiac Function; Compliant Endografts Are The Remedy |
| Presenter(s):Juan C. Parodi, MD | |
| 8:01 AM - 8:06 AM | Update On Isolated Limb Perfusion To Enable Amputated Limb Reimplantation |
| Presenter(s):Zachary M. Arthurs, MD | |
| View Slides in PDF | |
| 8:07 AM - 8:12 AM | Panel Discussion |
| END OF SESSION 47 | |
| SESSION 48 SCHEDULE | |
|
Thursday
SESSION 48:
PROGRESS IN FENESTRATED AND BRANCHED EVAR (F/B/EVAR) AND PARALLEL GRAFTS FOR COMPLEX AAAs AND TAAAs; AND RELATED TOPICS
|
|
| x | |
| 8:12 AM - 8:17 AM | The “Shaggy Aorta”: What Is It; How Is It Determined; How Shaggy Does It Have To Be To Matter |
| Presenter(s):Germano Melissano, MD | |
| View Slides in PDF | |
| 8:18 AM - 8:23 AM | The US Aortic Research Consortium (US-ARC): What Is It And How Can It Better Answer Questions About F/B/EVAR Like "Does The Aortic Neck Dilate After F/EVAR And If So, What Are Its Consequences" |
| Presenter(s):Andres Schanzer, MD | |
| View Slides in PDF | |
| 8:24 AM - 8:29 AM | Updated Experience With The STABILISE Technique For Acute And Subacute TBADs: Indications, Technical Tips, Precautions And Results |
| Presenter(s):Germano Melissano, MD / Andrea Kahlberg, MD / Roberto L.V. Chiesa, MD | |
| View Slides in PDF | |
| 8:30 AM - 8:35 AM | Branched EVAR For TAAA Repair Can Be Performed With Only Transfemoral Access Using Steerable Sheaths: How To Do It And What Is The Best Device For Stable Access |
| Presenter(s):Tilo Koelbel, MD, PhD | |
| View Slides in PDF | |
| 8:36 AM - 8:41 AM | With Steerable Sheaths Upper Extremity Access With B/EVAR Is Unnecessary: Which Sheath Is Best And Pitfalls To Be Avoided |
| Presenter(s):Eric L.G. Verhoeven, MD, PhD | |
| View Slides in PDF | |
| 8:42 AM - 8:47 AM | Why Balloon Expandable Bridging Stent-Grafts Are Best For F/B/EVAR: Which One Is Best And Why: A US Perspective |
| Presenter(s):Mark A. Farber, MD | |
| View Slides in PDF | |
| 8:48 AM - 8:53 AM | Why Balloon Expandable Bridging Stent-Grafts Are Best For F/B/EVAR: Which One Is Best And Why: A European Perspective |
| Presenter(s):Eric L.G. Verhoeven, MD, PhD | |
| View Slides in PDF | |
| 8:54 AM - 8:59 AM | What Is The Best Bridging Covered Stent (Stent-Graft) For F/B/EVAR Based On An In Vitro Fatigue Testing Model And Other Considerations |
| Presenter(s):Martin J. Austermann, MD / Giovanni B. Torsello, MD | |
| View Slides in PDF | |
| 9:00 AM - 9:05 AM Power Point Presentation with Synched Audio |
With Complex AAAs, When F/B/EVAR; When Parallel Grafts; When Open Repair: All Have Their Pros And Cons |
| Presenter(s):Chang Shu, MD | |
| View Slides in PDF | |
| 9:06 AM - 9:11 AM | How To Deal With Bad Necks In AAA Treatment: We Need All Options: Chimneys, Endoanchors, Fenestrated And Branched Solutions: Case Selection Is The Key: How To Do It |
| Presenter(s):Götz M. Richter, MD, PhD | |
| View Slides in PDF | |
| 9:12 AM - 9:17 AM | How To Simply, Safely And Effectively Treat TAAAs With Off-The-Shelf (OTS) Devices Including Chimney And Sandwich Stent-Grafts: The Docking Station And Staging Approach: How To Do It And Mid-Term Results |
| Presenter(s):Manish Mehta, MD, MPH | |
| View Slides in PDF | |
| 9:18 AM - 9:26 AM | Panel Discussion |
| 9:26 AM - 9:38 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 48 | |
| SESSION 49 SCHEDULE | |
|
Thursday
SESSION 49:
MORE PROGRESS IN F/B/EVAR AND PARALLEL GRAFTS FOR COMPLEX AAAs AND TAAAs; AND RELATED TOPICS
|
|
| x | |
| 9:38 AM - 9:43 AM | Does Aortic Neck Dilatation Occur After F/EVAR And Is It A Problem |
| Presenter(s):Michael P. Jenkins, MBBS, BSc, MS, FRCS, FEBVS | |
| View Slides in PDF | |
| 9:44 AM - 9:49 AM | Percutaneous Femoral And Axillary Access For Complex Endovascular AAA Repair: How To Do It Safely And To Safely Downsize Femoral Sheaths To Restore Lower Extremity Flow |
| Presenter(s):Darren B. Schneider, MD | |
| View Slides in PDF | |
| 9:50 AM - 9:55 AM | The Lobato Parallel Graft Technique For Type B Aortic Dissection Complicated With Thoracoabdominal Aortic Aneurysm And Total True Lumen Occlusion Of The Infrarenal Aorta |
| Presenter(s):Armando C. Lobato, MD, PhD | |
| View Slides in PDF | |
| 9:56 AM - 10:01 AM | Value And Advantages Of Preloaded Wires And Catheters For F/B/EVAR: How Do They Work; Are There Pitfalls |
| Presenter(s):Mark A. Farber, MD | |
| View Slides in PDF | |
| 10:02 AM - 10:07 AM | DEBATE: The Case Against Ch/EVAR And Parallel Grafts For Complex AAA And TAAA Repairs: F/B/EVAR Is Much Better |
| Presenter(s):Adam Beck, MD | |
| View Slides in PDF | |
| 10:08 AM - 10:13 AM | DEBATE: Nonsense! Ch/EVAR And Parallel Grafts If Done Right Are As Safe And Effective As F/B/EVAR And In Some Cases Better And Cheaper Safe And Effective As F/B/EVAR And In Some Cases Better And Cheaper |
| Presenter(s):Manish Mehta, MD, MPH | |
| View Slides in PDF | |
| 10:14 AM - 10:19 AM | Indications For And Challenges With Inner Branched B/EVAR: Why The Choice Of Bridging Grafts Matters In This Setting |
| Presenter(s):Eric L.G. Verhoeven, MD, PhD | |
| View Slides in PDF | |
| 10:20 AM - 10:25 AM | Pros And Cons Of Inner Versus Outer Branches In Off-The-Shelf Endovascular TAAA Repair |
| Presenter(s):Timothy A. Resch, MD, PhD | |
| View Slides in PDF | |
| 10:26 AM - 10:31 AM | Technical Tips To Deploy F/EVAR Endografts Precisely With Tortuous Anatomy: How To Compensate For Endograft Rotation And Still Match Fenestrations To Branch Orifices Perfectly |
| Presenter(s):Nuno V. Dias, MD, PhD / Bjõrn Sonesson, MD, PhD | |
| View Slides in PDF | |
| 10:32 AM - 10:57 AM | Advantages Of Steerable (Variable Curve) Sheaths For Complex AAA And TAAA Repairs And TBADs: Which One Is Best And Why: Pitfalls And How To Prevent Them |
| Presenter(s):W. Anthony Lee, MD | |
| View Slides in PDF | |
| 10:38 AM - 10:43 AM | Technical Tips And Precautions For Using Steerable (Variable Curve) Sheaths For B/EVAR: Why They May Not Work And How To Make Them Work |
| Presenter(s):Geert Willem H. Schurink, MD, PhD | |
| View Slides in PDF | |
| 10:44 AM - 10:52 AM | Panel Discussion |
| END OF SESSION 49 | |
| SESSION 50 SCHEDULE | |
|
Thursday
SESSION 50:
A TRIBUTE TO OUR MILITARY AND MILITARY PHYSICIANS: SOME MILITARY HISTORY; TREATMENT OF MILITARY AND CIVILIAN VASCULAR INJURIES AND CONTROL OF HEMORRHAGE; INNOVATIVE TECHNOLOGIES SUPPORTED BY THE DEFENSE DEPARTMENT
Moderators:Todd E. Rasmussen, MD, FACS / Brandon Propper, MD
|
|
| x | |
| 10:52 AM - 11:02 AM | The World War II Naval Battle At Guadalcanal And Its Impact On The US Navy & Marines And The Japanese Imperial Navy: A Turning Point |
| Presenter(s):Wayne F. Yakes, MD | |
| View Slides in PDF | |
| 11:03 AM - 11:08 AM | Department of Defense Effort To Support Vascular Surgery Research And US National Preparedness For Mass Casualties |
| Presenter(s):Todd E. Rasmussen, MD, FACS | |
| View Slides in PDF | |
| 11:09 AM - 11:24 AM Power Point Presentation with Synched Audio |
A Vascular Surgeon’s Impressions About War In The Ukraine (15-Minute Talk) |
| Presenter(s):Andriy O. Nykonenko, MD | |
| View Slides in PDF | |
| 11:25 AM - 11:30 AM | Update On REBOA (Resuscitative Endovascular Balloon Occlusion Of The Aorta) For Treatment Of Hemorrhage, Trauma And Other Conditions: What Is New And Different: When And Where Should It Be Used And By Whom |
| Presenter(s):Tal M. Hoerer, MD, PhD | |
| View Slides in PDF | |
| 11:31 AM - 11:36 AM | New Improvements In REBOA: How Will They Make It Worthwhile For Battlefield Hemorrhage |
| Presenter(s):Brandon Propper, MD / Zachary M. Arthurs, MD / Todd E. Rasmussen, MD, FACS | |
| View Slides in PDF | |
| 11:37 AM - 11:42 AM | How Will We Train The Next Generation Of Surgeons To Treat Vascular Trauma: For Military Practice: For Civilian Practice: What Issues Complicate It |
| Presenter(s):Paul W. White, MD | |
| View Slides in PDF | |
| 11:43 AM - 11:48 AM | What Vascular Injury Killed Martin Luther King, Jr. And Why He Might Have Survived Today |
| Presenter(s):Cynthia K. Shortell, MD | |
| View Slides in PDF | |
| 11:49 AM - 11:54 AM | Major Amputation Prosthetics Can Be Fixed Into Bone: How Does Osteointegration Work And How Is Infection Avoided |
| Presenter(s):Zachary M. Arthurs, MD / Todd E. Rasmussen, MD, FACS | |
| View Slides in PDF | |
| 11:55 AM - 12:00 PM | Panel Discussion |
| 12:00 PM - 1:00 PM | Lunch Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 50 | |
| SESSION 51 SCHEDULE | |
|
Thursday
SESSION 51:
PROGRESS IN THE TREATMENT OF RUPTURED INFRARENAL AAAs, COMPLEX AAAs, TAAAs AND RELATED TOPICS
|
|
| x | |
| 1:00 PM - 1:05 PM | Value, Limitations And Technical Tips For Using The Nellix Endograft For Ruptured AAAs |
| Presenter(s):Tal M. Hoerer, MD, PhD | |
| View Slides in PDF | |
| 1:06 PM - 1:11 PM | The Incidence Of Ruptured AAAs Is Decreasing And So Is Their Mortality: Why Are These 2 Facts So |
| Presenter(s):Ross Milner, MD | |
| View Slides in PDF | |
| 1:12 PM - 1:17 PM | Statins Decrease The Growth Rate And Rupture Risk Of AAAs As Well As The Perioperative Mortality: Statins Should Be Given To All AAA Patients: When And What Dose |
| Presenter(s):Thomas L. Forbes, MD | |
| View Slides in PDF | |
| 1:18 PM - 1:23 PM | A New System For Estimating AAA Wall Weakness From Gated Dynamic CT Scans: A Better Way To Predict Rupture Risk (From ViTAA Medical) |
| Presenter(s):Randy D. Moore, MD | |
| View Slides in PDF | |
| 1:24 PM - 1:29 PM | Long-Term Results Of The AJAX RCT Comparing EVAR With Open Repair For Ruptured AAAs: EVAR Wins In The End – Especially In Patients >80 |
| Presenter(s):Willem Wisselink, MD | |
| View Slides in PDF | |
| 1:30 PM - 1:35 PM | Variation In Use Of EVAR Versus Open Repair For Ruptured AAAs Depends On Training And Bias Rather Than Data, Logic Or Facts: EVAR Is Clearly The Best Treatment If It Can Be Done |
| Presenter(s):Martin Malina, MD, PhD | |
| View Slides in PDF | |
| 1:36 PM - 1:41 PM | EVAR Should Be The Standard Of Care For Most Ruptured AAAs: Reasons Why It Is Not So And How To Overcome Them |
| Presenter(s):Hans-Henning Eckstein, MD, PhD | |
| View Slides in PDF | |
| 1:42 PM - 1:47 PM | Outcomes Of Ruptured AAA Repair Are Better In High Volume Institutions Both For EVAR And Open Repair: From A Meta-Analysis With >120,000 Cases |
| Presenter(s):George A. Antoniou, M.D., PhD, MSc, FEBVS | |
| View Slides in PDF | |
| 1:48 PM - 1:53 PM | DEBATE: With Ruptured Complex AAAs And TAAAs, Off-The-Shelf F/B/EVAR Is The Best Treatment |
| Presenter(s):Mark A. Farber, MD | |
| View Slides in PDF | |
| 1:54 PM - 1:59 PM | DEBATE: Not So: With Ruptured Complex AAAs And TAAAs Parallel Grafts Are Simpler, More Effective And Less Costly |
| Presenter(s):Manish Mehta, MD, MPH | |
| View Slides in PDF | |
| 2:00 PM - 2:06 PM | Panel Discussion |
| END OF SESSION 51 | |
| SESSION 52 SCHEDULE | |
|
Thursday
SESSION 52:
MORE NEW DEVELOPMENTS IN RUPTURED AAAs AND TAAAs; WHAT IS AND WHAT SHOULD BE HAPPENING WITH AAA SCREENING
|
|
| x | |
| NEW DEVELOPMENTS IN AAA SCREENING | |
| 2:06 PM - 2:11 PM | Why The Current US PSTF Guidelines For AAA Screening Are Insufficient: Many At Risk Patients Are Not Screened |
| Presenter(s):Malachi Sheahan, MD | |
| View Slides in PDF | |
| 2:12 PM - 2:17 PM | Update On Current Screening For AAAs In The US: Most Ruptured AAAs Occur In Patients Not Being Screened: How Should US PSTF Recommendations Be Changed And How Should Screening Groups Be Expanded |
| Presenter(s):Marc L. Schermerhorn, MD / Thomas F.X. O'Donnell, MD | |
| View Slides in PDF | |
| 2:18 PM - 2:23 PM | New Developments In AAA Screening: What Is Its Value And Who Should Be Screened |
| Presenter(s):Jes S. Lindholt, MD | |
| View Slides in PDF | |
| MORE ABOUT AAA RUPTURES AND THEIR TREATMENT | |
| 2:24 PM - 2:29 PM | With Ruptured Abdominal Aortic Aneurysms: How To Decrease Turn Down Rates And Procedural Mortality By Greatly Decreasing Delays Before Treatment: How To Do It |
| Presenter(s):Maarit Venermo, MD, PhD | |
| View Slides in PDF | |
| 2:30 PM - 2:35 PM | AAA Rupture After EVAR Behaves Differently From De Novo Rupture: How Should Treatment Be Modified In Patients With Post EVAR Ruptures |
| Presenter(s):Piotr Szopinski, MD, PhD | |
| View Slides in PDF | |
| 2:36 PM - 2:41 PM | Update On Treating All (100%) Ruptured AAAs With EVAR: The Orebro/Zurich 12-Year Experience Shows It Is The Best Treatment And Lowers The Turndown Rate |
| Presenter(s):David T. McGreevy, MD / Thomas Larzon, MD, PhD / Mario L. Lachat, MD / Tal M. Hoerer, MD, PhD | |
| View Slides in PDF | |
| 2:42 PM - 2:47 PM | Applicability And Results Of Cook t-Branch OTS Endograft In Complex Aortic Aneurysms (Ruptured And Elective) With Narrow Internal Aortic Lumens: Advantages And Limitations |
| Presenter(s):Ciro Ferrer, MD, PhD / Rocco Giudice, MD | |
| View Slides in PDF | |
| 2:48 PM - 2:53 PM | In Situ Laser Fenestration To Facilitate Endograft Treatment Of Ruptured TAAAs: When Is It Needed; How To Do It And Results |
| Presenter(s):Stephan Haulon, MD / Dominique Fabre, MD, PhD | |
| View Slides in PDF | |
| 2:54 PM - 2:59 PM | Open Repair For AAAs Should Not Be Used In Patients >80 Unless Their AAA Is >6 cm And They Are At Risk Of Rupture Or Ruptured: These Restrictions Do Not Apply To EVAR |
| Presenter(s):Hence J.M. Verhagen, MD, PhD | |
| View Slides in PDF | |
| 3:00 PM - 3:05 PM | How Can The Turndown Rate For Invasive Treatment Of Ruptured AAAs Be Decreased And Is It Beneficial |
| Presenter(s):Matthew W. Mell, MD, MS | |
| View Slides in PDF | |
| 3:06 PM - 3:11 PM | Urgent And Emergent Treatment Of Symptomatic And Ruptured Thoracoabdominal And Juxtarenal Aortic Pathologies Using Physician Modified Stent-Graft Based On 3D Aortic Models |
| Presenter(s):Daniela Branzan, MD / Andrej Schmidt, MD | |
| View Slides in PDF | |
| 3:12 PM - 3:17 PM | Update On Advances In Treatment Of Abdominal Compartment Syndrome Associated With Ruptured AAAs: When And How To Treat Medically And When And How To Treat With Opening The Abdomen |
| Presenter(s):Martin Bjorck, MD, PhD | |
| View Slides in PDF | |
| 3:18 PM - 3:20 PM | Panel Discussion And Break Visit Exhibits and Pavilions (2nd and 3rd Floors) |
| END OF SESSION 52 | |
| SESSION 53 SCHEDULE | |
|
Thursday
SESSION 53:
EXCITING NEW OR UPDATED CONCEPTS, TECHNIQUES AND TREATMENTS
Moderators:Nicholas J.W. Cheshire, MD / Reese A. Wain, MD
|
|
| x | |
| 3:30 PM - 3:35 PM | The Spur Stent System (Reflow Medical): A Temporary Stent With Pins To Penetrate The Arterial Wall And Facilitate DCB Drug Delivery: How Does It Work And Results To Date |
| Presenter(s):Gunnar Tepe, MD / Marianne Brodmann, MD / Andrew Holden, MBChB / Thomas Zeller, MD | |
| View Slides in PDF | |
| 3:36 PM - 3:41 PM | The Serranator Balloon Catheter (From Cagent Vascular) For Vessel Prep In BTK Arteries: It Makes Microserrations And Prevents Dissections With PTA: Current Status: The PRELUDE BTK Trial |
| Presenter(s):Andrew Holden, MBChB | |
| View Slides in PDF | |
| 3:42 PM - 3:47 PM | The No Intervention Option For Treatment Is More Commonly Elected For Women Than Men With CLTI, AAAs, Ruptured AAAs And Thoracic Aneurysms: It Is Wrong Headed And Unfair |
| Presenter(s):Janet T. Powell, MD, PhD | |
| View Slides in PDF | |
| 3:48 PM - 3:53 PM | Update On The Retrievable Rescue Stent-Graft To Control Massive Aortic Or Caval Bleeding: How Does It Work, How Is The Device Retrieved And Present Status: How Can It Be Used For Elective Aortic Repair |
| Presenter(s):Bryan W. Tillman, MD, PhD | |
| View Slides in PDF | |
| 3:54 PM - 3:59 PM | Transradial Approaches For Abdominal And Lower Extremity Interventions Including CTOs And As An Adjunct For EVARs And TEVARs: How To Make Them Work And Advantages Of The Terumo R2P System |
| Presenter(s):David O'Connor, MD | |
| View Slides in PDF | |
| 4:00 PM - 4:05 PM | Improving The Function Of A Hybrid Room: What Are The Elements And How Does The OR Black Box System Help |
| Presenter(s):Isabelle Van Herzeele, MD, PhD | |
| View Slides in PDF | |
| 4:06 PM - 4:11 PM Power Point Presentation with Synched Audio |
Update On A Clampless Sutureless Technique For Performing Aorto-Iliac Anastomoses Using Endograft Connectors: The VORTEC Technique – Useful When Arterial Control And Suturing Is Impossible |
| Presenter(s):Mario L. Lachat, MD | |
| 4:12 PM - 4:17 PM | Endovascular Treatment Of Hepatic Artery Stenosis After Liver Transplantation: Indications, Techniques And Precautions To Make It Safe |
| Presenter(s):W. Charles Sternbergh III, MD | |
| View Slides in PDF | |
| 4:18 PM - 4:23 PM | Bariatric Left Gastric Artery Embolization Using The Novel Endobar Device For The Treatment Of Obesity: A Prospective Multicenter Randomized, Controlled IDE Trial |
| Presenter(s):Robert E. Beasley, MD, FSIR, FSCAI | |
| View Slides in PDF | |
| 4:24 PM - 4:29 PM | The Many Possible Uses Of Femoral Veins For Arterial Procedures: How To Harvest Them Safely And Expeditiously |
| Presenter(s):Timur P. Sarac, MD | |
| View Slides in PDF | |
| 4:30 PM - 4:38 PM | Panel Discussion |
| END OF SESSION 53 | |
| SESSION 54 SCHEDULE | |
|
Thursday
SESSION 54:
PROGRESS IN RADIATION SAFETY AND MORE NEW CONCEPTS, DEVICES AND TECHNIQUES
Moderators:Lindsay Machan, MD / Glenn Jacobowitz, MD
|
|
| x | |
| PROGRESS IN RADIATION SAFETY | |
| 4:38 PM - 4:43 PM | Endovascular Team Radiation Safety Performance: How To Monitor It: It Is More Than Dose Measurement |
| Presenter(s):Isabelle Van Herzeele, MD, PhD | |
| View Slides in PDF | |
| 4:44 PM - 4:49 PM | Myths And Facts Regarding Radiation Protection And Safety: Light Weight Leaded Gowns Offer Less Protection |
| Presenter(s):Lindsay Machan, MD | |
| View Slides in PDF | |
| 4:50 PM - 4:55 PM | What Is New In Radiation Safety: Modern Standards For Optimal Radiation Protection During Endovascular Procedures And The Role Of Radiation Protection Guidelines |
| Presenter(s):Bijan Modarai, PhD, FRCS | |
| View Slides in PDF | |
| 4:56 PM - 5:01 PM | Small Tips And Modifications In Radiation Safety Can Make A Huge Impact On Staff Exposure: What Are They |
| Presenter(s):Maarit Venermo, MD, PhD | |
| View Slides in PDF | |
| 5:02 PM - 5:05 PM | Panel Discussion |
| NEW CONCEPTS, ETC. | |
| 5:05 PM - 5:10 PM | With Esophageal Cancer, When Is Prophylactic TEVAR Indicated To Prevent An Aorto-Esophageal Fistula |
| Presenter(s):I-Hui Wu, MD, PhD | |
| View Slides in PDF | |
| 5:11 PM - 5:16 PM | Endovascular Emergency Treatment Of Carotid Blowout From Head And Neck Cancer Or Carotid Patch Infections: Planning, Preparation And Technical Tips Are Essential |
| Presenter(s):Michael B. Silva, Jr., MD | |
| View Slides in PDF | |
| 5:17 PM - 5:22 PM | What Is New In Gene And Stem Cell Therapy In 2022 |
| Presenter(s):Richard J. Powell, MD | |
| View Slides in PDF | |
| 5:23 PM - 5:28 PM | Minimizing Contrast Induced Nephropathy With EVAR By Contrast Dilution |
| Presenter(s):Naoki Fujimura, MD, PhD | |
| View Slides in PDF | |
| 5:29 PM - 5:34 PM | Endovascular Options For The Control Of Submassive Hemoptysis: When And How To Do It |
| Presenter(s):Jacob Cynamon, MD, FACR, FSIR | |
| View Slides in PDF | |
| 5:35 PM - 5:40 PM | Vascular Access Considerations For Children: How To Do It |
| Presenter(s):Dawn M. Coleman, MD | |
| View Slides in PDF | |
| 5:41 PM - 5:46 PM | Aortic Patch For Focal Aortic Lesions: A New Endovascular Approach: How Does It Work And What Is The Progress To Date |
| Presenter(s):Vicente Riambau, MD, PhD | |
| View Slides in PDF | |
| 5:47 PM - 5:52 PM | Current Status Of AFX-3 And Ovation (With Anatomy Adaptive Sealing) Endografts (Both From Endologix) For AAA Repairs: Advantages And Limitations Of Each |
| Presenter(s):Francesco Speziale, MD / Pasqualino Sirignano, MD | |
| View Slides in PDF | |
| 5:53 PM - 5:58 PM | From Concept To Company: The Challenges, The Pain, The Rewards And How To Do It |
| Presenter(s):Peter A. Schneider, MD | |
| View Slides in PDF | |
| 5:59 PM - 6:07 PM | Panel Discussion |
| 6:07 PM - 6:07 PM | End of Program G |
| END OF SESSION 54 | |
| SESSION 55 SCHEDULE | |
|
Thursday
SESSION 55:
NEW OR IMPROVED DEVICES FOR INFRARENAL AAA REPAIR WITH STANDARD EVAR (5-MINUTE TALKS)
|
|
| x | |
| 6:55 AM - 7:00 AM | Treo Endograft (Terumo Aortic) For Standard Infrarenal EVAR: Status Of Approval In US And Japan |
| Presenter(s):Matthew J. Eagleton, MD | |
| View Slides in PDF | |
| 7:01 AM - 7:06 AM | Real World Outcomes With The TREO Endograft (Terumo Aortic): Results From The TIGER Registry |
| Presenter(s):Vicente Riambau, MD, PhD | |
| View Slides in PDF | |
| 7:07 AM - 7:12 AM | Update On The Gore Conformable Excluder With Variable Neck Angulation Control For AAAs With Imperfect Necks In The US: Mid-Term Data And FDA Status |
| Presenter(s):Robert Y. Rhee, MD | |
| View Slides in PDF | |
| 7:13 AM - 7:18 AM | Status Of The Gore Conformable Excluder For EVAR In Europe: 2-Year Results From The EXCeL Registry With 150 Implants |
| Presenter(s):Marc R.H.M. van Sambeek, MD, PhD / Colin D. Bicknell, MD, FRCS | |
| View Slides in PDF | |
| 7:19 AM - 7:24 AM | Altura Endograft With Kissing Proximal Stents For Standard EVAR: Advantages And Limitations: From An Experience With 150 Patients And Up To 5-Year Follow-Up |
| Presenter(s):Dainis K. Krievins, MD | |
| View Slides in PDF | |
| 7:25 AM - 7:31 AM | Panel Discussion |
| 7:32 AM - 7:37 AM | Advantages And Limitations Of The Cook ZENITH Alpha (Low Profile) Endograft For EVAR: Based On 2-Year Results Of The European Multicenter ZEPHYR TRIAL |
| Presenter(s):Philippe W.M. Cuypers, MD, PhD / Marc R.H.M. van Sambeek, MD, PhD / Dittmar Boeckler, MD | |
| View Slides in PDF | |
| 7:38 AM - 7:43 AM Power Point Presentation with Synched Audio |
How And Why Do The Endurant Endograft Results For EVAR In France Differ From The Global Results: What Are The Implications |
| Presenter(s):Jean Pierre Becquemin, MD, FRCS | |
| 7:44 AM - 7:49 AM | AAA Repairs With The Endurant Endograft Outside The IFU Can Provide Acceptable Results In Some Patients: When Is This So And When Not: From The EAGLE Registry |
| Presenter(s):Marc R.H.M. van Sambeek, MD, PhD | |
| View Slides in PDF | |
| 7:50 AM - 7:55 AM | Head To Head Comparison Of Endurant And Excluder Endografts For EVAR In Challenging Asian AAA Anatomy |
| Presenter(s):Naoki Fujimura, MD, PhD | |
| View Slides in PDF | |
| 7:56 AM - 8:01 AM | Updated LEOPARD RCT Results Show That AFX Endografts Compare Favorably To Standard Proximally Fixed Endografts For AAA Repair |
| Presenter(s):Christopher J. Kwolek, MD, MBA | |
| View Slides in PDF | |
| 8:02 AM - 8:07 AM | AFX Endografts Work Well In Conical (Flared) AAA Necks: Why, Results And Are There Disadvantages |
| Presenter(s):Naoki Fujimura, MD, PhD | |
| View Slides in PDF | |
| 8:08 AM - 8:14 AM | Panel Discussion |
| END OF SESSION 55 | |
| SESSION 56 SCHEDULE | |
|
Thursday
SESSION 56:
NEW OR UPDATED DEVICES FOR STANDARD EVAR, EVAS (ENDOVASCULAR ANEURYSM SEALING) AND F/EVAR
Moderators:Cynthia K. Shortell, MD / Ramon Berguer, MD, PhD
|
|
| x | |
| 8:14 AM - 8:19 AM | Alto Endograft (From Endologix) For Standard EVAR: This Latest Modification Of The Ovation Endograft Has More Proximal Polymer Sealing Rings: Results From The ELEVATE Trial And 3-4-Year Results From The New Zealand Experience Show Advantages: What Is The JAGUAR RCT |
| Presenter(s):Sean P. Lyden, MD / Andrew Holden, MBChB | |
| View Slides in PDF | |
| 8:20 AM - 8:25 AM | Update On The Ovation/Alto Ultra Low-Profile Endograft (Now From Endologix): Advantages, Long-Term Results, New Modifications And Limitations |
| Presenter(s):Gianmarco de Donato, MD | |
| View Slides in PDF | |
| 8:26 AM - 8:31 AM | Experience With The Nellix Endograft In 120 Patients With Up To 10 Years Follow-Up: What Is The Device's Future |
| Presenter(s):Dainis K. Krievins, MD | |
| View Slides in PDF | |
| 8:32 AM - 8:37 AM | Novel 5-Branch Custom Made Endograft (From Cook) For Treating Type 1A Endoleaks After EVAR Or Open Repair With Short Aortic Body Grafts Below The Renal Arteries |
| Presenter(s):Piotr M. Kasprzak, MD | |
| View Slides in PDF | |
| 8:38 AM - 8:43 AM | Comparison Of Ch/EVAS And Ch/EVAR: When Is Ch/EVAS Indicated: Advantages And Limitations |
| Presenter(s):Barend M.E. Mees, MD, PhD, FEBVS | |
| View Slides in PDF | |
| 8:44 AM - 8:49 AM | Update On Multicenter Results With F/EVAR Using The Fenestrated Anaconda Endograft: Advantages And Limitations: From The Global FACT Registry |
| Presenter(s):Clark J. Zeebregts, MD, PhD / Michel M.P. Reijnen, MD, PhD | |
| View Slides in PDF | |
| 8:50 AM - 8:55 AM Power Point Presentation with Synched Audio |
Value Of The Fenestrated Anaconda Endograft For Treating Failed EVAR |
| Presenter(s):Fadi Taher, MD / Afshin Assadian, MD | |
| 8:56 AM - 9:01 AM | Update On The Incraft Endograft For Standard Infrarenal EVAR: Is Its Low Profile An Advantage |
| Presenter(s):Giovanni B. Torsello, MD / Jean Pierre Becquemin, MD, FRCS / Matteo Orrico, MD / Nicola Mangialardi, MD | |
| View Slides in PDF | |
| 9:02 AM - 9:07 AM | Are We Overtreating AAAs: Based On New Scrutiny Of Old Trials And Current Practice, And New Data On Rupture Risk |
| Presenter(s):Timothy A. Resch, MD, PhD | |
| View Slides in PDF | |
| 9:08 AM - 9:15 AM | Panel Discussion |
| 9:15 AM - 9:26 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 56 | |
| SESSION 57 SCHEDULE | |
|
Thursday
SESSION 57:
NEW OR IMPROVED DEVICES FOR THE ASCENDING AORTA, THE AORTIC ARCH OR NEAR THE ARCH
Moderators:Tilo Koelbel, MD, PhD / Rodney A. White, MD
|
|
| x | |
| 9:26 AM - 9:31 AM | Changes In The Aortic Valve And Aortic Morphometrics After Ascending Aorta And Arch Endograft Placement |
| Presenter(s):Jean Bismuth, MD / Ross Milner, MD | |
| View Slides in PDF | |
| 9:32 AM - 9:37 AM | Outcomes Of The Custom Relay Ascending Aorta Endograft (Terumo Aortic): The European Experience |
| Presenter(s):Vicente Riambau, MD, PhD / Afshin Assadian, MD / Mo S. Hamady, MD, FRCR, EBIR, FSIR | |
| View Slides in PDF | |
| 9:38 AM - 9:43 AM | Status In The US Of The Relay Branch Investigational Device For Repair Of Aortic Arch Lesions: How Many Branches Can And Should Be Revascularized: Advantages And Limitations |
| Presenter(s):Luis A. Sanchez, MD / Eric E. Roselli, MD | |
| View Slides in PDF | |
| 9:44 AM - 9:49 AM | Long-Term Safety And Durable Effectiveness Of Relay (Terumo Aortic) Scalloped Endograft For TEVAR Treatment Of Lesions In Or Near The Aortic Arch |
| Presenter(s):Mo S. Hamady, MD, FRCR, EBIR, FSIR / Jean-Marc Alsac, MD, PhD | |
| View Slides in PDF | |
| 9:50 AM - 9:55 AM | Nexus OTS Endograft From Endospan For Treating Zone 0 And 1 Lesions Of The Aortic Arch: How Does It Work And 3-Year Clinical Results: Status In The US |
| Presenter(s):Felice Pecoraro, MD / Mario L. Lachat, MD / Ross Milner, MD / Andrew Holden, MBChB / Daniel G. Clair, MD / Nicola Mangialardi, MD | |
| View Slides in PDF | |
| 9:56 AM - 10:01 AM | Status Of And When And How To Use The Gore Conformable CTAG Endograft With Variable Angulation Control Optimally: Advantages And Limitations |
| Presenter(s):Sukgu Han, MD | |
| View Slides in PDF | |
| 10:02 AM - 10:07 AM | Value Of Endo TAAA Repair In Patients With Connective Tissue Disorders And Why Is The Gap Between Fenestration And Aortic Wall Important In F/EVAR |
| Presenter(s):Gustavo S. Oderich, MD FACS | |
| View Slides in PDF | |
| 10:08 AM - 10:15 AM | Panel Discussion |
| END OF SESSION 57 | |
| SESSION 58 SCHEDULE | |
|
Thursday
SESSION 58:
NEW OR IMPROVED DEVICES FOR THORACIC AORTIC LESION REPAIRS WITH TEVAR, AND FOR THORACOABDOMINAL ANEURYSM (TAAA) REPAIRS (ALL TALKS ARE 4 ¾-MINUTES)
Moderators:Giovanni B. Torsello, MD / James F. McKinsey, MD
|
|
| x | |
| DEVICES FOR TEVAR | |
| 10:15 AM - 10:20 AM | Low Profile Devices For TEVAR: Disadvantages And Advantages Based On A 10-Year Experience |
| Presenter(s):Giovanni B. Torsello, MD | |
| View Slides in PDF | |
| 10:20 AM - 10:25 AM | Mid-Term Results With The Cook ZENITH Alpha Thoracic Endograft For TEVAR In 500 Patients In A Real World Experience |
| Presenter(s):Germano Melissano, MD / Roberto L.V. Chiesa, MD | |
| View Slides in PDF | |
| 10:25 AM - 10:30 AM | A Modified Candy Plug Technique For False Lumen Treatment After TEVAR For TBAD |
| Presenter(s):Ali Azizzadeh, MD | |
| View Slides in PDF | |
| 10:30 AM - 10:35 AM | Fenestrated Endovascular Aortic Repair Plus Chimney Graft For TAAA Repairs: The FEVARCh Technique |
| Presenter(s):Ross Milner, MD | |
| View Slides in PDF | |
| 10:35 AM - 10:40 AM | The Gore TAMBE Device: Lessons Learned To Facilitate Its Use For TAAA And Complex AAA Repairs |
| Presenter(s):Bernardo C. Mendes, MD | |
| View Slides in PDF | |
| 10:40 AM - 10:46 AM | Panel Discussion |
| 10:46 AM - 10:51 AM | The Relay Pro (Terumo Aortic) Endograft For TEVAR And Its Advantages In Treating TBADs: Why Is It Better Than The Older Relay Plus Device |
| Presenter(s):Steven D. Abramowitz, MD / Edward Y. Woo, MD | |
| View Slides in PDF | |
| 10:51 AM - 10:56 AM | Patient Specific Custom Designed Relay Pro Endografts (Terumo Aortic): How Do They Work And What Are Their Advantages In Various Circumstances |
| Presenter(s):David M. Williams, MD | |
| View Slides in PDF | |
| 10:56 AM - 11:01 AM Power Point Presentation with Synched Audio |
Relay Custom-Made Endografts (Terumo Aortic) For TEVAR: Why Do They Provide Better Wall Apposition For Sealing |
| Presenter(s):Fadi Taher, MD / Afshin Assadian, MD | |
| NEW OR IMPROVED ENDO DEVICES FOR TAAA REPAIRS | |
| 11:01 AM - 11:06 AM | The Novel Artivion (Formerly CryoLife/Jotec) Off-The-Shelf (OTS) Inner Branched Device For TAAAs: Why Is It Better Than Outer Branched OTS Devices: Are There Limitations |
| Presenter(s):Lee Bouwman, MD, PhD, MSc | |
| View Slides in PDF | |
| 11:06 AM - 11:11 AM | Colt Concept And Its Evolution Towards The Inner Branch Endograft For Complex AAAs: Colt 2.0: How It Works And Early Outcomes |
| Presenter(s):Piotr Szopinski, MD, PhD | |
| View Slides in PDF | |
| 11:12 AM - 11:17 AM | Panel Discussion |
| 11:17 AM - 11:22 AM | To Treat Complex TAAAs: Combination Of Relay (Terumo) TEVAR And Fenestrated And Branched EVAR Is Best: Technical Tips And Outcomes |
| Presenter(s):Mo S. Hamady, MD, FRCR, EBIR, FSIR | |
| View Slides in PDF | |
| 11:22 AM - 11:27 AM | Target Vessel Outcomes With The Cook t-Branch OTS Endograft For TAAA Repair At 2 Years From A Multicenter Registry – Which Stent-Graft Types Are Better For Which Vessels |
| Presenter(s):Nikolaos Tsilimparis, MD; PhD | |
| View Slides in PDF | |
| 11:27 AM - 11:32 AM | Experience With The Cook t-Branch OTS Endograft Device For Juxta- And Pararenal AAAs: Advantages And Limitations |
| Presenter(s):Matteo Orrico, MD / Nicola Mangialardi, MD | |
| View Slides in PDF | |
| 11:32 AM - 11:37 AM | Comparison Of 3 OTS Endografts For Urgent TAAA Repairs: TAMBE (Gore) Versus E-nside (Jotec) Versus t-Branch (Cook): Advantages And Disadvantages Of Each |
| Presenter(s):Luca Bertoglio, MD / Roberto L.V. Chiesa, MD / Germano Melissano, MD | |
| View Slides in PDF | |
| 11:37 AM - 11:42 AM | Valiant Manifold OTS Endograft Device (Medtronic) For Repairing TAAAs: How Does It Work; Update On Clinical Experience And Future Prospects |
| Presenter(s):Murray L. Shames, MD | |
| View Slides in PDF | |
| 11:42 AM - 11:47 AM | Innovative Treatment Of Thoracoabdominal And Pararenal Aortic Aneurysms Using Treovance Endografts (Terumo) And Parallel VBX Stent-Grafts (Gore) |
| Presenter(s):James F. McKinsey, MD | |
| View Slides in PDF | |
| 11:48 AM - 11:53 AM | Is There A Role For Hyperbaric Oxygen Therapy In Preventing Or Treating Spinal Cord Ischemia After TAAA Repair |
| Presenter(s):Thomas F. Lindsay, MDCM, FRCS | |
| View Slides in PDF | |
| 11:53 AM - 12:00 PM | Panel Discussion |
| 12:00 PM - 1:00 PM | Lunch Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 58 | |
| SESSION 59 SCHEDULE | |
|
Thursday
SESSION 59:
NEW OR UPDATED INFORMATION ON MRI SAFETY WITH COVERED STENTS, A NEW EMBOLIC AGENT FOR BLEEDING, LOWER EXTREMITY PROSTHETIC GRAFTS, PERIGRAFT SEROMA AND VALUE OF A PROSTHETIC PERIGRAFT SIROLIMUS PATCH (SEE ALSO SESSION 28)
Moderators:Ali F. AbuRahma, MD / Patrick J. Lamparello, MD
|
|
| x | |
| 1:00 PM - 1:05 PM | Safety Of MRI Early After Deployment Of Various Covered Stents |
| Presenter(s):Maria A. Ruffino, MD, EBIR, FCIRSE | |
| View Slides in PDF | |
| A NEW EMBOLIC AGENT | |
| 1:06 PM - 1:11 PM | A New Liguid Embolic Agent (Lava LES) To Control Bleeding; How Does It Work And Pivotal Trial Results |
| Presenter(s):Mahmood Razavi, MD | |
| View Slides in PDF | |
| PROSTHETIC GRAFTS | |
| 1:12 PM - 1:17 PM | 3-Year Results Of The ZILVERPASS RCT Comparing Prosthetic PTFE Bypasses With Zilver PTX (Cook) Stents To Treat Long Fempop Lesions: Clinical And Financial Results And Their Implications |
| Presenter(s):Michel J. Bosiers, MD / Marc Bosiers, MD | |
| View Slides in PDF | |
| 1:18 PM - 1:23 PM | The 3DH Spiral Flow Prosthetic Graft: Does It Prevent Neointimal Hyperplasia In Leg Bypasses Or A-V Access |
| Presenter(s):Hosam F. El Sayed, MD | |
| View Slides in PDF | |
| 1:24 PM - 1:29 PM | Heparin Coated (Propaten) PTFE Grafts (Gore) Versus Autologous Vein Grafts For Bypasses To Targets Above And Below The Knee: Are The Heparin Coated Grafts Better And Worth The Cost |
| Presenter(s):David J. Dexter, MD | |
| View Slides in PDF | |
| 1:30 PM - 1:35 PM | Perigraft Seromas After PTFE Lower Extremity And Aortic Arterial Grafts: Frequency, Etiology And What To Do About Them |
| Presenter(s):Jae S. Cho, MD | |
| View Slides in PDF | |
| 1:36 PM - 1:41 PM | Update On External Sirolimus Patch Wrap-Arounds For PTFE Graft Anastomoses: Do They Decrease Neointimal Hyperplasia |
| Presenter(s):Sriram S. Iyer, MD; FACC | |
| 1:42 PM - 1:48 PM | Panel Discussion |
| END OF SESSION 59 | |
| SESSION 60 SCHEDULE | |
|
Thursday
SESSION 60:
NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ATHERECTOMY, STENTS, TACKS, ACCESSORIES, ETC. (SEE ALSO SESSIONS 23-27)
Moderators:Kenneth Ouriel, MD, MBA / Enrico Ascher, MD
|
|
| x | |
| 1:48 PM - 1:53 PM | Value And Limitations Of The Rotarex Device (From BD) For Atherectomy, Clot Removal And Treating ISR |
| Presenter(s):Miguel F. Montero, MD | |
| View Slides in PDF | |
| ATHERECTOMY RELATED TOPICS | |
| 1:54 PM - 1:59 PM | Atherectomy: When Is It The Best Vessel Prep: What Are Its Complications: How To Prevent And Treat Them |
| Presenter(s):Theodosios Bisdas, MD | |
| View Slides in PDF | |
| 2:00 PM - 2:05 PM | Value And Limitations Of 355 nm Auryon B-Laser™ (From AngioDynamics): It Enables Safe Crossing Of Difficult Lesions Not Crossed With A Guidewire: How Does It Work And Clinical Results |
| Presenter(s):Luis R. Leon, MD, RVT, FACS | |
| View Slides in PDF | |
| 2:06 PM - 2:11 PM | Orbital And Laser Atherectomy: Indications, Advantages And Precautions With Above And Below Knee De Novo Lesions And ISR |
| Presenter(s):Craig M. Walker, MD | |
| View Slides in PDF | |
| 2:12 PM - 2:17 PM | The Value Of Atherectomy And DCBs As Demonstrated By The Results Of The REALITY Trial |
| Presenter(s):Brian G. DeRubertis, MD | |
| View Slides in PDF | |
| ANCILLARY TECHNIQUES | |
| 2:18 PM - 2:23 PM | Value Of Wingman Catheter (Reflow Medical) For Crossing Difficult Lesions: How Does It Work And Results |
| Presenter(s):John R. Laird, MD | |
| View Slides in PDF | |
| 2:24 PM - 2:29 PM | Value Of New Dedicated Special Tools And Devices To Facilitate Trans-Radial Access For Lower Extremity Lesion Treatments: How Far Distally Can They Be Effective |
| Presenter(s):Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi) | |
| View Slides in PDF | |
| 2:30 PM - 2:36 PM | Panel Discussion |
| NEW INFORMATION ON STENTS | |
| 2:36 PM - 2:41 PM | Advantages Of Supera (Vasculomimetic – VMI) Stent For Complex Fempop Occlusive Lesions: Technical Tips: They Work Even In The Subintimal Position |
| Presenter(s):Erwin Blessing, MD | |
| View Slides in PDF | |
| 2:42 PM - 2:47 PM | Value Of The Supera VMI Stent For Common Femoral Artery (CFA) Occlusive Lesions: Better Than Endarterectomy: 2-Year Results And Status Of The SUPERSURG RCT (Versus Open Surgery) |
| Presenter(s):Yann Gouëffic, MD, PhD / Koen R. Deloose, MD | |
| View Slides in PDF | |
| 2:48 PM - 2:53 PM | Temporary Stent Assisted DCB Angioplasty In BTK Lesions: Update On The DEEPER OUS Trial |
| Presenter(s):Thomas Zeller, MD | |
| View Slides in PDF | |
| 2:54 PM - 2:59 PM | Value And Advantages Of Eluvia DESs (Boston Scientific) For Lower Extremity Occlusive Lesions: When To Use Them And How To Optimize Their Results |
| Presenter(s):Steven Kum, MD | |
| View Slides in PDF | |
| 3:00 PM - 3:05 PM | RCT Comparing A New Bare Metal Stent – Misago Versus Zilver PTX DESs For Fempop Lesions: 2-Year Results Of The BATTLE Trial: Misago Stents Can Be Deployed Via Radial Access |
| Presenter(s):Yann Gouëffic, MD, PhD | |
| View Slides in PDF | |
| 3:06 PM - 3:12 PM | Panel Discussion |
| 3:12 PM - 3:24 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 60 | |
| SESSION 61 SCHEDULE | |
|
Thursday
SESSION 61:
NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ANGIOPLASTY BALLOONS
Moderators:John R. Laird, MD / Thomas Zeller, MD
|
|
| x | |
| 3:24 PM - 3:29 PM | 3-Year Results Of TOBA II BTK Trial Of The Tack Device To Decrease Dissections With Balloon Angioplasty Of BTK Lesions Show Safety And 80% Patency |
| Presenter(s):Patrick J. Geraghty, MD | |
| View Slides in PDF | |
| 3:30 PM - 3:35 PM | Value Of High-Pressure Non-Compliant Balloons For BTK Arterial Lesion Treatment: Why They Work Better And Other Technical Tips |
| Presenter(s):Steven Kum, MD | |
| View Slides in PDF | |
| 3:36 PM - 3:41 PM | Update On The TANGO Trial Using The Bullfrog Balloon Device (Mercator Medical Systems) To Inject Sirolimus Drug Into Lesion Wall Before Angioplasty: How Does It Work And Updated Results |
| Presenter(s):William A. Gray, MD | |
| View Slides in PDF | |
| 3:42 PM - 3:47 PM | Value Of The Passeo-18Lux DCB For Treating BTK Lesions With Or Without Bare Metal Stents |
| Presenter(s):Gunnar Tepe, MD | |
| View Slides in PDF | |
| 3:48 PM - 3:53 PM Power Point Presentation with Synched Audio |
Unfavorable Balloon (Candy) Wrap Can Cause Dissections With Angioplasty: What Is The Mechanism: How Can It Be Recognized And Dissection Avoided |
| Presenter(s):Jos C. van den Berg, MD, PhD | |
| 3:54 PM - 3:59 PM | The Importance Of Dissection In Angioplasty Treatment Of BTK Lesions: How To Prevent And Treat Such Dissections: The Value Of Tacks (From Intact Vascular): How Do They Work |
| Presenter(s):Andrew Holden, MBChB | |
| View Slides in PDF | |
| 4:00 PM - 4:05 PM | Chocolate Touch DCBs (From TriReme Medical): How Do They Work, Advantages And Updated Clinical Results |
| Presenter(s):Andrew Holden, MBChB | |
| View Slides in PDF | |
| 4:06 PM - 4:12 PM | Panel Discussion |
| END OF SESSION 61 | |
| SESSION 62 SCHEDULE | |
|
Thursday
SESSION 62:
NEW OR IMPROVED DEVICES AND TECHNIQUES TO PREVENT OR TREAT ENDOLEAKS OR DEVICE MIGRATION: ENDOANCHORS, ETC.
Moderators:William D. Jordan Jr., MD / Jean-Paul de Vries, MD, PhD
|
|
| x | |
| 4:12 PM - 4:17 PM | Everything I Learned In Training Was Wrong: Endoanchors Work For Short Necks |
| Presenter(s):Mathew D. Wooster, MD, MBA | |
| View Slides in PDF | |
| 4:18 PM - 4:23 PM | New Developments From The ANCHOR Registry With Over 5 Years Of Follow-Up Show The Value Of Endoanchors When Used Prophylactically For Certain Indications Prevent Endoleaks And Migration: Large Diameter Necks Are One Of Those Indications |
| Presenter(s):William D. Jordan Jr., MD | |
| View Slides in PDF | |
| 4:24 PM - 4:29 PM | New Developments From The ANCHOR Registry With >5 Years Follow-Up Show That Endoanchors Can Be Used To Treat Endoleaks And Migration Effectively In Hostile Neck Anatomy: The Proof |
| Presenter(s):Jean-Paul de Vries, MD, PhD | |
| View Slides in PDF | |
| 4:30 PM - 4:35 PM | Vesteck – The Next Generation Of Endoanchor (Endosuturing) Technology: How Does It Work And Where Does It Stand |
| Presenter(s):David H. Deaton, MD, FACS | |
| View Slides in PDF | |
| 4:36 PM - 4:41 PM | Balloon Optimized Molding For Better Deployment And Sealing Of Ovation Alto Low Profile Endografts For EVAR: How To Do It And How It Helps Prevent Endoleaks And Migration |
| Presenter(s):David J. Minion, MD | |
| View Slides in PDF | |
| 4:42 PM - 4:48 PM | Panel Discussion |
| END OF SESSION 62 | |
| SESSION 63 SCHEDULE | |
|
Thursday
SESSION 63:
NEW OR IMPROVED ENDOVASCULAR DEVICES FOR CLOT REMOVAL OR EMBOLIZATION (SEE ALSO SESSION 30)
|
|
| x | |
| CLOT REMOVING DEVICES | |
| 4:48 PM - 4:53 PM | Percutaneous Embolectomy Or Thrombectomy With The Indigo System (From Penumbra): What Makes It Different, Technical Tips, Results And Limitations |
| Presenter(s):David J. Dexter, MD | |
| View Slides in PDF | |
| 4:54 PM - 4:59 PM | Newer Pharmaco-Mechanical Endovascular Clot Removal Systems: When And Why Is Each Device Best To Use |
| Presenter(s):Guillermo A. Escobar, MD | |
| View Slides in PDF | |
| 5:00 PM - 5:05 PM | Catheter Based Vacuum Assisted Thrombectomy For Acute Limb Ischemia: How Does It Work: Advantages And Limitations: From A Multicenter Study: Key Findings From The INDIAN Trial |
| Presenter(s):Carlo Setacci, MD / Gianmarco de Donato, MD | |
| View Slides in PDF | |
| VASCULAR OCCLUSIVE DEVICES | |
| 5:06 PM - 5:11 PM | Technical Tips For Effective Coil Embolization: Importance Of Dense Packing; Why Non-Fibered Coils Are Better Than Fibered Coils |
| Presenter(s):James F. Benenati, MD / Constantino Pena, MD | |
| View Slides in PDF | |
| 5:12 PM - 5:17 PM | Why Ruby Coils, The Penumbra Occlusion Device (POD) And Packing Coils Have Different Uses And Why They Are Valuable And Cost Effective For Different Lesions: Technical Tips For Optimizing |
| Presenter(s):Sean P. Lyden, MD | |
| View Slides in PDF | |
| 5:18 PM - 5:23 PM | Caterpillar™ Embolic Plug (From Bard): How Does It Work: Advantages And Clinical Results |
| Presenter(s):Andrew Holden, MBChB | |
| View Slides in PDF | |
| 5:24 PM - 5:29 PM | How To Treat Type 1A Endoleaks And Enlarging TBAD False Lumens With Ruby Coils: When Will They Work; When Will They Not: Technical Tips |
| Presenter(s):Mazin Foteh , MD | |
| View Slides in PDF | |
| 5:30 PM - 5:35 PM | How To Insert Large Vessel Embolization Devices (PODs) Through Low Profile Access |
| Presenter(s):Frank R. Arko, MD | |
| View Slides in PDF | |
| 5:36 PM - 5:41 PM | Newer Vascular Occlusion Devices: Caterpillar And Azur Devices: Advantages And Limitations |
| Presenter(s):Karthik Kasirajan, MD | |
| View Slides in PDF | |
| 5:42 PM - 5:52 PM | Panel Discussion |
| 5:52 PM - 5:52 PM | End of Program H |
| END OF SESSION 63 | |
| SESSION 64 SCHEDULE | |
|
Thursday
SESSION 64:
VENOUS CLINICAL EXAMINATION AND HEMODYNAMICS
|
|
| x | |
| 7:00 AM - 7:04 AM | Introduction To Veins At VEITH |
| Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT | |
| 7:05 AM - 7:10 AM | AVF CEAP Revision And Workbook |
| Presenter(s):Marc A. Passman, MD | |
| View Slides in PDF | |
| 7:11 AM - 7:16 AM | CEAP, VCSS, HASTI: Their Significance And How To Utilize |
| Presenter(s):Lowell S. Kabnick, MD, FACS, FAVLS | |
| View Slides in PDF | |
| 7:17 AM - 7:22 AM | Physiology Of Venous Return |
| Presenter(s):Brajesh K. Lal, MD | |
| View Slides in PDF | |
| 7:23 AM - 7:28 AM | Causation Of Symptoms In C0 Patients: Implications For Therapy |
| Presenter(s):Marc A. Passman, MD | |
| View Slides in PDF | |
| 7:29 AM - 7:34 AM | Evaluation Of Venous Reflux: Going Beyond The Reflux Duration |
| Presenter(s):Nicos Labropoulos, BSc (Med), PhD, DIC, RVT | |
| View Slides in PDF | |
| 7:35 AM - 7:40 AM | Hemodynamics Of Reflux |
| Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT | |
| View Slides in PDF | |
| 7:41 AM - 7:46 AM | An Algorithm To Predict Disease Severity In C2 Patients |
| Presenter(s):Mikel Sadek, MD | |
| View Slides in PDF | |
| 7:47 AM - 7:52 AM | Pathophysiology Of Varicose Veins: Evidence Summary |
| Presenter(s):Thomas W. Wakefield, MD | |
| View Slides in PDF | |
| 7:53 AM - 7:58 AM | The Importance Of Glycocalyx: Veins And Lymphatics |
| Presenter(s):Joseph D. Raffetto, MD | |
| View Slides in PDF | |
| 7:59 AM - 8:04 AM | Saphenous And Sural Nerve Anatomy |
| Presenter(s):Jean Luc Gerard, MD | |
| View Slides in PDF | |
| 8:05 AM - 8:10 AM | Genetics In Varicose Vein Disease |
| Presenter(s):Sarah Onida, MD, PhD | |
| View Slides in PDF | |
| 8:11 AM - 8:16 AM | Quality Of Life Tools Reflect Disease Severity, But They Can Be Improved |
| Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh, F | |
| View Slides in PDF | |
| 8:17 AM - 8:22 AM | Panel Discussion |
| END OF SESSION 64 | |
| SESSION 65 SCHEDULE | |
|
Thursday
SESSION 65:
VENOUS AND LYMPHATIC, IMAGING, AND BIOLOGY
Moderators:Antonios P. Gasparis, MD / Joseph D. Raffetto, MD
|
|
| x | |
| 8:23 AM - 8:28 AM | Identifying Reflux Pathways With Duplex Ultrasound Mapping |
| Presenter(s):Neil M. Khilnani, MD | |
| View Slides in PDF | |
| 8:29 AM - 8:34 AM | How Common Are And Why Care About Ancillary Findings During Lower Extremity Venous Duplex Imaging |
| Presenter(s):Michael C. Dalsing, MD | |
| View Slides in PDF | |
| 8:35 AM - 8:40 AM | Duplex Imaging: Is It Helpful For Reticular Or Telangiectatic Veins |
| Presenter(s):Pauline Raymond-Martimbeau, MD, CRF, FAVLS, DABVLM | |
| View Slides in PDF | |
| 8:41 AM - 8:46 AM | Ambulatory Venous Pressure, Air Plethysmography, And The Role Of Calf Venous Pump In Chronic Venous Disease |
| Presenter(s):Taimur Saleem, MD / Seshadri Raju, MD | |
| View Slides in PDF | |
| 8:47 AM - 8:52 AM | Role Of Foot Static Disorders In Chronic Venous Disease |
| Presenter(s):Nicos Labropoulos, BSc (Med), PhD, DIC, RVT | |
| View Slides in PDF | |
| 8:53 AM - 8:58 AM | Inflammation And CVD |
| Presenter(s):Joseph D. Raffetto, MD | |
| View Slides in PDF | |
| 8:59 AM - 9:04 AM | Does Deep Venous Reflux Matter With Superficial Ablation |
| Presenter(s):Mikel Sadek, MD | |
| View Slides in PDF | |
| 9:05 AM - 9:10 AM | Genetics Involving Venous Leg Ulcers |
| Presenter(s):Joseph D. Raffetto, MD | |
| View Slides in PDF | |
| 9:11 AM - 9:16 AM | Pharmacologic And Cell Based Therapies For Lymphedema |
| Presenter(s):Monika L. Gloviczki, MD, PhD | |
| View Slides in PDF | |
| 9:17 AM - 9:22 AM | Superficial Venous Disease Versus Outflow Obstruction: Treat Which First And Why |
| Presenter(s):Antonios P. Gasparis, MD | |
| View Slides in PDF | |
| 9:23 AM - 9:28 AM | Panel Discussion |
| END OF SESSION 65 | |
| SESSION 66 SCHEDULE | |
|
Thursday
SESSION 66:
SUPERFICIAL VEIN TREATMENT STRATEGIES AND TECHNIQUES
|
|
| x | |
| 9:29 AM - 9:34 AM | Results Of The Recent Randomized Controlled Superficial Venous Device Trials And Their Importance |
| Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh, F | |
| View Slides in PDF | |
| 9:35 AM - 9:40 AM | “Choosing Wisely” Items For Chemical Or Thermal Ablation In The Treatment Of The Incompetent Saphenous Veins And Recurrence |
| Presenter(s):Claudine M. Hamel-Desnos, MD | |
| 9:41 AM - 9:46 AM | Rethinking Endovenous Techniques To Define Cost-Effectiveness |
| Presenter(s):Armando Mansilha, MD, PhD, FEBVS | |
| View Slides in PDF | |
| 9:47 AM - 9:52 AM | Saphenous Sparing: Instructions For Users |
| Presenter(s):B. Erika Mendoza Borrmann, MD, PhD | |
| View Slides in PDF | |
| 9:53 AM - 9:58 AM | Thermal Saphenous Vein Recanalization: Risk Factors |
| Presenter(s):Omar L. Esponda, MD | |
| View Slides in PDF | |
| 9:59 AM - 10:04 AM | What Drugs Do I Recommend For Symptomatic Venous Disease |
| Presenter(s):Jorge H. Ulloa, MD, FACS | |
| View Slides in PDF | |
| 10:05 AM - 10:10 AM | Ablative Procedures And Cost Effectiveness |
| Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh, F | |
| View Slides in PDF | |
| 10:11 AM - 10:16 AM | Chronic Venous Disease And Diabetic Microangiopathy: Pathophysiology And Commonalities |
| Presenter(s):Armando Mansilha, MD, PhD, FEBVS | |
| View Slides in PDF | |
| 10:17 AM - 10:22 AM | Anterior Accessory Saphenous Vein Ablation: Our Experience And Should We Continue |
| Presenter(s):John F. Charitable, MD | |
| View Slides in PDF | |
| 10:23 AM - 10:28 AM | Saphenous Ablation On Anticoagulation; Is It Safe, Effective And Durable |
| Presenter(s):Glenn Jacobowitz, MD | |
| View Slides in PDF | |
| 10:24 AM - 10:29 AM | Panel Discussion |
| END OF SESSION 66 | |
| SESSION 67 SCHEDULE | |
|
Thursday
SESSION 67:
TRUNCAL ABLATION OF THE SAPHENOUS VENOUS SYSTEM
Moderators:Edward G. Mackay, MD / Cees H.A. Wittens, MD, PhD
|
|
| x | |
| THERMAL AND NON-THERMAL TRUNCAL VEIN ABLATION I | |
| 10:35 AM - 10:40 AM | Decision Making In Saphenous Ablation: What To Use When |
| Presenter(s):Ellen D. Dillavou, MD | |
| View Slides in PDF | |
| 10:41 AM - 10:46 AM | HIFU: Is It Ready For Prime Time |
| Presenter(s):Mark S. Whiteley, MS, FRCS | |
| View Slides in PDF | |
| 10:47 AM - 10:52 AM | Which Variables In Superficial Venous Interventions Will Improve QOL? |
| Presenter(s):Cees H.A. Wittens, MD, PhD | |
| View Slides in PDF | |
| 10:53 AM - 10:58 AM | Tips, Tricks And Limitations: Perforator Ablation |
| Presenter(s):Steve Elias, MD | |
| View Slides in PDF | |
| 10:59 AM - 11:04 AM | Tips, Tricks And Limitations: Varithena |
| Presenter(s):Edward G. Mackay, MD | |
| View Slides in PDF | |
| 11:05 AM - 11:10 AM | Tips, Tricks, And Limitations: Ultrasound Guided Foam Sclerotherapy |
| Presenter(s):Jean Luc Gerard, MD | |
| View Slides in PDF | |
| 11:11 AM - 11:16 AM | Panel Discussion |
| THERMAL AND NON-THERMAL ABLATION II | |
| Moderator(s): Lowell S. Kabnick, MD, FACS, FAVLS / Alan M. Dietzek, MD, RPVI, FACS | |
| 11:17 AM - 11:22 AM | Tips, Tricks, And Limitations: Liquid Sclerotherapy |
| Presenter(s):Victor M. Canata, MD, PhD | |
| View Slides in PDF | |
| 11:23 AM - 11:28 AM | Tips, Tricks And Limitations: ClariVein |
| Presenter(s):Steve Elias, MD | |
| View Slides in PDF | |
| 11:29 AM - 11:34 AM | Tips, Tricks And Limitations: Laser Truncal Ablation |
| Presenter(s):Lowell S. Kabnick, MD, FACS, FAVLS | |
| View Slides in PDF | |
| 11:35 AM - 11:40 AM | Tips, Tricks And Limitations: Radiofrequency Ablation |
| Presenter(s):Alan M. Dietzek, MD, RPVI, FACS | |
| View Slides in PDF | |
| 11:41 AM - 11:46 AM | Tips, Tricks And Limitations: Phlebectomy |
| Presenter(s):Gutenberg A. Gurgel, MSc, MD | |
| View Slides in PDF | |
| 11:47 AM - 11:52 AM | Tips, Tricks And Limitations: Venaseal |
| Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh, F | |
| View Slides in PDF | |
| 11:53 AM - 11:58 AM | Superficial Devices In Clinical Trials (Before Governmental Approval) |
| Presenter(s):Lowell S. Kabnick, MD, FACS, FAVLS | |
| View Slides in PDF | |
| 11:59 AM - 12:04 PM | Safety And Efficacy Of Endovenous Ablations In Octogenarians, Nonagenarians, And Centenarians |
| Presenter(s):Anil P. Hingorani, MD / Enrico Ascher, MD | |
| View Slides in PDF | |
| 12:05 PM - 12:10 PM | SVT Management: Anything New In 2022 |
| Presenter(s):Manj S. Gohel, MD, FRCS, FEBVS | |
| View Slides in PDF | |
| 12:11 PM - 12:16 PM | Panel Discussion |
| 12:17 PM - 12:45 PM | Lunch Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 67 | |
| SESSION 68 SCHEDULE | |
|
Thursday
SESSION 68:
SPIDER VEINS, TRUNCAL VEINS, TRIBUTARY VEINS, PELVIC VEIN TREATMENT
|
|
| x | |
| 12:45 PM - 12:50 PM | Foam Therapies (PCF Versus PEM): When To Use And Does It Make A Difference |
| Presenter(s):Edward G. Mackay, MD | |
| View Slides in PDF | |
| 12:51 PM - 12:56 PM | Risks And Contraindications Of Medical Compression Treatment - A Critical Reappraisal - An International Consensus Statement |
| Presenter(s):Mark H. Meissner, MD | |
| View Slides in PDF | |
| 12:57 PM - 1:02 PM | Randomized Controlled Study Of EVLA And Foam In The SSV-Fovelass Study: 3-Year Results |
| Presenter(s):Claudine M. Hamel-Desnos, MD | |
| 1:03 PM - 1:08 PM | CLACS In Paraguay Results Of The Aesthetic Phlebology Trial |
| Presenter(s):Victor M. Canata, MD, PhD | |
| View Slides in PDF | |
| 1:09 PM - 1:14 PM | Which Saphenous Vein Recanalization Should Be Treated |
| Presenter(s):Kathleen D. Gibson, MD | |
| View Slides in PDF | |
| 1:15 PM - 1:20 PM | Pelvic Origin Labial And Leg Varices: Choices And How I Do It |
| Presenter(s):Aleksandra Jaworucka-Kaczorowska, MD, PhD | |
| View Slides in PDF | |
| 1:21 PM - 1:26 PM | Is Combination Therapy Laser And Sclerotherapy More Efficacious For Telangiectatic Treatment |
| Presenter(s):Gutenberg A. Gurgel, MSc, MD | |
| View Slides in PDF | |
| 1:27 PM - 1:32 PM | How To Treat Pelvic Veins: Top Down Or Bottom Up |
| Presenter(s):Aleksandra Jaworucka-Kaczorowska, MD, PhD | |
| View Slides in PDF | |
| 1:33 PM - 2:38 PM | Panel Discussion |
| END OF SESSION 68 | |
| SESSION 69 SCHEDULE | |
|
Thursday
SESSION 69:
VENOUS SOCIETAL AND GOVERNANCE
Moderators:Kathleen J. Ozsvath, MD / Mark D. Iafrati, MD
|
|
| x | |
| 1:39 PM - 1:44 PM | What Happened With 2022 CMS Reimbursement And The Future |
| Presenter(s):John Blebea, MD, MBA | |
| View Slides in PDF | |
| 1:45 PM - 1:50 PM | Economic Venous Reimbursement Impact: Now And Through 2025 |
| Presenter(s):John Blebea, MD, MBA | |
| View Slides in PDF | |
| 1:51 PM - 1:56 PM | The Future Of Venous Reimbursement: Non CMS Insurance |
| Presenter(s):Mark D. Iafrati, MD | |
| View Slides in PDF | |
| 1:57 PM - 2:02 PM | What Evidence Is There For Compression Prior To Insurance Approval |
| Presenter(s):Omar L. Esponda, MD | |
| View Slides in PDF | |
| 2:03 PM - 2:08 PM | Who Should Fund The Management Of C2 Disease And Why |
| Presenter(s):Sarah Onida, MD, PhD | |
| View Slides in PDF | |
| 2:09 PM - 2:14 PM | The Irony Of Overtreatment And Undertreatment In Venous Disease: What Can Be Done |
| Presenter(s):Manj S. Gohel, MD, FRCS, FEBVS | |
| View Slides in PDF | |
| 2:15 PM - 2:20 PM | Tackling The “Grey Areas” Of Appropriate Use For Chronic Venous Disease |
| Presenter(s):Elna M. Masuda, MD | |
| View Slides in PDF | |
| 2:21 PM - 2:26 PM | AVF Venous Patient Outreach Survey |
| Presenter(s):Lowell S. Kabnick, MD, FACS, FAVLS | |
| View Slides in PDF | |
| 2:27 PM - 2:32 PM | Insurance Coverage Gaps In Venous Disease |
| Presenter(s):Kathleen J. Ozsvath, MD | |
| View Slides in PDF | |
| 2:33 PM - 2:38 PM | Focused Practice Designation – Venous Disease Treatment |
| Presenter(s):Brajesh K. Lal, MD | |
| View Slides in PDF | |
| 2:39 PM - 2:44 PM | Prior Authorization As A Utilization Management Tool For Elective Superficial Venous Procedures Is Worthless |
| Presenter(s):Todd Berland, MD | |
| View Slides in PDF | |
| 2:45 PM - 2:50 PM | Panel Discussion |
| END OF SESSION 69 | |
| SESSION 70 SCHEDULE | |
|
Thursday
SESSION 70:
MORE SUPERFICIAL VEIN TREATMENT STRATEGIES AND TECHNIQUES
Moderators:Raghu Kolluri, MD / Anil P. Hingorani, MD
|
|